WO2021230382A1 - (-)-enantiomer of triazole derivative, agricultural or horticultural chemical, and industrial material protectant - Google Patents

(-)-enantiomer of triazole derivative, agricultural or horticultural chemical, and industrial material protectant Download PDF

Info

Publication number
WO2021230382A1
WO2021230382A1 PCT/JP2021/018610 JP2021018610W WO2021230382A1 WO 2021230382 A1 WO2021230382 A1 WO 2021230382A1 JP 2021018610 W JP2021018610 W JP 2021018610W WO 2021230382 A1 WO2021230382 A1 WO 2021230382A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
phenyl
alkyl
enantiomer
halogen
Prior art date
Application number
PCT/JP2021/018610
Other languages
French (fr)
Japanese (ja)
Inventor
朋之 高下
竜行 越山
Original Assignee
株式会社クレハ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社クレハ filed Critical 株式会社クレハ
Publication of WO2021230382A1 publication Critical patent/WO2021230382A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647Triazoles; Hydrogenated triazoles
    • A01N43/6531,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P1/00Disinfectants; Antimicrobial compounds or mixtures thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P3/00Fungicides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Definitions

  • the present invention relates to a triazole derivative (-)-enantiomer, and an agricultural and horticultural agent containing the triazole derivative as an active ingredient, and an industrial material protective agent.
  • Patent Document 1 discloses a novel triazole derivative which is an active ingredient of an agricultural and horticultural drug.
  • the present invention has been made in view of the above problems, and an object thereof is to provide a compound having high antibacterial activity against plant diseases, which can be expected to have a high control effect against plant diseases even at a low application amount. To do.
  • the compound according to the present invention is a (-)-enantiomer of a triazole derivative represented by the following general formula (I) or a pesticide-acceptable salt thereof.
  • R 1 is -OR 4 or -NR 5 R 6 ;
  • R 4 , R 5 and R 6 are independently hydrogen, C 1- C 6 -alkyl group, C 2- C 6 -alkenyl group, C 2- C 6 -alkynyl group, C 3- C 8 -cyclo.
  • Alkyne group C 3- C 8 -cycloalkyl-C 1- C 4 -alkyl group, phenyl group, phenyl-C 1- C 4 -alkyl group, phenyl-C 2- C 4 -alkenyl group or phenyl-C 2 -C 4- It is an alkynyl group, and R 5 and R 6 may form a ring; Here, the aliphatic groups in R 4 , R 5 and R 6 may have 1, 2, 3 or the maximum possible number of the same or different groups R a , where R a is a halogen group.
  • cyano group, nitro group, C 1 -C 4 - alkoxy and C 1 -C 4 - is selected from haloalkoxy groups independently of each other;
  • R 2 is a halogen group, a cyano group, a nitro group, a phenyl group, a phenyl-oxy group, a C 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group, a C 1- C 4 -alkoxy group, and a C 1-.
  • R 3 is a halogen group, a cyano group, a nitro group, an amino group, a phenyl group, a phenyl-oxy group, a C 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group, and a C 1- C 4 -alkoxy group.
  • C 1 -C 4 - haloalkoxy group, C 1 -C 4 - alkylamino group, C 1 -C 4 - dialkylamino group, C 1 -C 4 - alkyl acyl amino group, in -SOR 7 or -SF 5 can be;
  • the cycloalkyl and phenyl group moieties in R 4 , R 5 , and R 6 and the phenyl group moieties in R 3 have 1, 2, 3, 4, 5 or the maximum number of possible identical or different groups R b .
  • R b is halogen, cyano, nitro, C 1 -C 4 - alkyl group, C 1 -C 4 - alkoxy group, C 1 -C 4 - haloalkyl and C 1 -C 4- Selected independently of each other from the haloalkoxy group;
  • R 7 is, C 1 -C 4 - alkyl group or a C 1 -C 4 - haloalkyl group;
  • n is 0,1,2,3, or 4;
  • m is 1,2,3,4 or 5
  • An asterisk (*) refers to an asymmetric carbon atom. ]
  • the (-)-enantiomer of the triazole derivative according to the present invention has an excellent bactericidal action against many bacteria that cause diseases to plants even at a low application amount.
  • Triazole derivative enantiomer The (-)-enantiomer of the triazole derivative according to the present embodiment is the (-)-enantiomer (hereinafter, triazole derivative (-) in the triazole derivative represented by the following general formula (I) (hereinafter referred to as triazole derivative (I))). ) -Called an enantiomer).
  • the asterisk (*) in the following general formula (I) refers to an asymmetric carbon atom.
  • the "(-)-enantiomer” refers to an enantiomer that rotates the vibration plane of the linearly polarized light of the sodium D line to the left
  • the "(+)-enantiomer” refers to the sodium D line. Refers to an enantiomer that rotates the vibrating plane of linearly polarized light to the right.
  • R 1 is -OR 4 or -NR 5 R 6 , preferably -OR 4 .
  • R 4 , R 5 and R 6 are independently hydrogen, C 1- C 6 -alkyl group, C 2- C 6 -alkenyl group, C 2- C 6 -alkynyl group, C 3- C 8 -cyclo. Alkyl group, C 3- C 8 -cycloalkyl-C 1- C 4 -alkyl group, phenyl group, phenyl-C 1- C 4 -alkyl group, phenyl-C 2- C 4 -alkenyl group or phenyl-C 2 -C 4 -Alkynyl group.
  • R 5 and R 6 may form a ring together with the nitrogen atom to which R 5 and R 6 are bonded.
  • C 1 -C 6 - alkyl group is a straight chain or branched chain alkyl group with a carbon number 1-6, for example, a methyl group, an ethyl group, a 1-methylethyl group, 1,1-dimethyl Ethyl group, propyl group, 1-methylpropyl group, 2-methylpropyl group, 1,1-dimethylpropyl group, 2,2-dimethylpropyl group, 1-ethylpropyl group, butyl group, 1-methylbutyl group, 2- Methylbutyl group, 3-methylbutyl group, 3,3-dimethylbutyl group, 2,2-dimethylbutyl group, 1,1-dimethylbutyl group, 1-ethylbutyl group, 2-ethylbutyl group, pentyl group, 1-methylpentyl group , 2-Methylpentyl group, 3-methylpentyl group and 4-methylpentyl group.
  • C 2 -C 6 - alkenyl group is a linear or branched alkenyl group having a carbon atom is 2-6, for example, ethenyl, 2-propenyl group, 1-methyl-2-propenyl group , 2-Methyl-2-propenyl group, 1-butenyl group, 2-butenyl group, 3-methyl-2-butenyl group, 1-methyl-2-butenyl group, 3-butenyl group, 1-pentenyl group, 2- Examples include a pentanyl group, a 1-hexenyl group and a 5-hexenyl group.
  • C 2 -C 6 - alkynyl group a linear or branched chain alkynyl group having a carbon atom is 2-6, for example, ethynyl group, 1-propynyl, 2-propynyl, 1-butynyl Examples include groups, 2-butynyl groups, 3-butynyl groups, pentynyl groups and 1-hexynyl groups.
  • the C 3- C 8 -cycloalkyl group is a cyclic alkyl having 3 to 8 carbon atoms, and examples thereof include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, and a cyclooctyl group. Be done.
  • the C 3- C 8 -cycloalkyl-C 1- C 4 -alkyl group consists of a cyclic cycloalkyl group having 3 to 8 carbon atoms and a linear or branched-chain alkyl group having 1 to 4 carbon atoms. Indicates that they are combined. For example, cyclopropylmethyl group, cyclobutylmethyl group, cyclopentylmethyl group, cyclohexylmethyl group, 2-cyclopropylethyl group, 1-cyclopropylethyl group, 2-cyclohexylethyl group, 3-cyclopropylpropyl group, 2-cyclo Examples thereof include a propylpropyl group and a 4-cyclopropylbutyl group.
  • the phenyl-C 1- C 4 -alkyl group is a linear or branched alkyl group having 1 to 4 carbon atoms substituted with a phenyl group, for example, a phenylmethyl group, a 2-phenylethyl group, and the like. Examples include 3-phenylpropyl group and 4-phenylbutyl group.
  • the phenyl-C 2- C 4 -alkenyl group has a linear or branched alkenyl group having 2 to 4 carbon atoms bonded to the phenyl group, for example, a phenylethenyl group or a phenyl-1-propenyl.
  • Groups include groups, phenylisopropenyl groups, and phenylbutenyl groups.
  • the phenyl-C 2- C 4 -alkynyl group has an alkynyl group having 2 to 4 carbon atoms bonded to the phenyl group, and is, for example, a phenylethynyl group, a phenyl-1-propynyl group, or a phenyl-2-propynyl group. , Phenyl-1-butynyl group, phenyl-2-butynyl group, and phenyl-3-butynyl group.
  • R 4 is preferably, C 1 -C 6 - alkyl group.
  • the aliphatic groups in R 1 , R 4 , R 5 and R 6 may have 1, 2, 3 or the maximum possible number of the same or different groups R a , where R a is a halogen group. , cyano group, nitro group, C 1 -C 4 - independently of each other selected from haloalkoxy group - alkoxy group and C 1 -C 4.
  • halogen group examples include a chlorine group, a bromine group, an iodine group or a fluorine group.
  • a chloromethyl group, a 2-chloroethyl group, a 2,3-dichloropropyl group, a bromomethyl group, a chlorodifluoromethyl group, a trifluoromethyl group, and a 3,3,3-trifluoropropyl group can be mentioned.
  • C 1 -C 4 - alkoxy group is a linear or branched alkoxy group having 1 to 4 carbon atoms, e.g., methoxy, ethoxy, n- propoxy, isopropoxy, n- butoxy Examples include a group, a sec-butoxy group, and a tert-butoxy group.
  • halogen groups may be the same or different.
  • R 2 is a halogen group, a cyano group, a nitro group, a phenyl group, a phenyl-oxy group, a C 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group, a C 1- C 4 -alkoxy group, and a C 1 -C 4 -haloalkoxy group, -SOR 7 or -SF 5 .
  • Halogen C 1 -C 4 - alkyl group, C 1 -C 4 - haloalkyl group, C 1 -C 4 - alkoxy groups, and C 1 -C 4 - haloalkoxy group, an organic group represented by R a
  • R a The groups mentioned as an example of the above can be mentioned.
  • R 2 is preferably a halogen group, a cyano group, C 1 -C 4 - alkyl group, C 1 -C 4 - haloalkyl group, C 1 -C 4 - alkoxy group, an -SOR 7, or -SF 5, more preferably, a halogen group, a cyano group, C 1 -C 4 - alkoxy group - alkyl group, C 1 -C 4 - haloalkyl group or a C 1 -C 4.
  • R 7 is, C 1 -C 4 - alkyl group or a C 1 -C 4 - haloalkyl group.
  • the substitution position of R 2 is the 2nd, 3rd, 5th or 6th position, preferably the 2nd position.
  • n is 0, 1, 2, 3 or 4, preferably 1.
  • R 3 is a halogen group, a cyano group, a nitro group, an amino group, a phenyl group, a phenyl-oxy group, a C 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group, and a C 1- C 4 -alkoxy group.
  • C 1 -C 4 - haloalkoxy group C 1 -C 4 - alkylamino group, C 1 -C 4 - dialkylamino group, C 1 -C 4 - alkyl acyl amino group, -SOR 7, or -SF 5 Yes
  • the halogen group, C 1- C 4 -alkyl C 1- C 4 -haloalkyl group, C 1- C 4 -alkoxy group or C 1- C 4 -halo alkoxy group, and -SOR 7 are represented by R 2. Examples of the organic groups mentioned above can be mentioned.
  • R 3 is preferably a halogen group, a nitro group, an amino group, C 1 -C 4 - alkyl group, C 1 -C 4 - haloalkyl group, C 1 -C 4 - alkoxy group, C 1 -C 4 - halo alkoxy groups, C 1 -C 4 - alkylamino group, C 1 -C 4 - dialkylamino group, C 1 -C 4 - alkyl acyl amino group, an -SOR 7, or -SF 5, more preferably a halogen group , C 1- C 4 -alkyl group, C 1- C 4 -haloalkyl group, C 1- C 4 -alkoxy group or C 1- C 4 -haloalkoxy group.
  • C 1 -C 4 - alkylamino group is one of an amino group substituted with a straight-chain or branched alkyl group having 1 to 4 carbon atoms of the hydrogen atom of the amino group, e.g., methylamino
  • Examples include groups, ethylamino groups, n-propylamino groups, isopropylamino groups, and tert-butylamino groups.
  • C 1 -C 4 - dialkylamino group is an amino group in which a hydrogen atom of two co-having amino group substituted by a straight or branched chain alkyl group having 1 to 4 carbon atoms, e.g., N , N-dimethylamino group, N, N-diethylamino group, N, N-di-n-propylamino group, N, N-diisopropylamino group, and N, N-di-tert-butylamino group.
  • C 1 -C 4 - alkyl acyl amino group it is one or two amino groups substituted with a linear or branched alkyl acyl group of 1 to 4 carbon atoms of the hydrogen atom of the amino group
  • Examples thereof include N, N-di-n-propyl acylamino groups, N, N-diisopropyl acylamino groups, and N, N-di-tert-butyl acylamino groups.
  • the cycloalkyl or phenyl group moiety in R 4 , R 5 , R 6 or the phenyl group moiety in R 3 has 1, 2, 3, 4, 5 or the maximum number of possible identical or different groups R b .
  • R b is halogen, cyano, nitro, C 1 -C 4 - alkyl group, C 1 -C 4 - alkoxy group, C 1 -C 4 - haloalkyl and C 1 -C 4- Selected independently of each other from the haloalkoxy group.
  • R 1 is located at -OR 4;
  • R 2 is halogen, cyano, C 1 -C 4 - Alkoxy group, C 1- C 4 -haloalkyl group, C 1- C 4 -alkoxy group, -SOR 7 or -SF 5 ;
  • R 3 is halogen group, nitro group, cyano group, amino group, C 1- C 4 - alkyl group, C 1 -C 4 - haloalkyl group, C 1 -C 4 - alkoxy group, C 1 -C 4 - haloalkoxy group, C 1 -C 4 - alkylamino group, C 1 -C 4 - dialkylamino group, C 1 -C 4 - alkyl acyl amino group, an -SOR 7, or -SF 5, triazole derivative (-) - include enantiomers.
  • R 1 is -OR 4 and R 4 is a C 1- C 6 -alkyl group
  • R 2 is a halogen group, a cyano group, a C 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group or a C 1- C 4 -alkoxy group
  • R 3 is a halogen group, a cyano group, C.
  • Examples thereof include a triazole derivative (-)-enantiomer which is a 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group, a C 1- C 4 -alkoxy group or a C 1- C 4-haloalkoxy group.
  • a triazole derivative (-)-enantiomer which is a 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group, a C 1- C 4 -alkoxy group or a C 1- C 4-haloalkoxy group.
  • Agriculturally acceptable salts of triazole derivative (-)-enantiomers in particular salts of these cations or acids thereof, whose cations and anions do not adversely affect the action of the triazole derivative (-)-enantiomer.
  • Suitable cations are particularly ammonium ions of alkali metals (preferably sodium and potassium), alkaline earth metals (preferably calcium, magnesium and barium), transition metals (preferably manganese, copper, zinc and iron) and also.
  • 1 to 4 C 1 -C if desired 4 - alkyl substituents and / or one phenyl substituent or benzyl substituent optionally may ammonium ions (preferably diisopropyl ammonium have, tetramethylammonium, tetrabutylammonium, trimethylbenzylammonium), furthermore phosphonium ions, sulfonium ions (preferably tri (C 1 -C 4 - alkyl) sulfonium), and sulfoxonium ions (preferably tri (C 1 -C 4 - alkyl) sulfonium It is also (xonium).
  • ammonium ions preferably diisopropyl ammonium have, tetramethylammonium, tetrabutylammonium, trimethylbenzylammonium
  • phosphonium ions preferably tri (C 1 -C 4 - alkyl) sulfonium
  • the anions of useful acid addition salts are mainly chloride ion, bromide ion, fluoride ion, hydrogen sulfate ion, sulfate ion, dihydrogen phosphate ion, hydrogen phosphate ion, phosphate ion, nitrate ion, bicarbonate.
  • These can be formed by reacting the triazole derivative (-)-enantiomer with the corresponding anionic acid (preferably hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid or nitric acid).
  • Triazole derivative (-)-Production method of enantiomer [1. Preparation of triazole derivative (-)-enantiomer by optical resolution]
  • the triazole derivative (-)-enantiomer can be obtained by preparative separation from the racemate of the triazole derivative (I).
  • the racemate of the triazole derivative (I) can be obtained, for example, according to the method described in Patent Document 1.
  • the obtained triazole derivative is a racemate.
  • Examples of the method for separating enantiomers include a method for separating by chiral chromatography. Specifically, amylostris (3,5-dimethylphenylcarbamate), cellulosetris (3,5-dimethylphenylcarbamate), cellulosetris (3,5-dichlorophenylcarbamate), amylostris [(S) - ⁇ -methyl Benzyl carbamate], cellulose tris (4-methylbenzoate), amylose tris (5-chloro-2-methylphenyl carbamate) or cellulose tris (3-chloro-4-methylphenyl carbamate) on a stationary phase immobilized on a silica gel carrier.
  • the triazole derivative (I) is separated from the racemic form.
  • a triazole derivative (-)-enantiomer can be prepared.
  • optical rotation of the separated (-)-enantiomer may be determined according to a conventionally known method.
  • compound (N) the compound represented by the general formula (N) (where N is an arbitrary Roman numeral) in the overall scheme is referred to as compound (N).
  • Step 1 a compound (VII) is obtained by introducing a methyl group into the compound (VIII).
  • R 7 in the compound (VIII) is C 1 -C 6 - alkyl group.
  • a methylation reagent is added to a solution of compound (VIII) at a low temperature (for example, ⁇ 78 ° C.) and reacted.
  • methylation reagent examples include trimethylaluminum, methylmagnesium chloride, methylmagnesium bromide, and methyllithium.
  • solvent in step 1 examples include ethers such as tetrahydrofuran, dioxane and diethyl ether, and organic solvents such as toluene and hexane which are inert to the reaction.
  • Step 2 a compound (VI) is obtained by forming an exoolefin from the compound (VII) by a dehydration reaction using an acid catalyst.
  • step 3 the ester portion of compound (VI) is reduced to alcohol to obtain compound (V).
  • the compound (V) is obtained by mixing the compound (VI) and the hydride reducing agent in a solvent at a low temperature (for example, 0 ° C.) or at room temperature.
  • solvent in step 3 examples include ethers such as tetrahydrofuran, dioxane and diethyl ether, reaction-inactive toluene and dichloromethane, and organic solvents such as a mixture thereof.
  • hydride reducing agent examples include lithium aluminum hydride and diisobutylaluminum hydride.
  • step 4 compound (IV) is obtained by epoxidizing the olefin moiety of compound (V).
  • titanium (IV) tetraisopropoxide, diethyl L- (+)-diethyl tartrate and tert-butyl hydroperoxide are mixed in dichloromethane at a low temperature (for example, -20 ° C.), and compound (V) is added thereto.
  • a low temperature for example, -20 ° C.
  • compound (V) is added thereto.
  • examples thereof include, but are not limited to, a method of adding and reacting at a low temperature.
  • step 5 compound (III) is obtained by oxidizing the alcohol moiety of compound (IV) to a carboxylic acid. Specifically, compound (III) is obtained by mixing ruthenium trichloride, sodium periodate and compound (IV) in a solvent at room temperature.
  • Examples of the solvent in step 5 include water, carbon tetrachloride, acetonitrile and ethyl acetate, and a mixed solvent composed of these solvents.
  • step 6 compound (II) is obtained from compound (III).
  • R 1 is OR 4 and R 4 is hydrogen, the compound (II) and the compound (III) are the same, so that this step is not necessary.
  • R 1 is OR 4 and R 4 is alkyl
  • a method of obtaining compound (II) by alkylating compound (III) can be mentioned.
  • carbonates examples include sodium carbonate, potassium carbonate, cesium carbonate and lithium carbonate.
  • LG has a leaving group that can be substituted nucleophilically, for example, a leaving group selected from a halogen group, an alkylsulfonyloxy group and an arylsulfonyloxy group.
  • compound (II) is obtained by condensing compound (III) with an amine.
  • Specific examples thereof include a method in which compound (III), an amine, a base and a condensing agent are mixed in a solvent and reacted at room temperature.
  • Examples of the solvent in step 6 include amides such as N, N-dimethylacetamide, N-methylpyrrolidone and N, N-dimethylformaldehyde, and organic solvents such as dichloromethane and dichloroethane which are inert to the reaction.
  • amides such as N, N-dimethylacetamide, N-methylpyrrolidone and N, N-dimethylformaldehyde
  • organic solvents such as dichloromethane and dichloroethane which are inert to the reaction.
  • Examples of the base include trisubstituted amines such as triethylamine, diisopropylethylamine and N, N-dimethyl-4-aminopyridine.
  • condensing agent examples include 1- [bis (dimethylamino) methylene] -1H-1,2,3-triazolo [4,5-b] pyridinium 3-oxide hexafluorophosphate (HATU) and 1- [bis. (Dimethylamino) Methylene] -1H-benzotriazolinium 3-oxide hexafluorophosphate (HBTU) and 1H-benzotriazole-1-yloxytripyrrolidinophosphonium hexafluorophosphate (PyBOP) and the like.
  • HATU 1- [bis (dimethylamino) methylene] -1H-1,2,3-triazolo [4,5-b] pyridinium 3-oxide hexafluorophosphate
  • HBTU -1H-benzotriazolinium 3-oxide hexafluorophosphate
  • PyBOP 1H-benzotriazole-1-yloxytripyrrolidinophosphonium
  • step 7 the oxylan ring in the compound (II) is obtained by mixing the compound (II) and the azole compound in a solvent by a known method (for example, the method described in Patent Document: Japanese Patent Application Laid-Open No. 2013-100238).
  • the compound (I), that is, the triazole derivative (I) is produced by forming a carbon-nitrogen bond between the carbon atom constituting the compound and the nitrogen atom of the azole compound.
  • Examples of the azole compound include 1,2,4-triazole or an alkali metal salt thereof.
  • the solvent of step 7 is not particularly limited, and for example, alcohols such as methanol and ethanol, aromatic hydrocarbons such as benzene, toluene, xylene and chlorobenzene, N, N-dimethylacetamide, N-methylpyrrolidone and N, N. -Amids such as dimethylformaldehyde, as well as dimethylsulfoxide can be mentioned.
  • a base may be added if desired.
  • the base include alkali metal alkoxides such as sodium methoxide, sodium ethoxide, sodium t-butoxide and potassium t-butoxide, and potassium carbonate and the like.
  • the triazole derivative (-)-enantiomer has a 1,2,4-triazolyl group, it forms an acid addition salt or metal complex of an inorganic acid and an organic acid. Therefore, it can be used as an active ingredient of agricultural and horticultural chemicals as a part of an acid addition salt and a metal complex.
  • the fungicide for agriculture and horticulture in the present embodiment exhibits a control effect against a wide range of plant diseases.
  • Examples of applicable diseases include the following.
  • the parentheses after each disease indicate the main pathogens that cause the disease.
  • Soybean rust Phakopsora pachyrhizi, Phakopsora meibomiae
  • soybean brown spot disease Zymoseptria glycines
  • soybean purple spot disease Cercospora kikuchiri
  • soybean brown spot disease Alter
  • spot Cercocopora sojina
  • soybean lysoctonia root rot Rhizoctonia soly
  • soybean leaf rot Rhizoctonia soly
  • soybean black spot disease Diaporthe phaselorum
  • Rapeseed Phoma leaf spot / stem canker Leptosphaeria maculans, Leptosphaeria biglobosa
  • Light leaf of rapeseed spot Pyrenopeziza brassicae
  • rapeseed root-knot disease Clubloot Piericae
  • Cercosporidium personatum Cercospora arachidicola, Cercospora lorfsi, Puccinia arachidis, Banana yellow shigatoka, Mycosphaerella Gray mold (Botrytis sinerea), disease of the genus Pythium (Pythium spp) and mycosphaerella (Cercospora), etc. that damage various crops.
  • the genus Aspergillus the genus Cochliobolus, the genus Corticium, the genus Diplodia, the genus Pencillum, the genus Gibberala, the genus Mucor, the genus Phoma, the genus Phomopsis, the genus Pyrenophora, and the genus Pyrenophora. Seed-borne diseases or early-growth diseases of various plants caused by the genus Trichoderma, the genus Ustylago, and the like.
  • the fungicide for agriculture and gardening according to the present embodiment exhibits a particularly excellent control effect against the diseases of wheat such as wheat leaf blight and barley Fusarium head blight. Therefore, agricultural and horticultural fungicides are suitably used for controlling wheat, but are not limited thereto.
  • the agricultural and horticultural fungicides in this embodiment can be used for all plants, and examples of applicable plants include the following.
  • Satoimo family such as Satoimo
  • Urushi family such as mango, Pineapple family such as pineapple
  • Papaya family such as papaya
  • Kakinoki family such as oyster
  • Tsutsuji family such as blueberry
  • Walnut such as Pekan Family
  • Basho family such as banana
  • Mokusei family such as olive
  • Palm family such as Coco palm and Natsume palm
  • Mikan family such as tangerine, orange, grapefruit and lemon
  • Grape family such as grape, Flowers and ornamental plants), trees other than fruit trees, and other ornamental plants.
  • wild plants, plant cultivars, plants and plant cultivars obtained by conventional biological breeding such as crossbreeding or progenitor fusion, and genetically modified plant cultivars obtained by genetic engineering and approved in each country can be mentioned. ..
  • Examples of such genetically modified plant cultivars include those accumulated in the database of the International Agribio Corporation (ISAAA). Specifically, Roundup Ready, Liberty Link, IMI, SCS, Clearfield, Enlist, B.I. t.
  • the agricultural and horticultural chemicals are prepared by mixing the triazole derivative (-)-enantiomer according to the present embodiment, which is an active ingredient, with a solid carrier or a liquid carrier (diluent), a surfactant, other pharmaceutical adjuncts, and the like, and powder and water. It is formulated and used in various forms such as Japanese preparations, granules and emulsions.
  • These preparations contain the triazole derivative (-)-enantiomer as an active ingredient in an amount of 0.05 to 95% by weight, preferably 0.25 to 90% by weight, and more preferably 1 to 80% by weight.
  • solid carriers, liquid carriers and surfactants used as formulation aids are as follows. First, solid carriers are used as powder carriers, granular carriers and the like, and clay, talc, diatomaceous earth, zeolite, montmorillonite, bentonite and acidic.
  • Minerals such as white clay, active white clay, attapargit, calculus, vermiculite, pearlite, pebbles, silica sand; synthetic organic substances such as urea; salts such as calcium carbonate, sodium carbonate, sodium sulfate, limestone, and baking soda; amorphous such as white carbon.
  • Synthetic inorganic substances such as quality silica and titanium dioxide; plants such as wood flour, corn stalk (cob), walnut shell (hard fruit hull), fruit nucleus, fir, oak, bran, soybean flour, powdered cellulose, starch, dextrin, sugar, etc.
  • Sex carriers crosslinked lignin, cationic gels, gelatin gelled with heating or polyvalent metal salts, water-soluble polymer gels such as agar, and chlorinated polyethylene, chlorinated polypropylene, polyvinyl acetate, polyvinyl chloride, ethylene-vinyl acetate.
  • examples thereof include various polymer carriers such as copolymers and urea-aldevido resins.
  • Liquid carriers include fatty acid solvents (paraffins), aromatic solvents (xylene, alkylbenzene, alkylnaphthalene, solvent naphtha, etc.), mixed solvents (kerosene), machine oils (refined high boiling fatty acid hydrocarbons), alcohols (alcohols).
  • paraffins paraffins
  • aromatic solvents xylene, alkylbenzene, alkylnaphthalene, solvent naphtha, etc.
  • mixed solvents kerosene
  • machine oils refined high boiling fatty acid hydrocarbons
  • alcohols alcohols
  • nonionic surfactant examples include sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, sucrose fatty acid ester, polyoxyethylene fatty acid ester, polyoxyethylene resin acid ester, and polyoxyethylene fatty acid diester.
  • Anionic surfactants include alkyl sulfate, polyoxyethylene alkyl ether sulfate, polyoxyethylene alkylphenyl ether sulfate, polyoxyethylene benzyl (or styryl) phenyl (or phenylphenyl) ether sulfate, polyoxyethylene, and polyoxypropylene.
  • Salts of sulfates such as block polymer sulfate, paraffin (alkane) sulfonate, ⁇ -olefin sulfonate, dialkyl sulfosuccinate, alkylbenzene sulfonate, mono or dialkylnaphthalene sulfonate, naphthalene sulfonate formalin condensate, alkyldiphenyl ether disulfonate, lignin sulfonate, Salts of sulfonates such as polyoxyethylene alkylphenyl ether sulfonates, polyoxyethylene alkyl ether sulfosuccinic acid half esters, fatty acids, salts of fatty acids such as N-methyl-fatty acid sarcosinates, resin acids, polyoxyethylene alkyl ether phosphates, Polyoxyethylene mono or dialkylphenyl ether phosphate, polyoxyethylene benzyl (or
  • Cationic surfactants include ammonium salts such as alkyltrimethylammonium chloride, methylpolyoxyethylene alkylammonium chloride, alkyl N-methylpyridium bromide, mono or dialkylmethylated ammonium chloride, alkylpentamethylpropylenediaminedichloride and alkyldimethyl.
  • ammonium salts such as alkyltrimethylammonium chloride, methylpolyoxyethylene alkylammonium chloride, alkyl N-methylpyridium bromide, mono or dialkylmethylated ammonium chloride, alkylpentamethylpropylenediaminedichloride and alkyldimethyl.
  • benzalkonium salts such as benzalkonium chloride and benzethonium chloride (octylphenoxyethoxyethyldimethylbenzylammonium chloride).
  • biosurfactants for example, mannosylargitol lipid, sophorolipid, ramnolipid, trehalose lipid, cellobiose lipid, glucose lipid, oligosaccharide fatty acid ester, surfactin, serauetchin, lykencin, arslofactin, spiclesporic acid, corinomicol). Acid, agaric acid, emalzan, etc. may be contained as a surfactant.
  • biosurfactants for example, mannosylargitol lipid, sophorolipid, ramnolipid, trehalose lipid, cellobiose lipid, glucose lipid, oligosaccharide fatty acid ester, surfactin, serauetchin, lykencin, arslofactin, spiclesporic acid, corinomicol). Acid, agaric acid, emalzan, etc.
  • compositions include inorganic salts such as sodium and potassium as pH adjusters, fluorine-based and silicone-based defoaming agents, water-soluble salts such as salt, and xattan gum and guar gum used as thickeners.
  • Water-soluble polymers such as carboxymethyl cellulose, polyvinylpyrrolidone, carboxyvinyl polymer, acrylic polymer, polyvinyl alcohol, starch derivatives, polysaccharides, alginic acid and its salts, metal stearate used as a disintegrant dispersant, sodium tripolyphosphate, hexametallin Acid soda and others include preservatives, colorants, antioxidants, UV absorbers, and chemical damage reducing agents.
  • the concentration of the triazole derivative (-)-enantiomer when diluted and used is preferably in the range of 0.0005 to 1.0%.
  • the amount of the triazole derivative (-)-enantiomer used is 10 to 5000 g, more preferably 25 to 2000 g per 1 ha of horticultural land such as fields, rice fields, orchards and greenhouses. Since these concentrations and amounts used vary depending on the dosage form, timing of use, method of use, place of use, target crop, etc., they can be increased or decreased without being particular about the above range.
  • the agricultural and horticultural agent containing the triazole derivative (-)-enantiomer (I) in the present embodiment can be used in combination with other known active ingredients to enhance the performance as the agricultural and horticultural agent.
  • Other known active ingredients include known active ingredients contained in fungicides, insecticides, acaricides, nematodes, and plant growth regulators.
  • bactericides include nucleic acid synthesis and metabolism inhibitors, threaded nucleus division / cell division inhibitors, respiratory inhibitors, amino acid / protein biosynthesis inhibitors, signal transduction inhibitors, lipid biosynthesis or transport / Examples include cell membrane structure or function inhibitors, cell membrane sterol biosynthesis inhibitors, cell wall biosynthesis inhibitors, melanin biosynthesis inhibitors, host plant resistance inducers, and multi-action point bactericides.
  • nucleic acid synthesis metabolism inhibitor examples include benaraxil, benaraxyl M, furaxyl, offrace, bupirimate, dimethyrimol, etilimol, octylinone, metalaxil, metalaxil-M, oxadixil and himexazole, and are at least one selected from these. obtain.
  • filamentous fission / cell division inhibitor examples include benomyl, carbendazim, fuberidazole, thiabendazole, thiophanate, thiophanate-methyl, dietofencarb, zoxamide, etaboxam, pencyclon, fluoricorid, phenamaclyl, metrafenone and pyriophenone. Can be at least one.
  • Respiratory inhibitors include tolfenpyrado, diflumethrim, phenazakin, pidiflumethofen, fenfuran, carboxin, oxycarboxin, benodanyl, flutranil, mepronil, isofetamide, benzobindiflupill, bixaphen, fluindapyl, fluxapyroxado, Flametopill, isopyrazam, penflufen, penthiopyrado, sedaxan, isoflusiplum, boscalid, fluopirum, thyfluzamide, pyraziflumid, pyribencarb, fluoxastrobin, phenamiden, mandestrobin, azoxystrobin, spumoxystrobin, enoxastrobin, full Phenoxystrobin, picoxystrobin, pyracrostrobin, pyraoxystrobin, trichloropyricalve, famoxadon, dymoxystrobin
  • amino acid / protein biosynthesis inhibitor examples include cyprodinyl, mepanipyrim, pyrimethanyl, blastsidedin, kasugamycin, streptomycin, oxytetracycline and the like, and may be at least one selected from these.
  • Examples of the signal transduction inhibitor include quinoxyphen, proquinazide, clozoline, dimethacron, phenpicronyl, fludioxonyl, iprodion, procymidone, vinclozoline and the like, and may be at least one selected from these.
  • Lipid biosynthesis or transport / cell membrane structure or function inhibitors include isoprothiolan, edifenphos, iprobenphos (IBP), pyrazophos, biphenyl, chloroneb, dichloran, quintozen (PCNB), technazen (TCNB), torquelophos- Methyl, etridiazole, prothiocarb, propamocarb, natamycin, oxathiapiproline, fluoxapiproline and the like can be mentioned and may be at least one selected from these.
  • Cell membrane sterol biosynthesis inhibitors include imazalyl, oxpoconazole, pefrazoate, prochloraz, triflumizole, trifolin, pyrifenox, pyrisoxazole, phenalimol, nuarimol, azaconazole, bitertanol, bromconazole, cyproconazole, Diphenoconazole, diniconazole, epoxyconazole, etaconazole, fenbuconazole, fluconazole, fluconazole, flutrifolin, hexaconazole, imibenconazole, metconazole, ipconazole, microbutanyl, penconazole, propiconazole, simeconazole, tebuconazole, tetra.
  • Nazole Triazimefon, Triazimenol, Triticonazole, Mefentrifluconazole, Prothioconazole, Tridemorph, Fenpropimorph, Fenpropidine, Piperline, Spiroxamine, Fempyrazamine, Fenhexamide, Naftiffin, Turbinafin, Pyribycarb and Examples include ipfentrifluconazole and the like, and may be at least one selected from these.
  • cell wall biosynthesis inhibitor examples include polyoxin, dimethmorph, fulmorph, pyrimorph, mandipropamide, benchavaricarb, iprovaricarb, and varifenalate, and may be at least one selected from these.
  • melanin biosynthesis inhibitor examples include fusalide, tricyclazole, pyrochyron, carpropamide, diclosimet, phenoxanyl, tolprocarb and the like, and may be at least one selected from these.
  • Host plant resistance inducers include acibenzolar-S-methyl, probenazole, thiazinyl, laminarin, isothianyl, laminarin, phocetyl-Al, phosphoric acid and phosphate, with at least one selected from these. could be.
  • Multi-action point fungicides include simoxanyl, tecrophthalam, triazoxide, flusulfamide, dichromedin, siflufenamide, dodine, fluthianyl, ferlimzone, tebuflokin, picalbutrazox, varydamycin, mineral oil, baking soda, potassium carbonate, copper and copper compounds, sulfur, Farbam, Manzeb, Manneb, Metylum, Propineb, Thiram, Dineb, Diram, Captan, Captan, Folpet, Chlorotalonyl (TPN), Guazatin, Iminoctadine acetate, Iminoctadine albesylate, Anilazine, Dithianone, Fluorimide, Metasulfocarb , Florylpicoxamide, fluopimomid, ipflufenokin, quinomethionate, pyridaclomethyl, aminopyridene, diclobenazox, quino
  • fenamiden fenitropan, halpin, isonial, diclobenazox, picalbutrazox, hydroxyisoxazole, fluorimide, quinomethionate, chloroinconazide, trichoderma mycelium extract, Gosei Kayupte (tea tree) extract, vegetable oil (eugenol, geraniol, timol), Oitadori extract, cell wall of Saccharomyces cerevisiae LAS117 strain and biopesticides (Agrobacterium radiobacter, Pseudomonas fluorescens, Pseudomonas rodesia, Pseudomonas chlororafis AFS009 strain, Bacillus subtilis, Bacillus symplex, Bacillus amyloliquefaciens, Bacillus mycoides, non-pathogenic Elvinia carotbora, Lactobacillus
  • Known active ingredients in pesticides include nicotinic acetylcholine receptor antagonist modulators, sodium channel modulators, lianodine receptor modulators, acetylcholinesterase inhibitors, oxidative phosphorylation uncouplers, and mitochondrial electron transport chain complex I. Inhibitors and the like can be mentioned.
  • nicotinic acetylcholine receptor antagonist modulator examples include acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid, thiamethoxam, sulfoxaflor, flupyradiflon, and triflumezopyrim, and may be at least one selected from these.
  • Examples of the sodium channel modulator include pyrethroid compounds, and examples of the pyrethroid compounds include acrinathrin, arereslin, cypermethrin, bifenthrin, cycloprothrin, cyhalothrin, deltamethrin, dimefluthrin, esphenvalerate, etofenprox, and fenpropathrin.
  • Fenvalerate flubrocitrinate, flucitrinate, fluvalinate, halfenprox, cyhalothrin, metoflutrin, monfluorothrin, permethrin, profluthrin, tefluthrin, tralomethrin, imiprothrin, pyrethrin and ciphenothrin, chloropralesrin, epsilonmethrin Trin and epsilon monfluorothrin and the like can be mentioned and may be at least one selected from these.
  • ryanodine receptor modulator examples include chloranthraniliprole, cyantraniliprole, flubendiamide, sihalodiamide, and the like, and may be at least one selected from these.
  • Acetylcholinesterase inhibitors include acephate, azinephos-methyl, kazusaphos, chlorethoxyphos, chlorfenbinphos, chlorpyriphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos (DDVP), dicrotophos, dimethote, disulfoton, etion, etoplophos.
  • EPN phenamiphos, fenitrothion (MEP), fenthion (MPP), hostizate, imiciaphos, isofenphos, isoxathione, malathion, metamidphos, metidathion, mevinphos, monochromotophos, ometoate, oxydemethonemethyl, parathion, parathion-methyl, pholate, , Hosalon, Hosmet, Phosfamidon, Hoxime, Pyrimiphosmethyl, Profenophos, Prothiophos, Pyraclophos, Pyridafenthion, Kinalphos, Tebupyrimhos, Telbuhos, Triazophos and Trichlorfon (DEP), Aranicarb, Ardicalve, Benfracarb, BPMC, Carbofuran, Carbofuran , Cartap, phenoxycarb (BPMC), formethanate, isoprocarb (MIPC), methiocarb, mesomil,
  • oxidative phosphorylation uncoupler examples include chlorfenapyr, DNOC, sulflamide and the like, and may be at least one selected from these.
  • mitochondrial electron transport chain complex I inhibitor examples include tebufenpyrado, tolfenpyrado, phenazakin, phenpyroxymate, pyridaben, pyrimidiphen and rotenone, and may be at least one selected from these.
  • Known active ingredients in plant growth regulators include aminoethoxyvinylglycine, chlormecoat, chlorpropham, cyclanilide, dikegrac, daminogit, etephone, fluluprimidol, flumethrolin, holchlorphenurone, gibberellin, hydrazide maleate. Salts, mepicort chloride, methylcyclopropham, benzylaminopurine, paclobutrazol, prohexadione, thydiazulone, tributylphosphorotrithioate, trinexacacethyl and uniconazole, and the like, and at least one selected from these. Can be one.
  • Known active ingredients (mite-killing active ingredients) contained in the acaricide include, for example, acequinocil, hydramethylnon, amideflumet, amitraz, azocyclotin, biphenazate, bromopropirate, clofentezine, quinomethionate, phenisobromolate, and the like.
  • nematode active ingredients contained in nematode nematodes include, for example, DD (1,3-dichloropropene), DCIP (dichlorodiisopropyl ether), methylisothiocyanate, carbam sodium salt, and the like.
  • avelmectin tetrachlorolantraniliplol, diafentiurone, ethiprol, fipronil, fronicamid, fluenesulfone, indoxacarb, metaflumison, metaaldehyde, pimetrodin, pyridalyl, pyrifluquinazone, silafluofen.
  • Examples include compounds, fatty acid monoesters with glycerin or propanediol, neem oil, boberia baciana, metallidium anisoprie, pequiromyces fumosoloseus, diatomaceous soil and the like.
  • the agricultural and horticultural chemicals in this embodiment can be used in cultivated or non-agricultural lands such as fields, paddy fields, lawns, and orchards. Further, the agricultural and horticultural chemicals in the present embodiment can be applied not only by foliage treatment such as foliage spraying, but also by non-foliage treatment such as seed treatment including treatment of bulbs and tubers, irrigation treatment, and water surface treatment. Therefore, the method for controlling plant diseases in the present embodiment is a method including a procedure for performing foliage treatment or non-foliage treatment using the above-mentioned agricultural and horticultural agents. In addition, when the non-foliage treatment is performed, the labor can be reduced as compared with the case where the foliage treatment is performed.
  • the chemicals are attached to the seeds by mixing the wettable powder and powder with the seeds and stirring, or by immersing the seeds in the diluted wettable powder. It also includes a seed coating process.
  • the amount of the active ingredient used in the seed treatment is, for example, 0.005 to 10000 g, preferably 0.05 to 1000 g per 100 kg of seeds. Seeds treated with agricultural and horticultural chemicals may be used in the same manner as normal seeds.
  • the application by irrigation treatment is performed by treating the planting hole or its surroundings with granules, etc. at the time of transplanting seedlings, or treating the soil around the seeds or plants with granules, wettable powders, etc. ..
  • the amount of the active ingredient used in the irrigation treatment is, for example, 0.005 to 10000 g, preferably 0.05 to 1000 g per 1 m 2 of agricultural and horticultural land.
  • Water surface treatment is performed by treating the surface water of the paddy field with granules or the like.
  • the amount of the active ingredient used in the water surface treatment is, for example, 0.05 to 10000 g, preferably 0.5 to 1000 g per paddy field 10a.
  • the amount of the active ingredient used for foliage spraying is, for example, 10 to 5000 g, more preferably 25 to 2000 g per 1 ha of agricultural and horticultural fields such as fields, rice fields, orchards and greenhouses.
  • concentration and amount of use differ depending on the dosage form, timing of use, method of use, place of use, target crop, etc., it is possible to increase or decrease without being particular about the above range.
  • the liquid carrier is not particularly limited as long as it does not react with the active ingredient.
  • the liquid carrier include water, alcohols (eg, methyl alcohol, ethyl alcohol, ethylene glycol, cellosolve, etc.), ketones (eg, acetone, methyl ethyl ketone, etc.), ethers (eg, dimethyl ether, diethyl ether, dioxane, hydrocarbon, etc.).
  • aromatic hydrocarbons eg, benzene, toluene, xylene, methylnaphthalene, etc.
  • aliphatic hydrocarbons eg, gasoline, kerosine, kerosene, machine oil, fuel oil, etc.
  • acid amides eg, dimethylformamide.
  • N-Methylpyrrolidone, etc. Halogenated hydrocarbons (eg, chloroform, carbon tetrachloride, etc.), esters (eg, ethyl acetate esters, fatty acid glycerin esters, etc.), nitriles (eg, acetonitrile, etc.) and dimethylsulfoxide. And so on.
  • fine powders or granules such as kaolin clay, bentonite, acidic clay, pyrophyllite, talc, diatomaceous earth, calcite, urea, and ammonium sulfate can be used.
  • surfactants such as soaps, alkylsulfonic acids, alkylarylsulfonic acids, dialkylsulfosuccinic acids, quaternary ammonium salts, oxyalkylamines, fatty acid esters, polyalkylene oxides, and anhydrosorbitols. Can be used.
  • the content ratio varies depending on the dosage form and the purpose of use, but is 0.1 to 99.9% by weight based on the total amount of the pharmaceutical product. do it.
  • the treatment concentration is usually adjusted to 0.0025 to 5% by weight, preferably 0.005 to 1% by weight by appropriately adding a solvent, a diluent, a bulking agent or the like. It is preferable to do so.
  • the triazole derivative (-)-enantiomer shows an excellent bactericidal action against many bacteria that cause plant diseases. That is, the agricultural and horticultural disease control agent containing the triazole derivative (-)-enantiomer as an active ingredient has low toxicity to humans and animals, is excellent in handling safety, and can exhibit a high control effect on a wide range of plant diseases.
  • the triazole derivative (-)-enantiomer according to the present embodiment can also be used as an industrial material protectant because it exhibits an excellent effect of protecting the material from a wide range of harmful microorganisms that attack the industrial material. Examples of such microorganisms include the following microorganisms.
  • Paper and pulp-deteriorating microorganisms including slime-forming microorganisms
  • Aspergillus sp. Trichoderma sp., Penicillium sp., Geotrichum sp., Chaetomium sp. (Cadophora sp. ), Ceratostomella sp., Cladosporium sp., Corticium sp., Lentinus sp., Lentinus sp., Phomatics sp.
  • Polysticus sp. Pulularia sp., Stereum sp., Trichosporium sp., Aerobacter sp., Bacillus sp., Desulfobibrio sp. , Pseudomonas sp., Flavobacterium sp., Micrococcus sp., and other fiber-degrading microorganisms such as Aspergillus sp., Penicillium sp., Penicillium sp. ), Micrococcium sp., Curvularia sp., Gliomatics sp., Memnoniella sp., Sarcopodium sp., Sarcopodium sp.
  • Penicillium sp. Chaetomium sp., Cladosporium sp., Mucor sp., Paecilomyces sp., Pilobus sp.
  • Trichosporon sp. Trichothecium sp., Aspergillus sp., Penicillium sp., Rhizopus sp., Trichothecium sp., Trichothecium sp., Trichothecium sp., Trichothecium sp.
  • the industrial material protective agent containing the triazole derivative (-)-enantiomer as an active ingredient may contain various components other than the triazole derivative (-)-enantiomer.
  • the industrial material protectant containing the triazole derivative (-)-enantiomer as an active ingredient can be dissolved or dispersed in a suitable liquid carrier, or mixed with a solid carrier for use.
  • the industrial material protectant containing the triazole derivative (-)-enantiomer as an active ingredient may further contain an emulsifier, a dispersant, a spreading agent, a penetrant, a wetting agent, a stabilizer and the like, if necessary.
  • Examples of the dosage form of the industrial material protective agent containing the triazole derivative (-)-enantiomer as an active ingredient include wettable powders, powders, granules, tablets, pastes, suspensions and spray materials. can.
  • the industrial material protective agent containing the triazole derivative (-)-enantiomer as an active ingredient may contain other fungicides, insecticides, deterioration inhibitors and the like.
  • the liquid carrier is not particularly limited as long as it does not react with the active ingredient.
  • the liquid carrier include water, alcohols (eg, methyl alcohol, ethyl alcohol, ethylene glycol, cellosolve, etc.), ketones (eg, acetone, methyl ethyl ketone, etc.), ethers (eg, dimethyl ether, diethyl ether, dioxane, hydrocarbon, etc.).
  • aromatic hydrocarbons eg, benzene, toluene, xylene, methylnaphthalene, etc.
  • aliphatic hydrocarbons eg, gasoline, kerosine, kerosene, machine oil, fuel oil, etc.
  • acid amides eg, dimethylformamide.
  • N-Methylpyrrolidone, etc. Halogenated hydrocarbons (eg, chloroform, carbon tetrachloride, etc.), esters (eg, ethyl acetate esters, fatty acid glycerin esters, etc.), nitriles (eg, acetonitrile, etc.), dimethylsulfoxide, etc. Can be mentioned.
  • fine powders or granules such as kaolin clay, bentonite, acidic clay, pyrophyllite, talc, diatomaceous earth, calcite, urea and ammonium sulfate can be used.
  • surfactants such as soaps, alkylsulfonic acids, alkylarylsulfonic acids, dialkylsulfosuccinic acids, quaternary ammonium salts, oxyalkylamines, fatty acid esters, polyalkylene oxides and anhydrosorbitolscan be used.
  • the content ratio varies depending on the dosage form and the purpose of use, but is 0.05 to 99.9% by weight based on the total amount of the pharmaceutical product. do it.
  • the treatment concentration is usually adjusted to 0.0025 to 5% by weight, preferably 0.005 to 1% by weight by appropriately adding a solvent, a diluent, a bulking agent, or the like. It is preferable to do so.
  • the compound according to the present invention is a (-)-enantiomer of the triazole derivative represented by the above general formula (I) or a pesticide-acceptable salt thereof.
  • R 1 is -OR 4 ;
  • R 2 is a halogen group, a cyano group, a C 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group, a C 1- C 4 -alkoxy group, -SOR 7 or -SF 5 ;
  • R 3 is a halogen group, a nitro group, a cyano group, an amino group, a C 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group, a C 1- C 4 -alkoxy group, and a C 1- C 4 -halo.
  • alkoxy groups C 1 -C 4 - alkyl acyl amino group, the compound or a salt thereof -SOR 7 or -SF 5 - alkylamino group, C 1 -C 4 - dialkylamino group, C 1 -C 4.
  • R 4 is, C 1 -C 6 - an alkyl group
  • R 2 is halogen, cyano, C 1 -C 4 - alkyl group, C 1 -C 4 - haloalkyl group or a C 1 -C 4 - alkoxy group
  • R 3 is halogen, cyano, C 1 -C 4 - haloalkoxy group - alkyl group, C 1 -C 4 - haloalkyl group, C 1 -C 4 - alkoxy group or a C 1 -C 4.
  • Agricultural and horticultural agents or industrial material protective agents containing the triazole derivative (-)-enantiomer according to the present invention as an active ingredient are also included in the category of the present invention.
  • High Performance Liquid Chromatograph Preparative Column: Product Name "CHIRALPAK IG", manufactured by Daicel Chemical Industries, Ltd., Inner diameter 4.6 mm, Length 250 mm, Particle size 5 ⁇ m Sample concentration: 0.5 mg / mL Mobile phase: 100% methanol flow rate: 1.0 mL / min Column temperature: 40 ° C Detection wavelength: 230nm
  • the specific rotation was measured using P-1020 (manufactured by JASCO Corporation, Na lamp: 589 nm). The specific measurement results are as follows.
  • the same crude product C 2 was obtained by performing the same operation as the above operation. Together, they were purified as crude product C by silica gel column chromatography (silica gel 40 g hexane / ethyl acetate: 20 ⁇ 50%) to obtain 3.68 g of the title compound as a colorless liquid.
  • reaction solution B was added dropwise to the reaction solution A using a Pasteur pipette. After stirring for 6 hours under cooling at ⁇ 20 ° C., the reaction was stopped by adding a saturated aqueous sodium hydrogen carbonate solution and a saturated aqueous sodium sulfite solution to the reaction solution.
  • High Performance Liquid Chromatograph Preparative Column: Product Name "CHIRALPAK IG", manufactured by Daicel Chemical Industries, Ltd., Inner diameter 4.6 mm, Length 150 mm, Particle size 5 ⁇ m Sample concentration: 1.0 mg / mL Mobile phase: 100% methanol flow rate: 1.0 mL / min Column temperature: 40 ° C Detection wavelength: 230nm
  • wettable powder> A hydrate was prepared as follows using any of the prepared triazole derivatives (-)-enantiomers described in this patent.
  • ⁇ Pharmaceutical example 2 Emulsion> An emulsion was prepared as follows using any of the prepared triazole derivatives (-)-enantiomers described in this patent.
  • Triazole derivative (-)-enantiomer 5.0 parts polyoxyalkylene alkyl ether / alkylbenzene sulfonic acid metal salt / alkylbenzene mixture 3.75 parts polyoxyalkylene alkyl ether 11.25 parts 5- (dimethylamino) -2-methyl-5 -Methyl oxopentanoate 12.0 parts N, N-dimethyloctaneamide / N, N-dimethyldecaneamide 44.0 parts Solventnaphtha 24.0 parts are uniformly mixed and dissolved to form an emulsion, which is diluted with water before use. bottom.
  • ⁇ Test Example 1 Antibacterial test against phytopathogens> The antibacterial property of compound 1 (-) prepared in Production Example 1 against various plant pathogens was tested by a Petri dish test.
  • Compound 1 (racemic) was used as a control compound. After sterilization by autoclave, compound 1 (-) or compound 1 dissolved in dimethyl sulfoxide (DMSO) so as to have a drug concentration of 2.5 mg / L in PDA medium (potato-dextrose-agar medium) cooled to around 60 ° C. (Potato) was added to PDA medium at 1% v / v. The mixture was mixed so that the drug concentration in the PDA medium was uniform, and the medium was poured into a petri dish to prepare a plate medium containing compound 1 ( ⁇ ) or compound 1 (racemic).
  • DMSO dimethyl sulfoxide
  • the flora of various phytopathogens shown in Table 1 previously cultured on the PDA medium was punched out with a cork borer having a diameter of 4 mm and inoculated into the above-mentioned drug-containing plate medium. After culturing at a temperature for a predetermined period, the bacterial flora diameter was measured on a drug-treated plate medium. The hyphal elongation inhibition rate (%) was calculated by the following formula in comparison with the diameter of the flora on the untreated plate containing no drug. The greater the rate of hyphal elongation inhibition, the better the antibacterial property.
  • Hyphal elongation inhibition rate (%) (1-Diameter of flora on drug-treated plate / Diameter of flora on untreated plate) x 100
  • the results of the hyphal elongation inhibition rate R (%) are shown in Table 1.
  • Example 2 Wheat red rust control effect test> Compound 1 (-) or compound 1 (racemic) prepared in Production Example 1 was dissolved in acetone so as to have a predetermined drug concentration, and 5% v / v was added to ion-exchanged water containing Gramin S (of Gramin S). Final concentration 60 ppm). The prepared drug was sprayed at a rate of 1000 L / ha on wheat (variety: Norin 61) in the first and second leaf stages cultivated in a square plastic pot (6 cm ⁇ 6 cm) (drug treatment group). The untreated plot was obtained by spraying wheat with ion-exchanged water containing 5% acetone (final concentration of Gramin S 60 ppm) containing no compound.
  • Control value (%) (1-Average diseased area in drug-treated area / Average diseased area in untreated area) x 100
  • Example 3 Wheat powdery mildew control effect test> Compound 1 (-) or compound 1 (racemic) prepared in Production Example 1 was dissolved in acetone so as to have a predetermined drug concentration, and 5% v / v was added to ion-exchanged water containing Gramin S (of Gramin S). Final concentration 60 ppm). The prepared drug was sprayed at a rate of 1000 L / ha on wheat (variety: Norin 61) in the first and second leaf stages cultivated in a square plastic pot (6 cm ⁇ 6 cm) (drug treatment group). The untreated plot was obtained by spraying wheat with ion-exchanged water containing 5% acetone (final concentration of Gramin S 60 ppm) containing no compound.
  • the spray liquid on the wheat leaves was air-dried, sprinkled with spores of wheat powdery mildew, and inoculated, and managed in a greenhouse.
  • the affected area of wheat powdery mildew was investigated, and the control value (%) was calculated.
  • control value of compound 1 was 38% at a concentration of 7.5 g / ha, whereas the control value of compound 1 (-) was 56%.
  • the (-)-enantiomer of the triazole derivative according to the present invention can be suitably used as an active ingredient of a fungicide for agriculture and horticulture and a protective agent for industrial materials.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Agronomy & Crop Science (AREA)
  • Health & Medical Sciences (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Provided is a plant disease control agent which has low toxicity to humans and animals and high safety in handling and which exhibits excellent antimicrobial effects, even at a low application dose, on a large number of microorganisms causing plant diseases. The present invention pertains to the (-)-enantiomer of a compound represented by general formula (I) or an agrochemically acceptable salt thereof.

Description

トリアゾール誘導体の(-)-エナンチオマー、農園芸用薬剤および工業用材料保護剤Triazole derivative (-)-enantiomers, agricultural and horticultural agents and industrial material protectants
 本発明はトリアゾール誘導体の(-)-エナンチオマー、ならびにこれを有効成分として含む農園芸用薬剤および工業用材料保護剤に関する。 The present invention relates to a triazole derivative (-)-enantiomer, and an agricultural and horticultural agent containing the triazole derivative as an active ingredient, and an industrial material protective agent.
 従来人畜に対する毒性が低く取扱い安全性に優れ、かつ広範な植物病害に対して高い防除効果を示す農園芸用薬剤が求められている。このような状況下、特許文献1には、農園芸用薬剤の有効成分となる新規のトリアゾール誘導体が開示されている。 Conventionally, there is a demand for agricultural and horticultural chemicals that are less toxic to humans and animals, have excellent handling safety, and have a high control effect against a wide range of plant diseases. Under such circumstances, Patent Document 1 discloses a novel triazole derivative which is an active ingredient of an agricultural and horticultural drug.
国際公開WO2019/093522International release WO2019 / 093522
 しかしながら、特許文献1に記載の化合物においても適用量が低い場合には十分な効果が得られない場合もある。 However, even with the compound described in Patent Document 1, if the applied amount is low, a sufficient effect may not be obtained.
 そこで、本発明は上記の問題点に鑑みてなされたものであり、その目的は、低い適用量においても植物病害に対して高い防除効果が期待できる、植物病菌に対する高い抗菌性を有する化合物を提供することにある。 Therefore, the present invention has been made in view of the above problems, and an object thereof is to provide a compound having high antibacterial activity against plant diseases, which can be expected to have a high control effect against plant diseases even at a low application amount. To do.
 上記課題を解決するために、本発明に係る化合物は、下記一般式(I)で表されるトリアゾール誘導体の(-)-エナンチオマーまたはその農薬学的に許容可能な塩である。 In order to solve the above problems, the compound according to the present invention is a (-)-enantiomer of a triazole derivative represented by the following general formula (I) or a pesticide-acceptable salt thereof.
Figure JPOXMLDOC01-appb-C000002
Figure JPOXMLDOC01-appb-C000002
 [式(I)中、
 Rは、-ORまたは-NRであり;
 R、RおよびRは、それぞれ独立に、水素、C-C-アルキル基、C-C-アルケニル基、C-C-アルキニル基、C-C-シクロアルキル基、C-C-シクロアルキル-C-C-アルキル基、フェニル基、フェニル-C-C-アルキル基、フェニル-C-C-アルケニル基またはフェニル-C-C-アルキニル基であり、RとRとは環を形成していてもよく;
 ここで、R、R、およびRにおける脂肪族基は、1、2、3もしくは可能な最大数の同一のまたは異なる基Rを有していてもよく、Rは、ハロゲン基、シアノ基、ニトロ基、C-C-アルコキシ基およびC-C-ハロアルコキシ基から互いに独立して選択され;
 Rはハロゲン基、シアノ基、ニトロ基、フェニル基、フェニル-オキシ基、C-C-アルキル基、C-C-ハロアルキル基、C-C-アルコキシ基、C-C-ハロアルコキシ基、-SORまたは-SFであり;
 Rは、ハロゲン基、シアノ基、ニトロ基、アミノ基、フェニル基、フェニル-オキシ基、C-C-アルキル基、C-C-ハロアルキル基、C-C-アルコキシ基またはC-C-ハロアルコキシ基、C-C-アルキルアミノ基、C-C-ジアルキルアミノ基、C-C-アルキルアシルアミノ基、-SORまたは-SFであり;
 R、R、およびRにおけるシクロアルキル基およびフェニル基部分ならびにRにおけるフェニル基部分は、1、2、3、4、5もしくは可能な最大数の同一のまたは異なる基Rを有していてもよく、Rは、ハロゲン基、シアノ基、ニトロ基、C-C-アルキル基、C-C-アルコキシ基、C-C-ハロアルキル基およびC-C-ハロアルコキシ基から互いに独立して選択され;
 ここで、Rは、C-C-アルキル基またはC-C-ハロアルキル基であり;
 nは0,1,2,3,または4であり;
 mは1,2,3,4または5であり、
 アスタリスク(*)は不斉炭素原子を指す。]
[In formula (I),
R 1 is -OR 4 or -NR 5 R 6 ;
R 4 , R 5 and R 6 are independently hydrogen, C 1- C 6 -alkyl group, C 2- C 6 -alkenyl group, C 2- C 6 -alkynyl group, C 3- C 8 -cyclo. Alkyne group, C 3- C 8 -cycloalkyl-C 1- C 4 -alkyl group, phenyl group, phenyl-C 1- C 4 -alkyl group, phenyl-C 2- C 4 -alkenyl group or phenyl-C 2 -C 4- It is an alkynyl group, and R 5 and R 6 may form a ring;
Here, the aliphatic groups in R 4 , R 5 and R 6 may have 1, 2, 3 or the maximum possible number of the same or different groups R a , where R a is a halogen group. , cyano group, nitro group, C 1 -C 4 - alkoxy and C 1 -C 4 - is selected from haloalkoxy groups independently of each other;
R 2 is a halogen group, a cyano group, a nitro group, a phenyl group, a phenyl-oxy group, a C 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group, a C 1- C 4 -alkoxy group, and a C 1-. C 4 -haloalkoxy group, -SOR 7 or -SF 5 ;
R 3 is a halogen group, a cyano group, a nitro group, an amino group, a phenyl group, a phenyl-oxy group, a C 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group, and a C 1- C 4 -alkoxy group. or C 1 -C 4 - haloalkoxy group, C 1 -C 4 - alkylamino group, C 1 -C 4 - dialkylamino group, C 1 -C 4 - alkyl acyl amino group, in -SOR 7 or -SF 5 can be;
The cycloalkyl and phenyl group moieties in R 4 , R 5 , and R 6 and the phenyl group moieties in R 3 have 1, 2, 3, 4, 5 or the maximum number of possible identical or different groups R b . may also be, R b is halogen, cyano, nitro, C 1 -C 4 - alkyl group, C 1 -C 4 - alkoxy group, C 1 -C 4 - haloalkyl and C 1 -C 4- Selected independently of each other from the haloalkoxy group;
Wherein, R 7 is, C 1 -C 4 - alkyl group or a C 1 -C 4 - haloalkyl group;
n is 0,1,2,3, or 4;
m is 1,2,3,4 or 5,
An asterisk (*) refers to an asymmetric carbon atom. ]
 本発明に係るトリアゾール誘導体の(-)-エナンチオマーは、低い適用量においても、植物に病害を引き起こす多くの菌に対して優れた殺菌作用を有する。 The (-)-enantiomer of the triazole derivative according to the present invention has an excellent bactericidal action against many bacteria that cause diseases to plants even at a low application amount.
 以下、本発明に係るトリアゾール誘導体の(-)-エナンチオマーについて詳細に説明する。なお、以下に説明する実施形態は、本発明の代表的な実施形態の一例を示したものであり、これにより本発明の範囲が狭く解釈されることはない。 Hereinafter, the (-)-enantiomer of the triazole derivative according to the present invention will be described in detail. It should be noted that the embodiments described below show an example of a typical embodiment of the present invention, and the scope of the present invention is not narrowly interpreted by this.
 [1.トリアゾール誘導体エナンチオマー]
 本実施形態に係るトリアゾール誘導体の(-)-エナンチオマーは、下記一般式(I)で示されるトリアゾール誘導体(以下、トリアゾール誘導体(I)と称する)における(-)-エナンチオマー(以下、トリアゾール誘導体(-)-エナンチオマーと称する)である。下記一般式(I)におけるアスタリスク(*)が不斉炭素原子を指す。なお、本明細書において、「(-)-エナンチオマー」とは、ナトリウムD線の直線偏光の振動面を左に回転させるエナンチオマーのことを指し、「(+)-エナンチオマー」とは、ナトリウムD線の直線偏光の振動面を右に回転させるエナンチオマーのことを指す。
[1. Triazole derivative enantiomer]
The (-)-enantiomer of the triazole derivative according to the present embodiment is the (-)-enantiomer (hereinafter, triazole derivative (-) in the triazole derivative represented by the following general formula (I) (hereinafter referred to as triazole derivative (I))). ) -Called an enantiomer). The asterisk (*) in the following general formula (I) refers to an asymmetric carbon atom. In the present specification, the "(-)-enantiomer" refers to an enantiomer that rotates the vibration plane of the linearly polarized light of the sodium D line to the left, and the "(+)-enantiomer" refers to the sodium D line. Refers to an enantiomer that rotates the vibrating plane of linearly polarized light to the right.
Figure JPOXMLDOC01-appb-C000003
Figure JPOXMLDOC01-appb-C000003
 一般式(I)中、
 Rは、-ORまたは-NRであり、好ましくは-ORである。
In general formula (I),
R 1 is -OR 4 or -NR 5 R 6 , preferably -OR 4 .
 R、RおよびRは、それぞれ独立に、水素、C-C-アルキル基、C-C-アルケニル基、C-C-アルキニル基、C-C-シクロアルキル基、C-C-シクロアルキル-C-C-アルキル基、フェニル基、フェニル-C-C-アルキル基、フェニル-C-C-アルケニル基またはフェニル-C-C-アルキニル基である。RとRとは、RおよびRが結合している窒素原子とともに環を形成していてもよい。 R 4 , R 5 and R 6 are independently hydrogen, C 1- C 6 -alkyl group, C 2- C 6 -alkenyl group, C 2- C 6 -alkynyl group, C 3- C 8 -cyclo. Alkyl group, C 3- C 8 -cycloalkyl-C 1- C 4 -alkyl group, phenyl group, phenyl-C 1- C 4 -alkyl group, phenyl-C 2- C 4 -alkenyl group or phenyl-C 2 -C 4 -Alkynyl group. R 5 and R 6 may form a ring together with the nitrogen atom to which R 5 and R 6 are bonded.
 C-C-アルキル基は、炭素原子数が1~6個である直鎖または分岐鎖状アルキル基であり、例えば、メチル基、エチル基、1-メチルエチル基、1,1-ジメチルエチル基、プロピル基、1-メチルプロピル基、2-メチルプロピル基、1,1-ジメチルプロピル基、2,2-ジメチルプロピル基、1-エチルプロピル基、ブチル基、1-メチルブチル基、2-メチルブチル基、3-メチルブチル基、3,3-ジメチルブチル基、2,2-ジメチルブチル基、1,1-ジメチルブチル基、1-エチルブチル基、2-エチルブチル基、ペンチル基、1-メチルペンチル基、2-メチルペンチル基、3-メチルペンチル基および4-メチルペンチル基が挙げられる。 C 1 -C 6 - alkyl group is a straight chain or branched chain alkyl group with a carbon number 1-6, for example, a methyl group, an ethyl group, a 1-methylethyl group, 1,1-dimethyl Ethyl group, propyl group, 1-methylpropyl group, 2-methylpropyl group, 1,1-dimethylpropyl group, 2,2-dimethylpropyl group, 1-ethylpropyl group, butyl group, 1-methylbutyl group, 2- Methylbutyl group, 3-methylbutyl group, 3,3-dimethylbutyl group, 2,2-dimethylbutyl group, 1,1-dimethylbutyl group, 1-ethylbutyl group, 2-ethylbutyl group, pentyl group, 1-methylpentyl group , 2-Methylpentyl group, 3-methylpentyl group and 4-methylpentyl group.
 C-C-アルケニル基は、炭素原子数が2~6個である直鎖または分岐鎖状のアルケニル基であり、例えば、エテニル基、2-プロペニル基、1-メチル-2-プロペニル基、2-メチル-2-プロペニル基、1-ブテニル基、2-ブテニル基、3-メチル-2-ブテニル基、1-メチル-2-ブテニル基、3-ブテニル基、1-ペンテニル基、2-ペンテニル基、1-ヘキセニル基および5-ヘキセニル基が挙げられる。 C 2 -C 6 - alkenyl group is a linear or branched alkenyl group having a carbon atom is 2-6, for example, ethenyl, 2-propenyl group, 1-methyl-2-propenyl group , 2-Methyl-2-propenyl group, 1-butenyl group, 2-butenyl group, 3-methyl-2-butenyl group, 1-methyl-2-butenyl group, 3-butenyl group, 1-pentenyl group, 2- Examples include a pentanyl group, a 1-hexenyl group and a 5-hexenyl group.
 C-C-アルキニル基は、炭素原子数が2~6個である直鎖または分岐鎖状のアルキニル基であり、例えば、エチニル基、1-プロピニル基、2-プロピニル基、1-ブチニル基、2-ブチニル基、3-ブチニル基、ペンチニル基および1-ヘキシニル基が挙げられる。 C 2 -C 6 - alkynyl group, a linear or branched chain alkynyl group having a carbon atom is 2-6, for example, ethynyl group, 1-propynyl, 2-propynyl, 1-butynyl Examples include groups, 2-butynyl groups, 3-butynyl groups, pentynyl groups and 1-hexynyl groups.
 C-C-シクロアルキル基は、炭素原子数3~8個の環状のアルキルであり、例えば、シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基、シクロヘプチル基、およびシクロオクチル基が挙げられる。 The C 3- C 8 -cycloalkyl group is a cyclic alkyl having 3 to 8 carbon atoms, and examples thereof include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, and a cyclooctyl group. Be done.
 C-C-シクロアルキル-C-C-アルキル基は、炭素原子数3~8個の環状のシクロアルキル基が直鎖または分岐鎖状の炭素数1~4個のアルキル基に結合していることを示す。例えば、シクロプロピルメチル基、シクロブチルメチル基、シクロペンチルメチル基、シクロヘキシルメチル基、2-シクロプロピルエチル基、1-シクロプロピルエチル基、2-シクロヘキシルエチル基、3-シクロプロピルプロピル基、2-シクロプロピルプロピル基、4-シクロプロピルブチル基が挙げられる。 The C 3- C 8 -cycloalkyl-C 1- C 4 -alkyl group consists of a cyclic cycloalkyl group having 3 to 8 carbon atoms and a linear or branched-chain alkyl group having 1 to 4 carbon atoms. Indicates that they are combined. For example, cyclopropylmethyl group, cyclobutylmethyl group, cyclopentylmethyl group, cyclohexylmethyl group, 2-cyclopropylethyl group, 1-cyclopropylethyl group, 2-cyclohexylethyl group, 3-cyclopropylpropyl group, 2-cyclo Examples thereof include a propylpropyl group and a 4-cyclopropylbutyl group.
 フェニル-C-C-アルキル基は、炭素原子数1~4個の直鎖または分岐鎖状のアルキル基にフェニル基が置換しており、例えば、フェニルメチル基、2-フェニルエチル基、3-フェニルプロピル基、および4-フェニルブチル基が挙げられる。 The phenyl-C 1- C 4 -alkyl group is a linear or branched alkyl group having 1 to 4 carbon atoms substituted with a phenyl group, for example, a phenylmethyl group, a 2-phenylethyl group, and the like. Examples include 3-phenylpropyl group and 4-phenylbutyl group.
 フェニル-C-C-アルケニル基は、フェニル基に炭素原子数2~4個の直鎖または分岐鎖状のアルケニル基が結合しており、例えば、フェニルエテニル基、フェニル-1-プロペニル基、フェニルイソプロペニル基、およびフェニルブテニル基が挙げられる。 The phenyl-C 2- C 4 -alkenyl group has a linear or branched alkenyl group having 2 to 4 carbon atoms bonded to the phenyl group, for example, a phenylethenyl group or a phenyl-1-propenyl. Groups include groups, phenylisopropenyl groups, and phenylbutenyl groups.
 フェニル-C-C-アルキニル基は、フェニル基に炭素原子数2~4個のアルキニル基が結合しており、例えば、フェニルエチニル基、フェニル-1-プロピニル基、フェニル-2-プロピニル基、フェニル-1-ブチニル基、フェニル-2-ブチニル基、およびフェニル-3-ブチニル基が挙げられる。 The phenyl-C 2- C 4 -alkynyl group has an alkynyl group having 2 to 4 carbon atoms bonded to the phenyl group, and is, for example, a phenylethynyl group, a phenyl-1-propynyl group, or a phenyl-2-propynyl group. , Phenyl-1-butynyl group, phenyl-2-butynyl group, and phenyl-3-butynyl group.
 Rは、好ましくは、C-C-アルキル基である。 R 4 is preferably, C 1 -C 6 - alkyl group.
 R、R、R、およびRにおける脂肪族基は、1、2、3もしくは可能な最大数の同一のまたは異なる基Rを有していてもよく、Rは、ハロゲン基、シアノ基、ニトロ基、C-C-アルコキシ基およびC-C-ハロアルコキシ基から互いに独立して選択される。 The aliphatic groups in R 1 , R 4 , R 5 and R 6 may have 1, 2, 3 or the maximum possible number of the same or different groups R a , where R a is a halogen group. , cyano group, nitro group, C 1 -C 4 - independently of each other selected from haloalkoxy group - alkoxy group and C 1 -C 4.
 ハロゲン基としては塩素基、臭素基、ヨウ素基またはフッ素基が挙げられる。例えば、クロロメチル基、2-クロロエチル基、2,3-ジクロロプロピル基、ブロモメチル基、クロロジフルオロメチル基、トリフルオロメチル基、および3,3,3-トリフルオロプロピル基が挙げられる。 Examples of the halogen group include a chlorine group, a bromine group, an iodine group or a fluorine group. For example, a chloromethyl group, a 2-chloroethyl group, a 2,3-dichloropropyl group, a bromomethyl group, a chlorodifluoromethyl group, a trifluoromethyl group, and a 3,3,3-trifluoropropyl group can be mentioned.
 C-C-アルコキシ基は、炭素原子数1~4個の直鎖または分岐鎖状のアルコキシ基であり、例えば、メトキシ基、エトキシ基、n-プロポキシ基、イソプロポキシ基、n-ブトキシ基、sec-ブトキシ基、tert-ブトキシ基が挙げられる。 C 1 -C 4 - alkoxy group is a linear or branched alkoxy group having 1 to 4 carbon atoms, e.g., methoxy, ethoxy, n- propoxy, isopropoxy, n- butoxy Examples include a group, a sec-butoxy group, and a tert-butoxy group.
 C-C-ハロアルコキシ基は、上述のC-C-アルコキシ基の置換し得る位置に1または2以上のハロゲン原子が置換されており、置換されるハロゲン基が2以上の場合においてハロゲン基は同一または異なっても良い。 C 1 -C 4 - haloalkoxy group, the aforementioned C 1 -C 4 - 1 or more halogen atoms at positions which can replace the alkoxy group is substituted, if a halogen group which is substituted in the 2 or more The halogen groups may be the same or different.
 Rは、ハロゲン基、シアノ基、ニトロ基、フェニル基、フェニル-オキシ基、C-C-アルキル基、C-C-ハロアルキル基、C-C-アルコキシ基、C-C-ハロアルコキシ基、-SORまたは-SFである。 R 2 is a halogen group, a cyano group, a nitro group, a phenyl group, a phenyl-oxy group, a C 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group, a C 1- C 4 -alkoxy group, and a C 1 -C 4 -haloalkoxy group, -SOR 7 or -SF 5 .
 ハロゲン基、C-C-アルキル基、C-C-ハロアルキル基、C-C-アルコキシ基、およびC-C-ハロアルコキシ基は、Rで表される有機基の例示として挙げた基を挙げることができる。 Halogen, C 1 -C 4 - alkyl group, C 1 -C 4 - haloalkyl group, C 1 -C 4 - alkoxy groups, and C 1 -C 4 - haloalkoxy group, an organic group represented by R a The groups mentioned as an example of the above can be mentioned.
 Rは、好ましくは、ハロゲン基、シアノ基、C-C-アルキル基、C-C-ハロアルキル基、C-C-アルコキシ基、-SORまたは-SFであり、さらに好ましくは、ハロゲン基、シアノ基、C-C-アルキル基、C-C-ハロアルキル基またはC-C-アルコキシ基である。 R 2 is preferably a halogen group, a cyano group, C 1 -C 4 - alkyl group, C 1 -C 4 - haloalkyl group, C 1 -C 4 - alkoxy group, an -SOR 7, or -SF 5, more preferably, a halogen group, a cyano group, C 1 -C 4 - alkoxy group - alkyl group, C 1 -C 4 - haloalkyl group or a C 1 -C 4.
 Rは、C-C-アルキル基またはC-C-ハロアルキル基である。Rの置換位置は2位、3位、5位または6位であり、好ましくは2位である。nは、0、1、2、3または4であり、好ましくは1である。 R 7 is, C 1 -C 4 - alkyl group or a C 1 -C 4 - haloalkyl group. The substitution position of R 2 is the 2nd, 3rd, 5th or 6th position, preferably the 2nd position. n is 0, 1, 2, 3 or 4, preferably 1.
 Rは、ハロゲン基、シアノ基、ニトロ基、アミノ基、フェニル基、フェニル-オキシ基、C-C-アルキル基、C-C-ハロアルキル基、C-C-アルコキシ基、C-C-ハロアルコキシ基、C-C-アルキルアミノ基、C-C-ジアルキルアミノ基、C-C-アルキルアシルアミノ基、-SORまたは-SFであり、ハロゲン基、C-C-アルキルC-C-ハロアルキル基、C-C-アルコキシ基またはC-C-ハロアルコキシ基、および-SORはRで表される有機基の例示として挙げた基を挙げることができる。 R 3 is a halogen group, a cyano group, a nitro group, an amino group, a phenyl group, a phenyl-oxy group, a C 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group, and a C 1- C 4 -alkoxy group. , C 1 -C 4 - haloalkoxy group, C 1 -C 4 - alkylamino group, C 1 -C 4 - dialkylamino group, C 1 -C 4 - alkyl acyl amino group, -SOR 7, or -SF 5 Yes, the halogen group, C 1- C 4 -alkyl C 1- C 4 -haloalkyl group, C 1- C 4 -alkoxy group or C 1- C 4 -halo alkoxy group, and -SOR 7 are represented by R 2. Examples of the organic groups mentioned above can be mentioned.
 Rは、好ましくは、ハロゲン基、ニトロ基、アミノ基、C-C-アルキル基、C-C-ハロアルキル基、C-C-アルコキシ基、C-C-ハロアルコキシ基、C-C-アルキルアミノ基、C-C-ジアルキルアミノ基、C-C-アルキルアシルアミノ基、-SORまたは-SFであり、さらに好ましくは、ハロゲン基、C-C-アルキル基、C-C-ハロアルキル基、C-C-アルコキシ基またはC-C-ハロアルコキシ基である。 R 3 is preferably a halogen group, a nitro group, an amino group, C 1 -C 4 - alkyl group, C 1 -C 4 - haloalkyl group, C 1 -C 4 - alkoxy group, C 1 -C 4 - halo alkoxy groups, C 1 -C 4 - alkylamino group, C 1 -C 4 - dialkylamino group, C 1 -C 4 - alkyl acyl amino group, an -SOR 7, or -SF 5, more preferably a halogen group , C 1- C 4 -alkyl group, C 1- C 4 -haloalkyl group, C 1- C 4 -alkoxy group or C 1- C 4 -haloalkoxy group.
 C-C-アルキルアミノ基は、アミノ基が有する水素原子の1つが炭素原子数1~4個の直鎖または分岐鎖状のアルキル基に置換されたアミノ基であり、例えば、メチルアミノ基、エチルアミノ基、n-プロピルアミノ基、イソプロピルアミノ基、およびtert-ブチルアミノ基が挙げられる。 C 1 -C 4 - alkylamino group is one of an amino group substituted with a straight-chain or branched alkyl group having 1 to 4 carbon atoms of the hydrogen atom of the amino group, e.g., methylamino Examples include groups, ethylamino groups, n-propylamino groups, isopropylamino groups, and tert-butylamino groups.
 C-C-ジアルキルアミノ基は、アミノ基が有する水素原子2つ共が炭素原子数1~4個の直鎖または分岐鎖状のアルキル基に置換されたアミノ基であり、例えば、N,N-ジメチルアミノ基、N,N-ジエチルアミノ基、N,N-ジ-n-プロピルアミノ基、N,N-ジイソプロピルアミノ基、およびN,N-ジ-tert-ブチルアミノ基が挙げられる。 C 1 -C 4 - dialkylamino group is an amino group in which a hydrogen atom of two co-having amino group substituted by a straight or branched chain alkyl group having 1 to 4 carbon atoms, e.g., N , N-dimethylamino group, N, N-diethylamino group, N, N-di-n-propylamino group, N, N-diisopropylamino group, and N, N-di-tert-butylamino group.
 C-C-アルキルアシルアミノ基は、アミノ基が有する水素原子の1つまたは2つが炭素原子数1~4個の直鎖または分岐鎖状のアルキルアシル基に置換されたアミノ基であり、例えば、メチルアシルアミノ基、エチルアシルアミノ基、n-プロピルアシルアミノ基、イソプロピルアシルアミノ基、tert-ブチルアシルアミノ基、N,N-ジメチルアシルアミノ基、N,N-ジエチルアシルアミノ基、N,N-ジ-n-プロピルアシルアミノ基、N,N-ジイソプロピルアシルアミノ基、およびN,N-ジ-tert-ブチルアシルアミノ基が挙げられる。 C 1 -C 4 - alkyl acyl amino group, it is one or two amino groups substituted with a linear or branched alkyl acyl group of 1 to 4 carbon atoms of the hydrogen atom of the amino group For example, methyl acylamino group, ethyl acylamino group, n-propyl acylamino group, isopropyl acylamino group, tert-butyl acylamino group, N, N-dimethylacylamino group, N, N-diethylacylamino group, Examples thereof include N, N-di-n-propyl acylamino groups, N, N-diisopropyl acylamino groups, and N, N-di-tert-butyl acylamino groups.
 R、R、Rにおけるシクロアルキル基もしくはフェニル基部分、またはRにおけるフェニル基部分は、1、2、3、4、5もしくは可能な最大数の同一のまたは異なる基Rを有していてもよく、Rは、ハロゲン基、シアノ基、ニトロ基、C-C-アルキル基、C-C-アルコキシ基、C-C-ハロアルキル基およびC-C-ハロアルコキシ基から互いに独立して選択される。ハロゲン基、C-C-アルキル基、C-C-アルコキシ基、C-C-ハロアルキル基およびC-C-ハロアルコキシ基は、Rで表される有機基の例示として挙げた基を挙げることができる。 The cycloalkyl or phenyl group moiety in R 4 , R 5 , R 6 or the phenyl group moiety in R 3 has 1, 2, 3, 4, 5 or the maximum number of possible identical or different groups R b . may also be, R b is halogen, cyano, nitro, C 1 -C 4 - alkyl group, C 1 -C 4 - alkoxy group, C 1 -C 4 - haloalkyl and C 1 -C 4- Selected independently of each other from the haloalkoxy group. Halogen, C 1 -C 4 - alkyl group, C 1 -C 4 - alkoxy group, C 1 -C 4 - haloalkyl and C 1 -C 4 - haloalkoxy group, the organic group represented by R a The groups given as an example can be mentioned.
 以上から、トリアゾール誘導体(-)-エナンチオマーの好ましい一態様としては、一般式(I)において、Rが、-ORであり;Rが、ハロゲン基、シアノ基、C-C-アルキル基、C-C-ハロアルキル基、C-C-アルコキシ基、-SORまたは-SFであり;Rが、ハロゲン基、ニトロ基、シアノ基、アミノ基、C-C-アルキル基、C-C-ハロアルキル基、C-C-アルコキシ基、C-C-ハロアルコキシ基、C-C-アルキルアミノ基、C-C-ジアルキルアミノ基、C-C-アルキルアシルアミノ基、-SORまたは-SFである、トリアゾール誘導体(-)-エナンチオマーが挙げられる。 From the above, the triazole derivative (-) - as a preferred embodiment of the enantiomers, in the general formula (I), R 1 is located at -OR 4; R 2 is halogen, cyano, C 1 -C 4 - Alkoxy group, C 1- C 4 -haloalkyl group, C 1- C 4 -alkoxy group, -SOR 7 or -SF 5 ; R 3 is halogen group, nitro group, cyano group, amino group, C 1- C 4 - alkyl group, C 1 -C 4 - haloalkyl group, C 1 -C 4 - alkoxy group, C 1 -C 4 - haloalkoxy group, C 1 -C 4 - alkylamino group, C 1 -C 4 - dialkylamino group, C 1 -C 4 - alkyl acyl amino group, an -SOR 7, or -SF 5, triazole derivative (-) - include enantiomers.
 また、トリアゾール誘導体(-)-エナンチオマーのより好ましい一態様としては、一般式(I)において、Rが、-ORであり、かつRが、C-C-アルキル基であり;Rが、ハロゲン基、シアノ基、C-C-アルキル基、C-C-ハロアルキル基またはC-C-アルコキシ基であり;Rが、ハロゲン基、シアノ基、C-C-アルキル基、C-C-ハロアルキル基、C-C-アルコキシ基またはC-C-ハロアルコキシ基である、トリアゾール誘導体(-)-エナンチオマーが挙げられる。 Further, as a more preferable embodiment of the triazole derivative (-)-enantiomer, in the general formula (I), R 1 is -OR 4 and R 4 is a C 1- C 6 -alkyl group; R 2 is a halogen group, a cyano group, a C 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group or a C 1- C 4 -alkoxy group; R 3 is a halogen group, a cyano group, C. Examples thereof include a triazole derivative (-)-enantiomer which is a 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group, a C 1- C 4 -alkoxy group or a C 1- C 4-haloalkoxy group.
 トリアゾール誘導体(-)-エナンチオマーの農薬学的に許容可能な塩は、特に、そのカチオンおよびアニオンが、トリアゾール誘導体(-)-エナンチオマーの作用に悪影響を及ぼさない、これらのカチオンの塩またはこれらの酸の酸付加塩を包含する。好適なカチオンは特に、アルカリ金属(好ましくはナトリウムおよびカリウム)、アルカリ土類金属(好ましくはカルシウム、マグネシウムおよびバリウム)、遷移金属(好ましくはマンガン、銅、亜鉛および鉄)のイオンであり、また、所望の場合には1~4個のC-C-アルキル置換基および/または1個のフェニル置換基もしくはベンジル置換基を有していてよいアンモニウムイオン(好ましくはジイソプロピルアンモニウム、テトラメチルアンモニウム、テトラブチルアンモニウム、トリメチルベンジルアンモニウム)、さらにはホスホニウムイオン、スルホニウムイオン(好ましくはトリ(C-C-アルキル)スルホニウム)、およびスルホキソニウムイオン(好ましくはトリ(C-C-アルキル)スルホキソニウム)でもある。有用な酸付加塩のアニオンは、主に、塩化物イオン、臭化物イオン、フッ化物イオン、硫酸水素イオン、硫酸イオン、リン酸二水素イオン、リン酸水素イオン、リン酸イオン、硝酸イオン、重炭酸イオン、炭酸イオン、ヘキサフルオロケイ酸イオン、ヘキサフルオロリン酸イオン、安息香酸イオン、ならびにC-C-アルカン酸のアニオン、好ましくはギ酸イオン、酢酸イオン、プロピオン酸イオンおよび酪酸イオンである。これらは、トリアゾール誘導体(-)-エナンチオマーを、対応するアニオンの酸(好ましくは塩酸、臭化水素酸、硫酸、リン酸または硝酸)と反応させることにより形成することができる。 Agriculturally acceptable salts of triazole derivative (-)-enantiomers, in particular salts of these cations or acids thereof, whose cations and anions do not adversely affect the action of the triazole derivative (-)-enantiomer. Includes acid addition salts of. Suitable cations are particularly ammonium ions of alkali metals (preferably sodium and potassium), alkaline earth metals (preferably calcium, magnesium and barium), transition metals (preferably manganese, copper, zinc and iron) and also. 1 to 4 C 1 -C if desired 4 - alkyl substituents and / or one phenyl substituent or benzyl substituent optionally may ammonium ions (preferably diisopropyl ammonium have, tetramethylammonium, tetrabutylammonium, trimethylbenzylammonium), furthermore phosphonium ions, sulfonium ions (preferably tri (C 1 -C 4 - alkyl) sulfonium), and sulfoxonium ions (preferably tri (C 1 -C 4 - alkyl) sulfonium It is also (xonium). The anions of useful acid addition salts are mainly chloride ion, bromide ion, fluoride ion, hydrogen sulfate ion, sulfate ion, dihydrogen phosphate ion, hydrogen phosphate ion, phosphate ion, nitrate ion, bicarbonate. ions, carbonate ions, hexafluorosilicic acid ion, hexafluorophosphate ion, benzoate ion, and C 1 -C 4 - anions of alkanoic acids, preferably ion formic acid, acetate, propionate and butyrate. These can be formed by reacting the triazole derivative (-)-enantiomer with the corresponding anionic acid (preferably hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid or nitric acid).
 [2.トリアゾール誘導体(-)-エナンチオマーの製造方法]
 〔1.光学分割によるトリアゾール誘導体(-)-エナンチオマーの調製〕
 トリアゾール誘導体(-)-エナンチオマーは、トリアゾール誘導体(I)のラセミ体から、分取分離によって得ることができる。トリアゾール誘導体(I)のラセミ体は、例えば、特許文献1に記載の方法に従い得ることができる。なお、特許文献1に記載の方法に従ってトリアゾール誘導体を製造した場合、得られるトリアゾール誘導体はラセミ体となる。
[2. Triazole derivative (-)-Production method of enantiomer]
[1. Preparation of triazole derivative (-)-enantiomer by optical resolution]
The triazole derivative (-)-enantiomer can be obtained by preparative separation from the racemate of the triazole derivative (I). The racemate of the triazole derivative (I) can be obtained, for example, according to the method described in Patent Document 1. When the triazole derivative is produced according to the method described in Patent Document 1, the obtained triazole derivative is a racemate.
 エナンチオマーの分離方法としては、キラルクロマトグラフィーによって分離する方法が挙げられる。具体的には、アミローストリス(3,5-ジメチルフェニルカルバメート)、セルローストリス(3,5-ジメチルフェニルカルバメート)、セルローストリス(3,5-ジクロロフェニルカルバメート)、アミローストリス[(S)-α-メチルベンジルカルバメート]、セルローストリス(4-メチルベンゾエート)、アミローストリス(5-クロロ-2-メチルフェニルカルバメート)またはセルローストリス(3-クロロ-4-メチルフェニルカルバメート)をシリカゲル担体に固定化した固定相上で、ヘキサン/エタノール(100/0~0/100)、ヘキサン/イソプロパノール(100/0~0/100)、エタノール、メタノールまたはアセトニトリルを移動相として用いて、トリアゾール誘導体(I)のラセミ体から分取分離を行うことにより、トリアゾール誘導体(-)-エナンチオマーを調製できる。 Examples of the method for separating enantiomers include a method for separating by chiral chromatography. Specifically, amylostris (3,5-dimethylphenylcarbamate), cellulosetris (3,5-dimethylphenylcarbamate), cellulosetris (3,5-dichlorophenylcarbamate), amylostris [(S) -α-methyl Benzyl carbamate], cellulose tris (4-methylbenzoate), amylose tris (5-chloro-2-methylphenyl carbamate) or cellulose tris (3-chloro-4-methylphenyl carbamate) on a stationary phase immobilized on a silica gel carrier. Then, using hexane / ethanol (100/0 to 0/100), hexane / isopropanol (100/0 to 0/100), ethanol, methanol or acetonitrile as the mobile phase, the triazole derivative (I) is separated from the racemic form. By taking and separating, a triazole derivative (-)-enantiomer can be prepared.
 分取分離された(-)-エナンチオマーの旋光度は、従来公知の方法に従って決定すればよい。 The optical rotation of the separated (-)-enantiomer may be determined according to a conventionally known method.
 〔2.化学合成によるトリアゾール誘導体(-)-エナンチオマーの調製〕
 (全体スキーム)
[2. Preparation of triazole derivative (-)-enantiomer by chemical synthesis]
(Overall scheme)
Figure JPOXMLDOC01-appb-C000004
Figure JPOXMLDOC01-appb-C000004
 以下、各工程について説明する。なお、以下の説明では、全体スキーム中、一般式(N)(ここで、Nは任意のローマ数字)で示された化合物を、化合物(N)と称する。 Hereinafter, each process will be described. In the following description, the compound represented by the general formula (N) (where N is an arbitrary Roman numeral) in the overall scheme is referred to as compound (N).
 (工程1)
 工程1では、化合物(VIII)にメチル基を導入することにより、化合物(VII)を得る。ここで、化合物(VIII)におけるRはC-C-アルキル基である。一例としては、化合物(VIII)の溶液に低温下(例えば-78℃)でメチル化試薬を添加し、反応させる方法が挙げられる。
(Step 1)
In step 1, a compound (VII) is obtained by introducing a methyl group into the compound (VIII). Wherein, R 7 in the compound (VIII) is C 1 -C 6 - alkyl group. One example is a method in which a methylation reagent is added to a solution of compound (VIII) at a low temperature (for example, −78 ° C.) and reacted.
 メチル化試薬としては、トリメチルアルミニウム、メチルマグネシウムクロリド、メチルマグネシウムブロミドおよびメチルリチウムなどが挙げられる。 Examples of the methylation reagent include trimethylaluminum, methylmagnesium chloride, methylmagnesium bromide, and methyllithium.
 工程1の溶媒としては、テトラヒドロフラン、ジオキサンおよびジエチルエーテルなどのエーテル類、ならびに反応に不活性なトルエンおよびヘキサンなどの有機溶媒が挙げられる。 Examples of the solvent in step 1 include ethers such as tetrahydrofuran, dioxane and diethyl ether, and organic solvents such as toluene and hexane which are inert to the reaction.
 (工程2)
 工程2では、化合物(VII)から酸触媒を用いた脱水反応により、エキソオレフィンを形成することで、化合物(VI)を得る。
(Step 2)
In step 2, a compound (VI) is obtained by forming an exoolefin from the compound (VII) by a dehydration reaction using an acid catalyst.
 一例としては、ディーン・スターク装置を設置した反応容器にて、酸触媒としてパラトルエンスルホン酸一水和物、溶媒としてトルエンを用い、還流条件下で脱水しながら反応させる方法を挙げることができるが、これに限定されるものではない。 As an example, in a reaction vessel equipped with a Dean-Stark apparatus, a method of reacting while dehydrating under reflux conditions using paratoluenesulfonic acid monohydrate as an acid catalyst and toluene as a solvent can be mentioned. , Not limited to this.
 (工程3)
 工程3では化合物(VI)のエステル部分をアルコールに還元することにより、化合物(V)を得る。具体的には、溶媒中、化合物(VI)とヒドリド還元剤を低温下(例えば0℃)または室温下で混合することで化合物(V)を得る。
(Step 3)
In step 3, the ester portion of compound (VI) is reduced to alcohol to obtain compound (V). Specifically, the compound (V) is obtained by mixing the compound (VI) and the hydride reducing agent in a solvent at a low temperature (for example, 0 ° C.) or at room temperature.
 工程3の溶媒としては、テトラヒドロフラン、ジオキサンおよびジエチルエーテルなどのエーテル類、反応に不活性なトルエンおよびジクロロメタン、ならびにそれらの混合液といった有機溶媒を挙げることができる。 Examples of the solvent in step 3 include ethers such as tetrahydrofuran, dioxane and diethyl ether, reaction-inactive toluene and dichloromethane, and organic solvents such as a mixture thereof.
 ヒドリド還元剤としては、水素化アルミニウムリチウムおよび水素化ジイソブチルアルミニウムなどが挙げられる。 Examples of the hydride reducing agent include lithium aluminum hydride and diisobutylaluminum hydride.
 (工程4)
 工程4では化合物(V)のオレフィン部分をエポキシ化することにより、化合物(IV)を得る。
(Step 4)
In step 4, compound (IV) is obtained by epoxidizing the olefin moiety of compound (V).
 一例としては、ジクロロメタン中、低温下(例えば-20℃)でチタン(IV)テトライソプロポキシド、L-(+)-酒石酸ジエチルおよびtert-ブチルヒドロペルオキシドを混合し、ここに化合物(V)を添加し、低温下で反応させる方法を挙げることができるが、これに限定されるものではない。 As an example, titanium (IV) tetraisopropoxide, diethyl L- (+)-diethyl tartrate and tert-butyl hydroperoxide are mixed in dichloromethane at a low temperature (for example, -20 ° C.), and compound (V) is added thereto. Examples thereof include, but are not limited to, a method of adding and reacting at a low temperature.
 (工程5)
 工程5では化合物(IV)のアルコール部分をカルボン酸に酸化することにより、化合物(III)を得る。具体的には、三塩化ルテニウム、過ヨウ素酸ナトリウムおよび化合物(IV)を溶媒中で室温下にて混合することで化合物(III)を得る。
(Step 5)
In step 5, compound (III) is obtained by oxidizing the alcohol moiety of compound (IV) to a carboxylic acid. Specifically, compound (III) is obtained by mixing ruthenium trichloride, sodium periodate and compound (IV) in a solvent at room temperature.
 工程5の溶媒としては、水、四塩化炭素、アセトニトリルおよび酢酸エチル、ならびにこれらの溶媒から構成される混合溶媒が挙げられる。 Examples of the solvent in step 5 include water, carbon tetrachloride, acetonitrile and ethyl acetate, and a mixed solvent composed of these solvents.
 (工程6)
 工程6では、化合物(III)から化合物(II)を得る。なお、RがORであり、かつRが水素の場合には、化合物(II)と化合物(III)とは同じであるため、本工程は不要である。
(Step 6)
In step 6, compound (II) is obtained from compound (III). When R 1 is OR 4 and R 4 is hydrogen, the compound (II) and the compound (III) are the same, so that this step is not necessary.
 まず、RがORであり、かつRがアルキルの場合には、化合物(III)をアルキル化することにより、化合物(II)を得る方法が挙げられる。一例としては、溶媒中、炭酸塩およびアルキル化試薬としてジアルキル硫酸(ROS(=O)OR)もしくはR-LGを用いて、室温で反応をさせる方法が挙げられる。 First, when R 1 is OR 4 and R 4 is alkyl, a method of obtaining compound (II) by alkylating compound (III) can be mentioned. As an example, in a solvent, a dialkyl sulfate (R 4 OS (= O) OR 4) as carbonate and alkylating reagent or with R 4 -LG, and a method for the reaction at room temperature.
 炭酸塩は炭酸ナトリウム、炭酸カリウム、炭酸セシウムおよび炭酸リチウムが挙げられる。 Examples of carbonates include sodium carbonate, potassium carbonate, cesium carbonate and lithium carbonate.
 LGは求核的に置換可能な脱離基、例えば、ハロゲン基、アルキルスルホニルオキシ基およびアリールスルホニルオキシ基から選ばれる脱離基を有する。 LG has a leaving group that can be substituted nucleophilically, for example, a leaving group selected from a halogen group, an alkylsulfonyloxy group and an arylsulfonyloxy group.
 次に、RがNRである場合には、化合物(III)とアミンとを縮合させることにより、化合物(II)を得る。具体的には、溶媒中、化合物(III)、アミン、塩基および縮合剤を混合し、室温下で反応させる方法が挙げられる。 Next, when R 1 is NR 5 R 6 , compound (II) is obtained by condensing compound (III) with an amine. Specific examples thereof include a method in which compound (III), an amine, a base and a condensing agent are mixed in a solvent and reacted at room temperature.
 工程6の溶媒としては、N,N-ジメチルアセトアミド、N-メチルピロリドンおよびN,N-ジメチルホルムアルデヒドなどのアミド類、ならびに反応に不活性なジクロロメタンおよびジクロロエタンなどの有機溶媒を挙げることができる。 Examples of the solvent in step 6 include amides such as N, N-dimethylacetamide, N-methylpyrrolidone and N, N-dimethylformaldehyde, and organic solvents such as dichloromethane and dichloroethane which are inert to the reaction.
 塩基としては、トリエチルアミン、ジイソプロピルエチルアミンおよびN,N-ジメチル-4-アミノピリジンなどの三置換アミン類が挙げられる。 Examples of the base include trisubstituted amines such as triethylamine, diisopropylethylamine and N, N-dimethyl-4-aminopyridine.
 また、縮合剤としては、1-[ビス(ジメチルアミノ)メチレン]-1H-1,2,3-トリアゾロ[4,5-b]ピリジニウム3-オキシドヘキサフルオロホスファート(HATU)、1-[ビス(ジメチルアミノ)メチレン]-1H-ベンゾトリアゾリニウム3-オキシドヘキサフルオロホスファート(HBTU)および1H-ベンゾトリアゾール-1-イルオキシトリピロリジノホスホニウムヘキサフルオロホスファート(PyBOP)などが挙げられる。 Examples of the condensing agent include 1- [bis (dimethylamino) methylene] -1H-1,2,3-triazolo [4,5-b] pyridinium 3-oxide hexafluorophosphate (HATU) and 1- [bis. (Dimethylamino) Methylene] -1H-benzotriazolinium 3-oxide hexafluorophosphate (HBTU) and 1H-benzotriazole-1-yloxytripyrrolidinophosphonium hexafluorophosphate (PyBOP) and the like.
 (工程7)
 工程7では、公知の方法(例えば、特許文献:特開2013-100238号に記載の方法)によって、化合物(II)とアゾール化合物とを溶媒中で混合することにより、化合物(II)においてオキシラン環を構成する炭素原子とアゾール化合物の窒素原子との間に炭素-窒素結合が生成することで、化合物(I)、すなわち、トリアゾール誘導体(I)が製造される。
(Step 7)
In step 7, the oxylan ring in the compound (II) is obtained by mixing the compound (II) and the azole compound in a solvent by a known method (for example, the method described in Patent Document: Japanese Patent Application Laid-Open No. 2013-100238). The compound (I), that is, the triazole derivative (I) is produced by forming a carbon-nitrogen bond between the carbon atom constituting the compound and the nitrogen atom of the azole compound.
 アゾール化合物としては、1,2,4-トリアゾールまたはそのアルカリ金属塩が挙げられる。 Examples of the azole compound include 1,2,4-triazole or an alkali metal salt thereof.
 工程7の溶媒は特に限定されず、例えば、メタノール、エタノールなどのアルコール類、ベンゼン、トルエン、キシレンおよびクロロベンゼンなどの芳香族炭化水素類、N,N-ジメチルアセトアミド、N-メチルピロリドンおよびN,N-ジメチルホルムアルデヒドなどのアミド類、ならびにジメチルスルホキシドを挙げることができる。 The solvent of step 7 is not particularly limited, and for example, alcohols such as methanol and ethanol, aromatic hydrocarbons such as benzene, toluene, xylene and chlorobenzene, N, N-dimethylacetamide, N-methylpyrrolidone and N, N. -Amids such as dimethylformaldehyde, as well as dimethylsulfoxide can be mentioned.
 また、所望により塩基を添加してもよい。塩基としては、ナトリウムメトキシド、ナトリウムエトキシド、ナトリウムt-ブトキシドおよびカリウムt-ブトキシドなどのアルカリ金属のアルコキシド、ならびに炭酸カリウムなどを挙げることができる。 Further, a base may be added if desired. Examples of the base include alkali metal alkoxides such as sodium methoxide, sodium ethoxide, sodium t-butoxide and potassium t-butoxide, and potassium carbonate and the like.
 [3.農園芸用薬剤]
 トリアゾール誘導体(-)-エナンチオマーは、1,2,4-トリアゾリル基を有するので、無機酸および有機酸の酸付加塩または金属錯体を形成する。したがって、酸付加塩および金属錯体の一部として、農園芸用薬剤等の有効成分として使用することができる。
[3. Agricultural and horticultural chemicals]
Since the triazole derivative (-)-enantiomer has a 1,2,4-triazolyl group, it forms an acid addition salt or metal complex of an inorganic acid and an organic acid. Therefore, it can be used as an active ingredient of agricultural and horticultural chemicals as a part of an acid addition salt and a metal complex.
 〔1.植物病害防除効果〕
 本実施形態における農園芸用殺菌剤は、広汎な植物病害に対する防除効果を呈する。
[1. Plant disease control effect]
The fungicide for agriculture and horticulture in the present embodiment exhibits a control effect against a wide range of plant diseases.
 適用病害の例として以下を挙げることができる。なお、各病害の後ろの括弧内は、当該病害を引き起こす主な病原菌を示している。ダイズさび病(Phakopsora pachyrhizi、Phakopsora meibomiae)、ダイズ褐紋病(Zymoseptoria glycines)、ダイズ紫斑病(Cercospora kikuchii)、ダイズ褐点病(Alternaria sp.)、ダイズ炭疽病(Collectotrichum truncatum)、ダイズのFrogeye leaf spot(Cercocpora sojina)、ダイズのリゾクトニア根腐病(Rhizoctonia solani)、ダイズ葉腐病(Rhizoctonia solani)、ダイズ黒点病(Diaporthe phaseolorum)、ダイズ茎疫病(Phytophthora sojae)、インゲンマメ炭疽病(Colletotrichum lindemuthianum)、ナタネのPhoma leaf
 spot/stem canker(Leptosphaeria maculans、Leptosphaeria biglobosa)、ナタネのLight leaf
 spot(Pyrenopeziza brassicae)、ナタネ根こぶ病Clubroot(Plasmodiophora brassicae)、ナタネのバーティシリウム萎凋病(Verticillium longisporum)、ナタネのBlackspot(Alternaria spp)、イネいもち病(Pyricularia oryzae)、イネごま葉枯病(Cochliobolus miyabeanus)、イネ白葉枯病(Xanthomonas oryzae)、イネ紋枯病(Rhizoctonia solani)、イネ小黒菌核病(Helminthosporium sigmoideun)、イネばか苗病(Fusarium fujikuroi)、イネ苗立枯病(Pythium aphanidermatum)、イネ立枯病(Pythium graminicola)、オオムギうどんこ病(Erysiphe graminis f. sp hordei)、オオムギ黒さび病(Puccinia graminis)、オオムギ黄さび病(Puccinia striiformis)、オオムギ斑葉病(Pyrenophora graminea)、オオムギ雲形病(Rhynchosporium secalis)、オオムギ裸黒穂病(Ustilago nuda)、オオムギ網斑病(Pyrenophora teres)、オオムギ赤かび病(Fusarium graminearum、Microdochium nivale)、コムギうどんこ病(Erysiphe graminis f. sp tritici)、コムギ赤さび病(Puccinia recondita)、コムギ黄さび病(Puccinia striiformis)、コムギ眼紋病(Pseudocercosporella herpotrichoides)、コムギ赤かび病(Fusarium graminearum、Microdochium nivale)、コムギふ枯病(Phaeosphaeria nodorum)、コムギ葉枯病(Zymoseptoria tritici)、コムギ紅色雪腐病(Microdochium nivale)、コムギ立枯病(Gaeumannomyces graminis)、コムギ黒点病(Epicoccum spp)、コムギ黄斑病(Pyrenophora tritici-repentis)、コムギ小粒菌核病(Typhula incarnate、Typhula ishikariensis)、シバダラースポット病(Sclerotinia homoeocarpa)、シバラージパッチ病(Rhizoctonia solani)、ブラウンパッチ病(Rhizoctonia solani)、シバ炭疽病(Colletotrichum graminicola)、シバのGray leaf Spot(Pyricularia grisea)、シバのネクロティックリングスポット病(Ophiosphaerella korrae)、シバのRed thread(Laetisaria fuciformis)、シバさび病(Puccinia zoysiae)、シバのサマーパッチ病(Magnaporthe poae)、シバのRoot decline of warm-season grasses(Gaeumannomyces graminis)、シバのブラウンリングパッチ(Waitea circinata)、シバフェアリーリング病(Agaricus、Calvatia、Chlorophyllum、Clitocybe、Lepiota、Lepista、Lycoperdon、Marasmius、Scleroderma、Tricholomaなど)、シバ紅色雪腐病(Microdochium nivale)、シバ雪腐小粒菌核病(Typhula incarnate、Typhula ishikariensis)、シバカーブラリア葉枯病(Curvularia sp.)、シバ疑似葉腐病(Ceratobasidium sp.)、シバ立枯病(Zoysia decline)、トウモロコシ黒穂病(Ustilago maydis)、トウモロコシ炭疽病(Colletotrichum graminicola)、トウモロコシ褐斑病(Kabatiella zeae)、トウモロコシ灰色斑点病(Cercospora zeae-maydis)、トウモロコシすす紋病(Setosphaeria turcica)、トウモロコシ北方斑点病(Cochliobolus carbonum)、トウモロコシ斑点病(Physoderma maydis)、トウモロコシさび病(Puccinia spp)、トウモロコシごま葉枯病(Bipolaris maydis)、トウモロコシ黄色ごま葉枯病(Phyllosticta maydis)、トウモロコシ赤かび病(Gibberella zeae)、サトウキビさび病(Puccinia spp)、ウリ類うどんこ病(Sphaerotheca fuliginea)、ウリ類炭疸病(Colletotrichum lagenarium、Glomerella cingulata)、キュウリべと病(Pseudoperonospora cubensis)、キュウリ灰色疫病(Phytophthora capsici)、キュウリつる割病(Fusarium oxysporum f.sp.cucumerinum)、スイカつる割病(Fusarium oxysporum f.sp.niveum)、リンゴうどんこ病(Podosphaera leucotricha)、リンゴ黒星病(Venturia inaequalis)、リンゴモリニア病(Monilinia mali)、リンゴ斑点落葉病(Alternaria alternata apple pathotype)、リンゴ腐乱病(Valsa mali)、ナシ黒斑病(Alternaria alternata pear pathotype)、ナシうどんこ病(Phyllactinia pyri)、ナシ赤星病(Gymnosporangium asiaticum)、ナシ黒星病(Venturia nashicola)、イチゴうどんこ病(Sphaerotheca humuli)、核果類果樹の灰星病(Monilinia fructicola)、カンキツ青かび病(Penicillium italicum)、ブドウうどんこ病(Uncinula necator)、ブドウべと病(Plasmopara viticola)、ブドウ晩腐病(Glomerella cingulata)、ブドウのさび病(Phakopsora ampelopsidis)、斑葉病(シガトカ病)(Mycosphaerella fijiensis、Mycosphaerella musicola)、トマトうどんこ病(Erysiphe cichoracearum)、トマト輪紋病(Alternaria solani)、ナスうどんこ病(Erysiphe cichoracearum)、ジャカイモの夏疫病(Alternaria solani)、ジャカイモ炭疽病(Colletotrichum coccodes)、ジャカイモうどんこ病(Erysiphe spp、Leveillula taurica)、ジャカイモ疫病(Phytophthora infestans)、タバコうどんこ病(Erysiphe cichoracearum)、タバコ赤星病(Alternaria longipes)、テンサイ褐斑病(Cercospora beticola)、テンサイうどんこ病(Erysiphe betae)、テンサイ葉腐病(Thanatephorus cucumeris)、テンサイ根腐病(Thanatephorus cucumeris)、テンサイ黒根病(Aphanomyces cochlioides)、ダイコン萎黄病(Fusarium oxysporum f.sp.raphani)、チャ炭疽病(Discula theae-sinensis)、チャもち病(Exobasidium vexans)、チャ褐色円星病(Pseudocercospora ocellata、Cercospora chaae)、チャ輪紋病(Pestalotiopsis longiseta、Pestalotiopsis theae)、チャ網もち病(Exobasidium reticulatum)、ワタ黒斑病Alternaria leaf spot(Alternaria spp)、ワタ炭疽病(Glomerella spp)、ワタ輪紋病(Ascochyta gossypii)、ワタさび病(Puccinia spp、Phykopsora spp)、ワタのCercospora blight and leaf spot(Cercospora spp)、ワタのDiplopia boll rot(Diplopia spp)、ワタのHard lock(Fusarium spp)、ワタのPhoma blight(Phoma spp)、ワタのStemphyllium leaf spot(Stemphyllium spp)、ラッカセイ黒渋病(Cercosporidium personatum)、ラッカセイ褐斑病(Cercospora arachidicola)、ラッカセイ白絹病(Sclerotium rolfsii)、ラッカセイさび病(Puccinia arachidis)、バナナイエローシガトカ病(Mycosphaerella musicoka)、バナナブラックシガトカ病(Mycosphaerella fijiensis)、種々の作物をおかす灰色かび病(Botrytis cinerea)、ピシウム属菌の病害(Pythium spp)および菌核病(Sclerotinia sclerotiorum)など。また、Aspergillus属、Cochliobolus属、Corticium属、Diplodia属、Penicillium属、Fusarium属、Gibberella属、Mucor属、Phoma属、Phomopsis属、Pyrenophora属、Pythium属、Rhizoctonia属、Rhizopus属、Thielaviopsis属、Tilletia属、Trichoderma属、およびUstilago属等によって引き起こされる各種植物の種子伝染性病害または生育初期の病害。
Examples of applicable diseases include the following. The parentheses after each disease indicate the main pathogens that cause the disease. Soybean rust (Phakopsora pachyrhizi, Phakopsora meibomiae), soybean brown spot disease (Zymoseptria glycines), soybean purple spot disease (Cercospora kikuchiri), soybean brown spot disease (Alter) spot (Cercocopora sojina), soybean lysoctonia root rot (Rhizoctonia soly), soybean leaf rot (Rhizoctonia soly), soybean black spot disease (Diaporthe phaselorum), soybean stalk epidemic (Phoseolorum) Rapeseed Phoma leaf
spot / stem canker (Leptosphaeria maculans, Leptosphaeria biglobosa), Light leaf of rapeseed
spot (Pyrenopeziza brassicae), rapeseed root-knot disease Clubloot (Plasmodiophora brassicae), rapeseed verticillium wilt disease (Verticillium lonei rape), rapeseed Bla Cochliobolus miyabeanus, rice white leaf blight (Xanthomonas oryzae), rice crest blight (Rhizoctonia solani), rice small black fungus nucleus disease (Helminthosporium sigmoideun), rice seedlings , Phythium glaminicola, Omugi udonko disease (Erysipe graminis f. Sphordei), Omugi black rust (Puccinia graminis), Omugi Fusarium head blight (Puccinia), Fusarium head blight (Puccinia) Wilt disease (Rynchosporium secalis), Naked black scab (Ustilago nuda), Puccinia teres, Fusarium head blight (Fusarium head blight) , Puccinia recondita, Puccinia striformis, Pseudocercosporella herpotorichoides, Fusarium head blight, Fusarium head blight, Fusarium head blight, Fusarium head blight Blight (Zymoseptria tritici), Fusarium head blight (Microdochium nivale), Fusarium head blight (Gaeumanomyces graminis), Wheat black spot (Epicoccum spp), Wheat yellow spot (Puccinia) ritici-repentis, wheat small sclerotium nuclear disease (Typula incarnate, Cyphula ishikariensis), Shivadar spot disease (Sclerotinia homoeocarpa), Shivalaji patch disease (Rhizoctonia) ), Gray leaf Spot (Pyricularia grisea) of Shiva, Necrotic ring spot disease of Shiva (Ophiosphaerella korrae), Red threat (Laetisaria fuciformis) of Shiva, Rhizoctonia (Phizoctonia) , Sheba of Root decline of warm-season grasses (Gaeumannomyces graminis), lawn of brown ring patch (Waitea circinata), grass Fairy ring disease (Agaricus, Calvatia, Chlorophyllum, Clitocybe, Lepiota, Lepista, Lycoperdon, Marasmius, Scleroderma, Tricholoma, such as ), Shiva Rhizoctonia (Microdochium nivale), Shiva snow rot small sclerotia (Typhula incarnate, Typhula ishikariensis), Shiva Rhizoctonia leaf blight (Curvalaria sp.). ), Shiva pseudo-leaf rot (Ceratobasis sp.), Shiva blight (Zoysia decline), corn scab (Ustilago maydis), corn charcoal scab (Colletotrichum glaminicola), corn brown spot (Kaba) Diseases (Cercospora zeae-maydis), corn panama disease (Setosphaeria turcica), corn northern spot disease (Cochliobolus carbonum), corn spot disease (Physodorma maidis), corn rust (Pysodorma maidis), corn rust (Pusc) , Corn yellow sesame leaf blight (Phyllosticta maydis), corn red mold (Gibberella zeae), sugar cane rust (Puccinia spp), uri stag beetle (Sphaerotheca fusarium) ), Pseudoperonospora cubensis, Phytophthora capsici, Fusarium oxysporum f.sp.cuburiminum, watermelon panama disease, watermelon panama disease (Fustilago) Diseases (Podosphaera leucolicha), apple scab (Venturia inaequualis), apple morinia disease (Moniliina mari), apple spot foliar disease (Alternaria alternatea apple pathalia) , Pear Udonko disease (Phyllactinia pyri), Pear red scab (Gymnosporangium asiaticum), Pear scab (Ventria nashikola), Strawberry Udonko disease (Sphaerotheca funa) ), Erysiphe blue mold (Pencillium italicum), Uncinula necator, Plasmopara viticola, Glomerella chingulata, Glamella sigatoka, Phakops Black sigatoka) (Mycosphaerella fijiensis, Mycosphaerella mycosphaerella), Erysiphe cychoracearum, Tomato ring scab (Alternaria solani), Nasuta sickness (Erysiphe) (Collettricum cocodes), Erysiphe spp, Leveillula tarica, Mycosphaerella influenza, Tobacco sigatoka (Erysiphe sigatoka) Erysiphe betae, Thanatephorus cucumeris, Thanatephorus cucumeris, Aphanomyces cochlioides, Dycon wilt disease. sp. raphani), Cha charcoal scab (Discula thee-sinensis), Chamochi disease (Exobasidedium vexans), Cha brown circle disease (Pseudocercospora ocelata, Cercospora chaae), Chacospora chiapes (Exobasideium reticleutum), Wata black spot disease Alternaria leaf spot (Alternaria spp), Wata charcoal spt (Glomerella spp), Wata ring crest disease (Ascochyta gossypi), Wata spi leaf spot (Cercospora spp), Wata's Diplopia ball rot (Diplopia spp), Wata's Hard lock (Fusarium spp), Wata's Phoma blitz (Phoma spl) black sp. Cercosporidium personatum, Cercospora arachidicola, Cercospora lorfsi, Puccinia arachidis, Banana yellow shigatoka, Mycosphaerella Gray mold (Botrytis sinerea), disease of the genus Pythium (Pythium spp) and mycosphaerella (Cercospora), etc. that damage various crops. In addition, the genus Aspergillus, the genus Cochliobolus, the genus Corticium, the genus Diplodia, the genus Pencillum, the genus Gibberala, the genus Mucor, the genus Phoma, the genus Phomopsis, the genus Pyrenophora, and the genus Pyrenophora. Seed-borne diseases or early-growth diseases of various plants caused by the genus Trichoderma, the genus Ustylago, and the like.
 本実施形態に係る農園芸用殺菌剤は、上述した病害のなかでも、コムギ葉枯病およびオオムギ赤さび病といったムギ類赤かび病の病害に対して特に優れた防除効果を呈する。そのため、農園芸用殺菌剤は、ムギ類防除用として好適に用いられるが、これに限定されるものではない。 Among the above-mentioned diseases, the fungicide for agriculture and gardening according to the present embodiment exhibits a particularly excellent control effect against the diseases of wheat such as wheat leaf blight and barley Fusarium head blight. Therefore, agricultural and horticultural fungicides are suitably used for controlling wheat, but are not limited thereto.
 本実施形態における農園芸用殺菌剤は、全ての植物に利用することができるが、適用植物の例として以下を挙げることができる。イネ、コムギ、オオムギ、ライムギ、エンバク、トリチケール、トウモロコシ、モロコシ(ソルガム)、サトウキビ、シバ、ベントグラス、バミューダグラス、フェスクおよびライグラスなどのイネ科類、ダイズ、ラッカセイ、インゲンマメ、エンドウ、アズキおよびアルファルファなどのマメ科類、サツマイモなどのヒルガオ科類、トウガラシ、ピーマン、トマト、ナス、ジャガイモおよびタバコなどのナス科類、ソバなどのタデ科類、ヒマワリなどのキク科類、チョウセンニンジンなどのウコギ科類、ナタネ、ハクサイ、カブ、キャベツおよびダイコンなどのアブラナ科類、テンサイなどのアカザ科類、ワタなどのアオイ科類、コーヒーノキなどのアカネ科類、カカオなどのアオギリ科類、チャなどのツバキ科類、スイカ、メロン、キュウリおよびカボチャなどのウリ科類、タマネギ、ネギおよびニンニクなどのユリ科類、イチゴ、リンゴ、アーモンド、アンズ、ウメ、オウトウ、スモモ、モモおよびナシなどのバラ科類、ニンジンなどのセリ科類、サトイモなどのサトイモ科類、マンゴーなどのウルシ科類、パイナップルなどのパイナップル科類、パパイアなどのパパイア科類、カキなどのカキノキ科類、ブルーベリーなどのツツジ科類、ペカンなどのクルミ科類、バナナなどのバショウ科類、オリーブなどのモクセイ科類、ココヤシおよびナツメヤシなどのヤシ科類、みかん、オレンジ、グレープフルーツおよびレモンなどのミカン科類、ブドウなどのブドウ科類、草花(Flowers and ornamental plants)、果樹以外の樹ならびにその他の観賞用植物。また、野生植物、植物栽培品種、異種交配若しくは原形質融合などの従来の生物育種によって得られる植物および植物栽培品種、ならびに遺伝子操作によって得られる各国で認可を受けた遺伝子組み換え植物栽培品種が挙げられる。このような遺伝子組み換え植物栽培品種としては、国際アグリバイオ事業団(ISAAA)のデータベースに蓄積されているものを挙げることができる。具体的には、Roundup Ready、Liberty Link、IMI、SCS、Clearfield、Enlist、B.t.、BXN、Poast Compatible、AgriSure、Genuity、Optimum、Powercore、DroughtGard、YieldGard、Herculex、WideStrike、Twinlink、VipCot、GlyTol、Newleaf、KnockOut、BiteGard、BtXtra、StarLink、Nucotn、NatureGard、Protecta、SmartStax、Power core、InVigorおよびBollgardなどの登録商標を含むものを挙げることができる。 The agricultural and horticultural fungicides in this embodiment can be used for all plants, and examples of applicable plants include the following. Rice, wheat, barley, lime, embaku, triticale, corn, morokoshi (sorghum), sugar cane, shiva, bentgrass, Bermudagrass, fescue and ryegrass and other rice families, soybeans, lacquer, green beans, pea, azuki and alfalfa Mame family, Hirugao family such as sweet potato, Capsicum family such as pepper, pepper, tomato, eggplant, potato and tobacco, Tade family such as buckwheat, Kiku family such as sunflower, Ukogi family such as Chosen carrot, Abranaceae such as rapeseed, hakusai, cub, cabbage and daikon, red-spotted family such as tensai, blue-spotted family such as cotton, red-spotted family such as coffee tree, blue-spotted family such as cacao, camellia family such as cha, Uri families such as watermelons, melons, cucumbers and pumpkins, lilies such as onions, onions and garlic, roses such as strawberries, apples, almonds, apricots, sea urchins, peaches, peaches, peaches and pears, carrots, etc. Seri family, Satoimo family such as Satoimo, Urushi family such as mango, Pineapple family such as pineapple, Papaya family such as papaya, Kakinoki family such as oyster, Tsutsuji family such as blueberry, Walnut such as Pekan Family, Basho family such as banana, Mokusei family such as olive, Palm family such as Coco palm and Natsume palm, Mikan family such as tangerine, orange, grapefruit and lemon, Grape family such as grape, Flowers and ornamental plants), trees other than fruit trees, and other ornamental plants. In addition, wild plants, plant cultivars, plants and plant cultivars obtained by conventional biological breeding such as crossbreeding or progenitor fusion, and genetically modified plant cultivars obtained by genetic engineering and approved in each country can be mentioned. .. Examples of such genetically modified plant cultivars include those accumulated in the database of the International Agribio Corporation (ISAAA). Specifically, Roundup Ready, Liberty Link, IMI, SCS, Clearfield, Enlist, B.I. t. , BXN, Poast Compatible, AgriSure, Genuity, Optimum, Powercore, DroughtGard, YieldGard, Herculex, WideStrike, Twinlink, VipCot, GlyTol, Newleaf, KnockOut, BiteGard, BtXtra, StarLink, Nucotn, NatureGard, Protecta, SmartStax, Power core, InVigor And those including registered trademarks such as Bollgard.
 〔2.製剤〕
 農園芸用薬剤は、有効成分である本実施形態に係るトリアゾール誘導体(-)-エナンチオマーを固体担体または液体担体(希釈剤)、界面活性剤およびその他の製剤補助剤等と混合して粉剤、水和剤、粒剤および乳剤等の種々の形態に製剤して使用する。
[2. pharmaceutical formulation〕
The agricultural and horticultural chemicals are prepared by mixing the triazole derivative (-)-enantiomer according to the present embodiment, which is an active ingredient, with a solid carrier or a liquid carrier (diluent), a surfactant, other pharmaceutical adjuncts, and the like, and powder and water. It is formulated and used in various forms such as Japanese preparations, granules and emulsions.
 これらの製剤には有効成分としてトリアゾール誘導体(-)-エナンチオマーを、0.05~95重量%、好ましくは0.25~90重量%、より好ましくは1~80重量%含まれるように製剤する。製剤補助剤として使用する固体担体、液体担体および界面活性剤を例示すれば、まず、固体担体としては、粉末担体および粒状担体などとして用いられ、クレー、タルク、珪藻土、ゼオライト、モンモリロナイト、ベントナイト、酸性白土、活性白土、アッタパルジャイト、方解石、バーミキュライト、パーライト、軽石、珪砂などの鉱物;尿素などの合成有機物;炭酸カルシウム、炭酸ナトリウム、硫酸ナトリウム、消石灰、重曹などの塩類;ホワイトカーボンなどの非晶質シリカや二酸化チタンなどの合成無機物;木質粉、トウモロコシ茎(穂軸)、クルミ殻(堅果外皮)、果実核、モミガラ、オガクズ、ふすま、大豆粉、粉末セルロース、デンプン、デキストリン、糖類などの植物性担体;架橋リグニン、カチオンゲル、加熱または多価金属塩でゲル化するゼラチン、寒天などの水溶性高分子ゲル、および塩素化ポリエチレン、塩素化ポリプロピレン、ポリ酢酸ビニル、ポリ塩化ビニル、エチレン-酢酸ビニル共重合体、尿素-アルデビド樹脂などの種々の高分子担体などを挙げることができる。 These preparations contain the triazole derivative (-)-enantiomer as an active ingredient in an amount of 0.05 to 95% by weight, preferably 0.25 to 90% by weight, and more preferably 1 to 80% by weight. Examples of solid carriers, liquid carriers and surfactants used as formulation aids are as follows. First, solid carriers are used as powder carriers, granular carriers and the like, and clay, talc, diatomaceous earth, zeolite, montmorillonite, bentonite and acidic. Minerals such as white clay, active white clay, attapargit, calculus, vermiculite, pearlite, pebbles, silica sand; synthetic organic substances such as urea; salts such as calcium carbonate, sodium carbonate, sodium sulfate, limestone, and baking soda; amorphous such as white carbon. Synthetic inorganic substances such as quality silica and titanium dioxide; plants such as wood flour, corn stalk (cob), walnut shell (hard fruit hull), fruit nucleus, fir, oak, bran, soybean flour, powdered cellulose, starch, dextrin, sugar, etc. Sex carriers; crosslinked lignin, cationic gels, gelatin gelled with heating or polyvalent metal salts, water-soluble polymer gels such as agar, and chlorinated polyethylene, chlorinated polypropylene, polyvinyl acetate, polyvinyl chloride, ethylene-vinyl acetate. Examples thereof include various polymer carriers such as copolymers and urea-aldevido resins.
 液体担体としては、脂肪族溶剤(パラフィン類)、芳香族溶剤(キシレン、アルキルベンゼン、アルキルナフタレン、ソルベントナフサなど)、混合溶剤(灯油)、マシン油(精製高沸点脂肪族炭化水素)、アルコール類(メタノール、エタノール、イソプロパノール、シクロヘキサノールなど)、多価アルコール類(エチレングリコール、ジエチレングリコール、プロピレングリコール、ヘキシレングリコール、ポリエチレングリコール、ポリプロピレングリコールなど)、多価アルコール誘導体類(プロピレン系グリコールエーテルなど)、ケトン類(アセトン、アセトフェノン、シクロヘキサノン、メチルシクロヘキサノン、γ-ブチロラクトンなど)、エステル類(脂肪酸メチルエステル(ヤシ油脂肪酸メチルエステル)、乳酸エチルヘキシル、炭酸プロピレン、二塩基酸メチルエステル(コハク酸ジメチルエステル、グルタミン酸ジメチルエステル、アジピン酸ジメチルエステル))、含窒素担体類(N-アルキルピロリドン類)、油脂類(ヤシ油、大豆油、菜種油など)、アミド系溶剤(ジメチルホルムアミド、(N,N-ジメチルオクタンアミド、N,N-ジメチルデカンアミド、5-(ジメチルアミノ)-2-メチル-5-オキソ-吉草酸メチルエステル、N-アシルモルホリン系溶剤(CAS No.887947-29-7など))、ジメチルスルホキシドアセトニトリル、水などを挙げることができる。 Liquid carriers include fatty acid solvents (paraffins), aromatic solvents (xylene, alkylbenzene, alkylnaphthalene, solvent naphtha, etc.), mixed solvents (kerosene), machine oils (refined high boiling fatty acid hydrocarbons), alcohols (alcohols). Methanol, ethanol, isopropanol, cyclohexanol, etc.), polyhydric alcohols (ethylene glycol, diethylene glycol, propylene glycol, hexylene glycol, polyethylene glycol, polypropylene glycol, etc.), polyhydric alcohol derivatives (propylene-based glycol ether, etc.), ketones Classes (acetone, acetophenone, cyclohexanone, methylcyclohexanone, γ-butyrolactone, etc.), esters (fatty acid methyl ester (palm oil fatty acid methyl ester), ethyl hexyl lactate, propylene carbonate, dibasic acid methyl ester (succinic acid dimethyl ester, glutamate dimethyl ester) (Ester, adipic acid dimethyl ester)), nitrogen-containing carriers (N-alkylpyrrolidones), fats and oils (palm oil, soybean oil, rapeseed oil, etc.), amide-based solvents (dimethylformamide, (N, N-dimethyloctaneamide, etc.) N, N-dimethyldecaneamide, 5- (dimethylamino) -2-methyl-5-oxo-valeric acid methyl ester, N-acylmorpholin-based solvent (CAS No. 887947-29-7, etc.), dimethylsulfoxide acetonitrile , Water, etc.
 界面活性剤は、非イオン性界面活性剤としては、例えば、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ショ糖脂肪酸エステル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレン樹脂酸エステル、ポリオキシエチレン脂肪酸ジエステル、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンアルキルフェニルエーテル、ポリオキシエチレンジアルキルフェニルエーテル、ポリオキシエチレンアルキルフェニルエーテルホルマリン縮合物、ポリオキシエチレン/ポリオキシプロピレンブロックポリマー、アルキルポリオキシエチレン/ポリオキシプロピレンブロックポリマーエーテル、ポリオキシエチレンアルキルアミン、ポリオキシエチレン脂肪酸アミド、ポリオキシエチレン脂肪酸ビスフェニルエーテル、ポリオキシエチレンベンジルフェニル(またはフェニルフェニル)エーテル、ポリオキシエチレンスチリルフェニル(またはフェニルフェニル)エーテル、ポリオキシエチレンエーテルおよびエステル型シリコンおよびフッ素系界面活性剤、ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油、アルキルグリコシドなどを挙げられる。アニオン性界面活性剤としては、アルキルサルフェート、ポリオキシエチレンアルキルエーテルサルフェート、ポリオキシエチレンアルキルフェニルエーテルサルフェート、ポリオキシエチレンベンジル(またはスチリル)フェニル(またはフェニルフェニル)エーテルサルフェート、ポリオキシエチレン、ポリオキシプロピレンブロックポリマーサルフェートなどのサルフェート類の塩、パラフィン(アルカン)スルホネート、α-オレフィンスルホネート、ジアルキルスルホサクシネート、アルキルベンゼンスルホネート、モノまたはジアルキルナフタレンスルホネート、ナフタレンスルホネート・ホルマリン縮合物、アルキルジフェニルエーテルジスルホネート、リグニンスルホネート、ポリオキシエチレンアルキルフエニルエーテルスルホネート、ポリオキシエチレンアルキルエーテルスルホコハク酸ハーフエステルなどのスルホネート類の塩、脂肪酸、N-メチル-脂肪酸サルコシネート、樹脂酸などの脂肪酸類の塩、ポリオキシエチレンアルキルエーテルホスフェート、ポリオキシエチレンモノまたはジアルキルフェニルエーテルホスフェート、ポリオキシエチレンベンジル(またはスチリル)化フェニル(またはフェニルフェニル)エーテルホスフェート、ポリオキシエチレン/ポリオキシプロピレンブロックポリマー、ホスファチジルコリンホスファチジルエタノールイミン(レシチン)、アルキルホスフェートなどホスフェール類の塩などが挙げられる。カチオン性界面活性剤としては、アルキルトリメチルアンモニウムクロライド、メチルポリオキシエチレンアルキルアンモニウムクロライド、アルキルN-メチルピリジウムブロマイド、モノまたはジアルキルメチル化アンモニウムクロライド、アルキルペンタメチルプロピレンジアミンジクロライドなどのアンモニウム塩類およびアルキルジメチルベンザルコニウムクロライド、ベンゼトニウムクロライド(オクチルフェノキシエトキシエチルジメチルベンジルアンモニウムクロライド)などのベンザルコニウム塩類が挙げられる。また、従来公知のバイオサーファクタント(例えば、マンノシルアルジトールリピッド、ソホロリピッド、ラムノリピッド、トレハロースリピッド、セロビオースリピッド、グルコースリピッド、オリゴ糖脂肪酸エステル、サーファクチン、セラウエッチン、ライケンシン、アルスロファクチン、スピクルスポール酸、コリノミコール酸、アガリチン酸、およびエマルザン等)を界面活性剤として含んでいてもよい。 Examples of the nonionic surfactant include sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, sucrose fatty acid ester, polyoxyethylene fatty acid ester, polyoxyethylene resin acid ester, and polyoxyethylene fatty acid diester. , Polyoxyethylene alkyl ether, polyoxyethylene alkylphenyl ether, polyoxyethylene dialkylphenyl ether, polyoxyethylene alkylphenyl ether formalin condensate, polyoxyethylene / polyoxypropylene block polymer, alkylpolyoxyethylene / polyoxypropylene block Polymer ether, polyoxyethylene alkylamine, polyoxyethylene fatty acid amide, polyoxyethylene fatty acid bisphenyl ether, polyoxyethylene benzylphenyl (or phenylphenyl) ether, polyoxyethylene styrylphenyl (or phenylphenyl) ether, polyoxyethylene Examples thereof include ether and ester-type silicon and fluorine-based surfactants, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, and alkyl glycosides. Anionic surfactants include alkyl sulfate, polyoxyethylene alkyl ether sulfate, polyoxyethylene alkylphenyl ether sulfate, polyoxyethylene benzyl (or styryl) phenyl (or phenylphenyl) ether sulfate, polyoxyethylene, and polyoxypropylene. Salts of sulfates such as block polymer sulfate, paraffin (alkane) sulfonate, α-olefin sulfonate, dialkyl sulfosuccinate, alkylbenzene sulfonate, mono or dialkylnaphthalene sulfonate, naphthalene sulfonate formalin condensate, alkyldiphenyl ether disulfonate, lignin sulfonate, Salts of sulfonates such as polyoxyethylene alkylphenyl ether sulfonates, polyoxyethylene alkyl ether sulfosuccinic acid half esters, fatty acids, salts of fatty acids such as N-methyl-fatty acid sarcosinates, resin acids, polyoxyethylene alkyl ether phosphates, Polyoxyethylene mono or dialkylphenyl ether phosphate, polyoxyethylene benzyl (or styryl) phenyl (or phenylphenyl) ether phosphate, polyoxyethylene / polyoxypropylene block polymer, phosphatidylcholine phosphatidylethanolimine (resitin), alkyl phosphate, etc. Kind of salt and the like. Cationic surfactants include ammonium salts such as alkyltrimethylammonium chloride, methylpolyoxyethylene alkylammonium chloride, alkyl N-methylpyridium bromide, mono or dialkylmethylated ammonium chloride, alkylpentamethylpropylenediaminedichloride and alkyldimethyl. Examples thereof include benzalkonium salts such as benzalkonium chloride and benzethonium chloride (octylphenoxyethoxyethyldimethylbenzylammonium chloride). In addition, conventionally known biosurfactants (for example, mannosylargitol lipid, sophorolipid, ramnolipid, trehalose lipid, cellobiose lipid, glucose lipid, oligosaccharide fatty acid ester, surfactin, serauetchin, lykencin, arslofactin, spiclesporic acid, corinomicol). Acid, agaric acid, emalzan, etc.) may be contained as a surfactant.
 その他の製剤用補助剤としては、pH調節剤としてのナトリウムおよびカリウムなどの無機塩類、フッ素系、シリコーン系の消泡剤、食塩などの水溶性の塩類、増粘剤として用いられるキサタンガム、グアーガム、カルボキシメチルセルロース、ポリビニルピロリドン、カルボキシビニルポリマー、アクリル系ポリマー、ポリビニルアルコール、デンプン誘導体、多糖類などの水溶性高分子、アルギン酸およびその塩、崩壊分散剤として用いられるステアリン酸金属塩、トリポリリン酸ソーダ、ヘキサメタリン酸ソーダ、その他、防腐剤、着色剤、酸化防止剤、紫外線吸収剤、および薬害軽減剤などが挙げられる。 Other pharmaceutical aids include inorganic salts such as sodium and potassium as pH adjusters, fluorine-based and silicone-based defoaming agents, water-soluble salts such as salt, and xattan gum and guar gum used as thickeners. Water-soluble polymers such as carboxymethyl cellulose, polyvinylpyrrolidone, carboxyvinyl polymer, acrylic polymer, polyvinyl alcohol, starch derivatives, polysaccharides, alginic acid and its salts, metal stearate used as a disintegrant dispersant, sodium tripolyphosphate, hexametallin Acid soda and others include preservatives, colorants, antioxidants, UV absorbers, and chemical damage reducing agents.
 製剤には、そのまま使用するものと水等の希釈剤で所定濃度に希釈して使用するものとがある。希釈して使用するときのトリアゾール誘導体(-)-エナンチオマーの濃度は0.0005~1.0%の範囲が望ましい。 There are two types of pharmaceutical products, one that is used as it is and the other that is diluted to a predetermined concentration with a diluent such as water. The concentration of the triazole derivative (-)-enantiomer when diluted and used is preferably in the range of 0.0005 to 1.0%.
 また、トリアゾール誘導体(-)-エナンチオマーの使用量は、畑、田、果樹園および温室等の農園芸地1haあたり、10~5000g、より好ましくは25~2000gである。これらの使用濃度および使用量は剤形、使用時期、使用方法、使用場所および対象作物等によっても異なるため、上記の範囲にこだわることなく増減することが可能である。 The amount of the triazole derivative (-)-enantiomer used is 10 to 5000 g, more preferably 25 to 2000 g per 1 ha of horticultural land such as fields, rice fields, orchards and greenhouses. Since these concentrations and amounts used vary depending on the dosage form, timing of use, method of use, place of use, target crop, etc., they can be increased or decreased without being particular about the above range.
 〔3.他の有効成分〕
 本実施形態におけるトリアゾール誘導体(-)-エナンチオマー(I)を含有する農園芸用薬剤は、既知の他の有効成分と組み合わせ、農園芸用薬剤としての性能を高めて使用することもできる。既知の他の有効成分としては、殺菌剤、殺虫剤、殺ダニ剤、殺線虫剤、および植物生長調節剤に含まれる既知の有効成分を挙げることができる。
[3. Other active ingredients]
The agricultural and horticultural agent containing the triazole derivative (-)-enantiomer (I) in the present embodiment can be used in combination with other known active ingredients to enhance the performance as the agricultural and horticultural agent. Other known active ingredients include known active ingredients contained in fungicides, insecticides, acaricides, nematodes, and plant growth regulators.
 殺菌剤に含まれる既知の有効成分としては、核酸合成代謝阻害剤、有糸核分裂・細胞分裂阻害剤、呼吸阻害剤、アミノ酸・タンパク質生合成阻害剤、シグナル伝達阻害剤、脂質生合成または輸送/細胞膜の構造または機能阻害剤、細胞膜のステロール生合成阻害剤、細胞壁生合成阻害剤、メラニン生合成阻害剤、宿主植物の抵抗性誘導剤、および多作用点殺菌剤などが挙げられる。 Known active ingredients contained in bactericides include nucleic acid synthesis and metabolism inhibitors, threaded nucleus division / cell division inhibitors, respiratory inhibitors, amino acid / protein biosynthesis inhibitors, signal transduction inhibitors, lipid biosynthesis or transport / Examples include cell membrane structure or function inhibitors, cell membrane sterol biosynthesis inhibitors, cell wall biosynthesis inhibitors, melanin biosynthesis inhibitors, host plant resistance inducers, and multi-action point bactericides.
 核酸合成代謝阻害剤としては、ベナラキシル、ベナラキシルM、フララキシル、オフレース、ブピリメート、ジメチリモール、エチリモール、オクチリノン、メタラキシル、メタラキシル-M、オキサジキシルおよびヒメキサゾールなどが挙げられ、これらから選択される少なくとも1つであり得る。 Examples of the nucleic acid synthesis metabolism inhibitor include benaraxil, benaraxyl M, furaxyl, offrace, bupirimate, dimethyrimol, etilimol, octylinone, metalaxil, metalaxil-M, oxadixil and himexazole, and are at least one selected from these. obtain.
 有糸核分裂・細胞分裂阻害剤としては、ベノミル、カルベンダジム、フベリダゾール、チアベンダゾール、チオファネート、チオファネート-メチル、ジエトフェンカルブ、ゾキサミド、エタボキサム、ペンシクロン、フルオピコリド、フェナマクリル、メトラフェノンおよびピリオフェノンなどが挙げられ、これらから選択される少なくとも1つであり得る。 Examples of the filamentous fission / cell division inhibitor include benomyl, carbendazim, fuberidazole, thiabendazole, thiophanate, thiophanate-methyl, dietofencarb, zoxamide, etaboxam, pencyclon, fluoricorid, phenamaclyl, metrafenone and pyriophenone. Can be at least one.
 呼吸阻害剤としては、トルフェンピラド、ジフルメトリム、フェナザキン、ピジフルメトフェン、フェンフラン、カルボキシン、オキシカルボキシン、ベノダニル、フルトラニル、メプロニル、イソフェタミド、ベンゾビンヂフルピル、ビキサフェン、フルインダピル、フルキサピロキサド、フラメトピル、イソピラザム、ペンフルフェン、ペンチオピラド、セダキサン、イソフルシプラム、ボスカリド、フルオピラム、チフルザミド、ピラジフルミド、ピリベンカルブ、フルオキサストロビン、フェナミドン、マンデストロビン、アゾキシストロビン、クモキシストロビン、エノキサストロビン、フルフェノキシストロビン、ピコキシストロビン、ピラクロストロビン、ピラオキシストロビン、トリクロピリカルブ、ファモキサドン、ジモキシストロビン、フェナミンストロビン、メトミノストロビン、オリサストロビン、クレソキシム-メチル、トリフロキシストロビン、シアゾファミド、アミスルブロム、フェンピコキサミド、フロリルピコキサミド、ビナパクリル、メプチルジノカップ、ジノカップ、フルアジナム、酢酸トリフェニルスズ、塩化トリフェニルスズ、水酸化トリフェニルスズ、シルチオファム、アメトクトラジン、メチルテトラプロール、ピラプロポインおよびインピルフルキサムなどが挙げられ、これらから選択される少なくとも1つであり得る。 Respiratory inhibitors include tolfenpyrado, diflumethrim, phenazakin, pidiflumethofen, fenfuran, carboxin, oxycarboxin, benodanyl, flutranil, mepronil, isofetamide, benzobindiflupill, bixaphen, fluindapyl, fluxapyroxado, Flametopill, isopyrazam, penflufen, penthiopyrado, sedaxan, isoflusiplum, boscalid, fluopirum, thyfluzamide, pyraziflumid, pyribencarb, fluoxastrobin, phenamiden, mandestrobin, azoxystrobin, spumoxystrobin, enoxastrobin, full Phenoxystrobin, picoxystrobin, pyracrostrobin, pyraoxystrobin, trichloropyricalve, famoxadon, dymoxystrobin, phenaminestrobin, metminostrobin, orisastrobin, cresoxime-methyl, trifluorostrobin, siazophamid, Amisulbrom, fenpicoxamide, florylpicoxamide, binapacryl, meptyldinocup, dinocup, fluazinum, triphenyltin acetate, triphenyltin chloride, triphenyltin hydroxide, silthiofam, amethoctrazine, methyltetraplol, pyrapropoin and Impilfluxam and the like can be mentioned and at least one selected from these.
 アミノ酸・タンパク質生合成阻害剤としては、シプロジニル、メパニピリム、ピリメタニル、ブラストサイジン、カスガマイシン、ストレプトマイシンおよびオキシテトラサイクリンなどが挙げられ、これらから選択される少なくとも1つであり得る。 Examples of the amino acid / protein biosynthesis inhibitor include cyprodinyl, mepanipyrim, pyrimethanyl, blastsidedin, kasugamycin, streptomycin, oxytetracycline and the like, and may be at least one selected from these.
 シグナル伝達阻害剤としては、キノキシフェン、プロキナジド、クロゾリネート、ジメタクロン、フェンピクロニル、フルジオキソニル、イプロジオン、プロシミドンおよびビンクロゾリンなどが挙げられ、これらから選択される少なくとも1つであり得る。 Examples of the signal transduction inhibitor include quinoxyphen, proquinazide, clozoline, dimethacron, phenpicronyl, fludioxonyl, iprodion, procymidone, vinclozoline and the like, and may be at least one selected from these.
 脂質生合成または輸送/細胞膜の構造または機能阻害剤としては、イソプロチオラン、エディフェンホス、イプロベンフォス(IBP)、ピラゾホス、ビフェニル、クロロネブ、ジクロラン、キントゼン(PCNB)、テクナゼン(TCNB)、トルクロフォス-メチル、エトリジアゾール、プロチオカルブ、プロパモカルブ、ナタマイシン、オキサチアピプロリンおよびフルオキサピプロリンなどが挙げられ、これらから選択される少なくとも1つであり得る。 Lipid biosynthesis or transport / cell membrane structure or function inhibitors include isoprothiolan, edifenphos, iprobenphos (IBP), pyrazophos, biphenyl, chloroneb, dichloran, quintozen (PCNB), technazen (TCNB), torquelophos- Methyl, etridiazole, prothiocarb, propamocarb, natamycin, oxathiapiproline, fluoxapiproline and the like can be mentioned and may be at least one selected from these.
 細胞膜のステロール生合成阻害剤としては、イマザリル、オキスポコナゾール、ペフラゾエート、プロクロラズ、トリフルミゾール、トリフォリン、ピリフェノックス、ピリソキサゾール、フェナリモル、ヌアリモル、アザコナゾール、ビテルタノール、ブロムコナゾール、シプロコナゾール、ジフェノコナゾール、ジニコナゾール、エポキシコナゾール、エタコナゾール、フェンブコナゾール、フルキンコナゾール、フルシラゾール、フルトリアフォル、ヘキサコナゾール、イミベンコナゾール、メトコナゾール、イプコナゾール、ミクロブタニル、ペンコナゾール、プロピコナゾール、シメコナゾール、テブコナゾール、テトラコナゾール、トリアジメフォン、トリアジメノール、トリチコナゾール、メフェントリフルコナゾール、プロチオコナゾール、トリデモルフ、フェンプロピモルフ、フェンプロピジン、ピペラリン、スピロキサミン、フェンピラザミン、フェンヘキサミド、ナフティフィン、タービナフィン、ピリブチカルブおよびイプフェントリフルコナゾールなどが挙げられ、これらから選択される少なくとも1つであり得る。 Cell membrane sterol biosynthesis inhibitors include imazalyl, oxpoconazole, pefrazoate, prochloraz, triflumizole, trifolin, pyrifenox, pyrisoxazole, phenalimol, nuarimol, azaconazole, bitertanol, bromconazole, cyproconazole, Diphenoconazole, diniconazole, epoxyconazole, etaconazole, fenbuconazole, fluconazole, fluconazole, flutrifolin, hexaconazole, imibenconazole, metconazole, ipconazole, microbutanyl, penconazole, propiconazole, simeconazole, tebuconazole, tetra. Nazole, Triazimefon, Triazimenol, Triticonazole, Mefentrifluconazole, Prothioconazole, Tridemorph, Fenpropimorph, Fenpropidine, Piperline, Spiroxamine, Fempyrazamine, Fenhexamide, Naftiffin, Turbinafin, Pyribycarb and Examples include ipfentrifluconazole and the like, and may be at least one selected from these.
 細胞壁生合成阻害剤としては、ポリオキシン、ジメトモルフ、フルモルフ、ピリモルフ、マンジプロパミド、ベンチアバリカルブ、イプロバリカルブおよびバリフェナレートなどが挙げられ、これらから選択される少なくとも1つであり得る。 Examples of the cell wall biosynthesis inhibitor include polyoxin, dimethmorph, fulmorph, pyrimorph, mandipropamide, benchavaricarb, iprovaricarb, and varifenalate, and may be at least one selected from these.
 メラニン生合成阻害剤としては、フサライド、トリシクラゾール、ピロキロン、カルプロパミド、ジクロシメット、フェノキサニルおよびトルプロカルブなどが挙げられ、これらから選択される少なくとも1つであり得る。 Examples of the melanin biosynthesis inhibitor include fusalide, tricyclazole, pyrochyron, carpropamide, diclosimet, phenoxanyl, tolprocarb and the like, and may be at least one selected from these.
 宿主植物の抵抗性誘導剤としては、アシベンゾラル-S-メチル、プロベナゾール、チアジニル、ラミナリン、イソチアニル、ラミナリン、フォセチル-Al、リン酸およびリン酸塩などが挙げられ、これらから選択される少なくとも1つであり得る。 Host plant resistance inducers include acibenzolar-S-methyl, probenazole, thiazinyl, laminarin, isothianyl, laminarin, phocetyl-Al, phosphoric acid and phosphate, with at least one selected from these. could be.
 多作用点殺菌剤としては、シモキサニル、テクロフタラム、トリアゾキシド、フルスルファミド、ジクロメジン、シフルフェナミド、ドジン、フルチアニル、フェリムゾン、テブフロキン、ピカルブトラゾクス、バリダマイシン、鉱物油、重曹、炭酸カリウム、銅および銅化合物、硫黄、ファーバム、マンゼブ、マンネブ、メチラム、プロピネブ、チウラム、ジネブ、ジラム、キャプタン、キャプタフォル、フォルペット、クロロタロニル(TPN)、グアザチン、イミノクタジン酢酸塩、イミノクタジンアルベシル酸塩、アニラジン、ジチアノン、フルオロイミド、メタスルホカルブ、フロリルピコキサミド、フルオピモミド、イプフルフェノキン、キノメチオネート、ピリダクロメチル、アミノピリフェン、ジクロベンチアゾクス、キノフメリンおよびジピメチトロンなどが挙げられ、これらから選択される少なくとも1つであり得る。 Multi-action point fungicides include simoxanyl, tecrophthalam, triazoxide, flusulfamide, dichromedin, siflufenamide, dodine, fluthianyl, ferlimzone, tebuflokin, picalbutrazox, varydamycin, mineral oil, baking soda, potassium carbonate, copper and copper compounds, sulfur, Farbam, Manzeb, Manneb, Metylum, Propineb, Thiram, Dineb, Diram, Captan, Captan, Folpet, Chlorotalonyl (TPN), Guazatin, Iminoctadine acetate, Iminoctadine albesylate, Anilazine, Dithianone, Fluorimide, Metasulfocarb , Florylpicoxamide, fluopimomid, ipflufenokin, quinomethionate, pyridaclomethyl, aminopyridene, diclobenazox, quinofmerin, dipimethitron and the like, and may be at least one selected from these.
 また、その他の殺菌剤用途の化合物として、フェンアミドン、フェニトロパン、ハルピン、イソニアニル、ジクロベンチアゾックス、ピカルブトラゾックス、ヒドロキシイソキサゾール、フルオルイミド、キノメチオナート、クロロインコナジド、シイタケ菌糸体抽出物、ゴセイカユプテ(ティーツリー)の抽出物、植物油(オイゲノール、ゲラニオール、チモール)、オオイタドリ抽出液、サッカロミセス・セレビシエLAS117株の細胞壁および生物農薬(アグロバクテリウム・ラジオバクター、シュードモナス・フルオレッセンス、シュードモナス・ロデシア、シュードモナス・クロロラフィスAFS009株、バチルス・ズブチリス、バチルス・シンプレクス、バチルス・アミロリクエファシエンス、バチルス・ミコイデス、非病原性エルビニア・カロトボーラ、ラクトバチルス・プランタラム、バリオボラックス・パラドクス、スウェイングレア・グルティノーサ抽出物、トリコデルマ・アトロビリデLU132株、トリコデルマ・アトロビリデSC1株、トリコデルマ アスペレラムT34株、グリオクラディウム・カテヌラタムまたはクロノスタキス・ロゼア、ストレプトマイセス・グリセオビリディスK61株、ストレプトマイセス・ライディカスWYEC108等)等が挙げられる。 In addition, as compounds for other fungicide applications, fenamiden, fenitropan, halpin, isonial, diclobenazox, picalbutrazox, hydroxyisoxazole, fluorimide, quinomethionate, chloroinconazide, trichoderma mycelium extract, Gosei Kayupte (tea tree) extract, vegetable oil (eugenol, geraniol, timol), Oitadori extract, cell wall of Saccharomyces cerevisiae LAS117 strain and biopesticides (Agrobacterium radiobacter, Pseudomonas fluorescens, Pseudomonas rodesia, Pseudomonas chlororafis AFS009 strain, Bacillus subtilis, Bacillus symplex, Bacillus amyloliquefaciens, Bacillus mycoides, non-pathogenic Elvinia carotbora, Lactobacillus plantarum, Barrioborax paradox, Swingrea glutinosa extract , Trichoderma atroviride LU132 strain, Trichoderma atroviride SC1 strain, Trichoderma asperellam T34 strain, Gliocladium catenuratam or chronostakis rosea, Streptomyces glyceobilides K61 strain, Streptomyces lydicus WYEC108, etc.) Can be mentioned.
 殺虫剤に含まれる既知の有効成分としては、ニコチン性アセチルコリン受容体拮抗モジュレーター、ナトリウムチャネルモジュレーター、リアノジン受容体モジュレーター、アセチルコリンエステラーゼ阻害剤、酸化的リン酸化脱共役剤、およびミトコンドリア電子伝達系複合体I阻害剤などが挙げられる。 Known active ingredients in pesticides include nicotinic acetylcholine receptor antagonist modulators, sodium channel modulators, lianodine receptor modulators, acetylcholinesterase inhibitors, oxidative phosphorylation uncouplers, and mitochondrial electron transport chain complex I. Inhibitors and the like can be mentioned.
 ニコチン性アセチルコリン受容体拮抗モジュレーターとしては、アセタミプリド、クロチアニジン、ジノテフラン、イミダクロプリド、ニテンピラム、チアクロプリド、チアメトキサム、スルホキサフロル、フルピラジフロンおよびトリフルメゾピリムなどが挙げられ、これらから選択される少なくとも1つであり得る。 Examples of the nicotinic acetylcholine receptor antagonist modulator include acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid, thiamethoxam, sulfoxaflor, flupyradiflon, and triflumezopyrim, and may be at least one selected from these.
 ナトリウムチャネルモジュレーターとしては、ピレスロイド系化合物が挙げられ、該ピレスロイド系化合物としては、アクリナトリン、アレスリン、シペルメトリン、ビフェントリン、シクロプロトリン、シフルトリン、デルタメトリン、ジメフルトリン、エスフェンバレレート、エトフェンプロックス、フェンプロパトリン、フェンバレレート、フルブロシトリネート、フルシトリネート、フルバリネート、ハルフェンプロックス、シハロトリン、メトフルトリン、モンフルオロトリン、ペルメトリン、プロフルトリン、テフルトリン、トラロメトリン、イミプロトリン、ピレトリンおよびシフェノトリン、クロロプラレスリン、イプシロンメトフルトリンおよびイプシロンモンフルオロトリンなどが挙げられ、これらから選択される少なくとも1つであり得る。 Examples of the sodium channel modulator include pyrethroid compounds, and examples of the pyrethroid compounds include acrinathrin, arereslin, cypermethrin, bifenthrin, cycloprothrin, cyhalothrin, deltamethrin, dimefluthrin, esphenvalerate, etofenprox, and fenpropathrin. , Fenvalerate, flubrocitrinate, flucitrinate, fluvalinate, halfenprox, cyhalothrin, metoflutrin, monfluorothrin, permethrin, profluthrin, tefluthrin, tralomethrin, imiprothrin, pyrethrin and ciphenothrin, chloropralesrin, epsilonmethrin Trin and epsilon monfluorothrin and the like can be mentioned and may be at least one selected from these.
 リアノジン受容体モジュレーターとしては、クロラントラニリプロール、シアントラニリプロール、フルベンジアミドおよびシハロジアミドなどが挙げられ、これらから選択される少なくとも1つであり得る。 Examples of the ryanodine receptor modulator include chloranthraniliprole, cyantraniliprole, flubendiamide, sihalodiamide, and the like, and may be at least one selected from these.
 アセチルコリンエステラーゼ阻害剤としては、アセフェート、アジンホス-メチル、カズサホス、クロルエトキシホス、クロルフェンビンホス、クロルピリホス、シアノホス、デメトン-S-メチル、ダイアジノン、ジクロルボス(DDVP)、ジクロトホス、ジメトエート、ジスルホトン、エチオン、エトプロホス、EPN、フェナミホス、フエニトロチオン(MEP)、フェンチオン(MPP)、ホスチアゼート、イミシアホス、イソフェンホス、イソキサチオン、マラチオン、メタミドホス、メチダチオン、メビンホス、モノクロトホス、オメトエート、オキシデメトンメチル、パラチオン、パラチオン-メチル、フェントエート、ホレート、ホサロン、ホスメット、ホスファミドン、ホキシム、ピリミホスメチル、プロフェノホス、プロチオホス、ピラクロホス、ピリダフェンチオン、キナルホス、テブピリムホス、テルブホス、トリアゾホスおよびトリクロルホン(DEP)、アラニカルブ、アルジカルブ、ベンフラカルブ、BPMC、カルバリル(NAC)、カルボフラン、カルボスルファン、カルタップ、フェノキシカルブ(BPMC)、フォルメタネート、イソプロカルブ(MIPC)、メチオカルブ、メソミル、オキサミル、ピリミカルブ、チオジカルブ、XMC、ベンダイオカルブ、エチオフェンカルブ、フェノブカルブ、フェノチオカルブ、フラチオカルブ、メトルカルブおよびキシリルカルブなどが挙げられ、これらから選択される少なくとも1つであり得る。 Acetylcholinesterase inhibitors include acephate, azinephos-methyl, kazusaphos, chlorethoxyphos, chlorfenbinphos, chlorpyriphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos (DDVP), dicrotophos, dimethote, disulfoton, etion, etoplophos. , EPN, phenamiphos, fenitrothion (MEP), fenthion (MPP), hostizate, imiciaphos, isofenphos, isoxathione, malathion, metamidphos, metidathion, mevinphos, monochromotophos, ometoate, oxydemethonemethyl, parathion, parathion-methyl, pholate, , Hosalon, Hosmet, Phosfamidon, Hoxime, Pyrimiphosmethyl, Profenophos, Prothiophos, Pyraclophos, Pyridafenthion, Kinalphos, Tebupyrimhos, Telbuhos, Triazophos and Trichlorfon (DEP), Aranicarb, Ardicalve, Benfracarb, BPMC, Carbofuran, Carbofuran , Cartap, phenoxycarb (BPMC), formethanate, isoprocarb (MIPC), methiocarb, mesomil, oxamil, pyrimicalve, thiodicalve, XMC, bendiocarb, ethiophencarb, phenobucarb, phenothiocarb, fratiocarb, metorcarb and xylylcarb. It can be at least one selected from these.
 酸化的リン酸化脱共役剤としては、クロルフェナピル、DNOCおよびスルフラミドなどが挙げられ、これらから選択される少なくとも1つであり得る。 Examples of the oxidative phosphorylation uncoupler include chlorfenapyr, DNOC, sulflamide and the like, and may be at least one selected from these.
 ミトコンドリア電子伝達系複合体I阻害剤としては、テブフェンピラド、トルフェンピラド、フェナザキン、フェンピロキシメート、ピリダベン、ピリミジフェンおよびロテノンなどが挙げられ、これらから選択される少なくとも1つであり得る。 Examples of the mitochondrial electron transport chain complex I inhibitor include tebufenpyrado, tolfenpyrado, phenazakin, phenpyroxymate, pyridaben, pyrimidiphen and rotenone, and may be at least one selected from these.
 植物成長調整剤に含まれる既知の有効成分としては、アミノエトキシビニルグリシン、クロルメコート、クロルプロファム、シクラニリド、ジケグラック、ダミノジット、エテホン、フルルプリミドール、フルメトラリン、ホルクロルフェニュロン、ジベレリン、マレイン酸ヒドラジド塩、メピコートクロリド、メチルシクロプロペン、ベンジルアミノプリン、パクロブトラゾール、プロヘキサジオン、チジアズロン、トリブチルホスホロトリチオエート、トリネキサパックエチルおよびウニコナゾールなどが挙げられ、これらから選択される少なくとも1つであり得る。 Known active ingredients in plant growth regulators include aminoethoxyvinylglycine, chlormecoat, chlorpropham, cyclanilide, dikegrac, daminogit, etephone, fluluprimidol, flumethrolin, holchlorphenurone, gibberellin, hydrazide maleate. Salts, mepicort chloride, methylcyclopropham, benzylaminopurine, paclobutrazol, prohexadione, thydiazulone, tributylphosphorotrithioate, trinexacacethyl and uniconazole, and the like, and at least one selected from these. Can be one.
 殺ダニ剤に含まれる既知の有効成分(殺ダニ活性成分)としては、例えばアセキノシル、ヒドラメチルノン、アミドフルメット、アミトラズ、アゾシクロチン、ビフェナゼート、ブロモプロピレート、クロルフェンソン、キノメチオネート、フェニソブロモレート、ベンゾキシメート、クロフェンテジン、シエノピラフェン、シフルメトフェン、シヘキサチン、ジフロビダジン、ジエノクロル、エトキサゾール、フェナザキン、酸化フェンブタスズ、フェンピロキシメート、フェノチオカルブ、フルアクリピリム、ヘキシチアゾクス、プロパルギット(BPPS)、ピフルブミド、ピリダベン、ピリミジフェン、スピロジクロフェン、スピロメシフェン、テブフェンピラド、テトラジホン、アシノナピル、シエトピラフェン、フルペンチオフェノックス、および調合油等が挙げられる。 Known active ingredients (mite-killing active ingredients) contained in the acaricide include, for example, acequinocil, hydramethylnon, amideflumet, amitraz, azocyclotin, biphenazate, bromopropirate, clofentezine, quinomethionate, phenisobromolate, and the like. Benzoximate, clofentezine, cyenopyraphen, siflumethofen, cyhexatin, difluorovidazine, dienochlor, etoxazole, phenazakin, fenbutatin oxide, phenpyroximate, phenothiocarb, fluaclipirim, hexitiazox, propargite (BPPS), piflubumid, pyridaben Examples include fen, tebufenpyrado, tetradiphon, asinonapill, cyhexatinifene, flupentiophenox, blended oil and the like.
 殺線虫剤に含まれる既知の有効成分(殺線虫活性成分)としては、例えばD-D(1,3-ジクロロプロペン)、DCIP(ジクロロジイソプロピルエーテル)、メチルイソチオシアネート、カーバムナトリウム塩、カズサホス、ホスチアゼート、イミシアホス、酒石酸モランテル、塩酸レバミゾール、ネマデクチン、シクロブトリフルラムおよびチオキサザフェン等が挙げられる。 Known active ingredients (nematode active ingredients) contained in nematode nematodes include, for example, DD (1,3-dichloropropene), DCIP (dichlorodiisopropyl ether), methylisothiocyanate, carbam sodium salt, and the like. C.
 また、その他の殺虫剤用途の化合物として、アベルメクチン、テトラクロラントラニリプロール、ジアフェンチウロン、エチプロール、フィプロニル、フロニカミド、フルエンスルホン、インドキサカルブ、メタフルミゾン、メタアルデヒド、ピメトロジン、ピリダリル、ピリフルキナゾン、シラフルオフェン、スピロジオン、スピロテトラマト、スルホキサフロール、アフィドピロペン、ブロフラニリド、シクラニリプロール、ジクロロメゾチアズ、フロメトキン、フルアザインドリジン、フルヘキサホン、フルキサメタミド、ピリプロール、テトラニリプロール、ヒドロプレン、キノプレン、メトプレン、チクロピラゾフロー(tyclopyrazoflor)、フルピリミン、スピロピジオン、ベンズピリモキサン、イソシクロセラム、スルフルラミド、ニコフルプロール、ジムプロピリダズ、臭化メチル、クロルピクリン、クリオライト、フッ化スルフリル、ホウ砂、ホウ酸、八ホウ酸ナトリウム、メタほう酸ナトリウム、吐酒石、ダゾメット、メタム、リン化アルミニウム、リン化カルシウム、ホスフィン、リン化亜鉛、シアン化カルシウム、シアン化カリウム、シアン化ナトリウム、シプロフラニリド、コドリンガ顆粒病ウイルス、コドリンガモドキ顆粒病ウイルス、ビロードマイケムシ核多角体病ウイルス、オオタバコガ核多角体病ウイルス、GS-オメガ/カッパHXTX-Hv1aペプチド、アザジラクチン、ジコホル、石灰硫黄合剤、バークホルデリア属菌、ボルバキア・ピピエンティス(Zap)、アリタソウ抽出物、グリセリンまたはプロパンジオールを持った脂肪酸モノエステル、ニームオイル、ボーベリア バシアーナ、メタリジウム アニソプリエ、ペキロマイセス フモソロセウス、珪藻土等が挙げられる。 In addition, as compounds for other pesticide applications, avelmectin, tetrachlorolantraniliplol, diafentiurone, ethiprol, fipronil, fronicamid, fluenesulfone, indoxacarb, metaflumison, metaaldehyde, pimetrodin, pyridalyl, pyrifluquinazone, silafluofen. , Spirosion, Spirotetramato, Sulfoxaflor, Afidopyropen, Brofuranilide, Cycraniliprol, Dichloromesothiaz, Frometkin, Fluazindridin, Fluhexaphon, Fluxametamide, Pyryprol, Tetraniliprol, Hydroprene, Kinoprene, Metoprene, Ticropira Zoflo (tyclopyrazoflor), flupyrimin, spiropidione, benzpyrimoxane, isocycloselam, sulfurulamide, nicofluprol, gympropyridas, methyl bromide, chlorpicrin, cryolite, sulfryl fluoride, boric acid, boric acid, sodium octaborate , Sodium metaborate, Insecticide, Dazomet, Metam, Aluminum phosphide, Calcium phosphate, Hosphin, Zinc phosphate, Calcium cyanide, Potassium cyanide, Sodium cyanide, Ciproflanilide, Kodlinga granule disease virus, Kodlinga modoki granule disease virus, Boric acid beetle nuclear polymorphism virus, Tobacco moth nuclear polymorphic disease virus, GS-omega / kappa HXTX-Hv1a peptide, azadilactin, dicohol, lime sulfur mixture, Burkhorderia spp. Examples include compounds, fatty acid monoesters with glycerin or propanediol, neem oil, boberia baciana, metallidium anisoprie, pequiromyces fumosoloseus, diatomaceous soil and the like.
 〔4.植物病害防除方法〕
 本実施形態における農園芸用薬剤は、例えば、畑、水田、芝生、および果樹園などの農耕地または非農耕地において使用することができる。また、本実施形態における農園芸用薬剤は、茎葉散布といった茎葉処理に加えて、球根および塊茎などへの処理も含めた種子処理、潅注処理、および水面処理などの非茎葉処理によっても施用できる。したがって、本実施形態における植物病害防除方法は、上述の農園芸用薬剤を用いて茎葉処理または非茎葉処理を行う手順を含む方法である。なお、非茎葉処理を行う場合には、茎葉処理を行う場合に比べて、労力を低減させることができる。
[4. Plant disease control method]
The agricultural and horticultural chemicals in this embodiment can be used in cultivated or non-agricultural lands such as fields, paddy fields, lawns, and orchards. Further, the agricultural and horticultural chemicals in the present embodiment can be applied not only by foliage treatment such as foliage spraying, but also by non-foliage treatment such as seed treatment including treatment of bulbs and tubers, irrigation treatment, and water surface treatment. Therefore, the method for controlling plant diseases in the present embodiment is a method including a procedure for performing foliage treatment or non-foliage treatment using the above-mentioned agricultural and horticultural agents. In addition, when the non-foliage treatment is performed, the labor can be reduced as compared with the case where the foliage treatment is performed.
 種子処理による施用では、水和剤および粉剤などを種子と混合し攪拌することにより、あるいは希釈した水和剤などに種子を浸漬することにより、薬剤を種子に付着させる。また、種子コーティング処理も含まれる。種子処理の場合の有効成分の使用量は、種子100kgに対して例えば0.005~10000gであり、好ましくは0.05~1000gである。農園芸用薬剤で処理した種子については、通常の種子と同様に利用すればよい。 In the application by seed treatment, the chemicals are attached to the seeds by mixing the wettable powder and powder with the seeds and stirring, or by immersing the seeds in the diluted wettable powder. It also includes a seed coating process. The amount of the active ingredient used in the seed treatment is, for example, 0.005 to 10000 g, preferably 0.05 to 1000 g per 100 kg of seeds. Seeds treated with agricultural and horticultural chemicals may be used in the same manner as normal seeds.
 潅注処理による施用は、苗の移植時などに植穴またはその周辺に粒剤などを処理したり、種子または植物体の周囲の土壌に粒剤および水和剤などを処理したりすることによって行う。潅注処理の場合の有効成分の使用量は、農園芸地1mあたり例えば0.005~10000gであり、好ましくは0.05~1000gである。 The application by irrigation treatment is performed by treating the planting hole or its surroundings with granules, etc. at the time of transplanting seedlings, or treating the soil around the seeds or plants with granules, wettable powders, etc. .. The amount of the active ingredient used in the irrigation treatment is, for example, 0.005 to 10000 g, preferably 0.05 to 1000 g per 1 m 2 of agricultural and horticultural land.
 水面処理による施用は、水田の田面水に粒剤などを処理することによって行う。水面処理の場合の有効成分の使用量は、水田10aあたり例えば0.05~10000gであり、好ましくは0.5~1000gである。 Application by water surface treatment is performed by treating the surface water of the paddy field with granules or the like. The amount of the active ingredient used in the water surface treatment is, for example, 0.05 to 10000 g, preferably 0.5 to 1000 g per paddy field 10a.
 茎葉散布に用いる場合の有効成分の使用量は、畑、田、果樹園および温室などの農園芸地1haあたり例えば10~5000g、より好ましくは25~2000gである。 The amount of the active ingredient used for foliage spraying is, for example, 10 to 5000 g, more preferably 25 to 2000 g per 1 ha of agricultural and horticultural fields such as fields, rice fields, orchards and greenhouses.
 なお、使用濃度および使用量は、剤形、使用時期、使用方法、使用場所および対象作物などによっても異なるため、上記の範囲にこだわることなく増減することが可能である。 Since the concentration and amount of use differ depending on the dosage form, timing of use, method of use, place of use, target crop, etc., it is possible to increase or decrease without being particular about the above range.
 液体担体としては、有効成分と反応しないものであれば特に限定されるものではない。液体担体としては、例えば、水、アルコール類(例えば、メチルアルコール、エチルアルコール、エチレングリコール、セロソルブ等)、ケトン類(例えば、アセトン、メチルエチルケトンなど)、エーテル類(例えばジメチルエーテル、ジエチルエーテル、ジオキサン、テトラヒドロフラン等)、芳香族炭化水素類(例えば、ベンゼン、トルエン、キシレン、メチルナフタレン等)、脂肪族炭化水素類(例えばガソリン、ケロシン、灯油、機械油、燃料油等)、酸アミド類(例えばジメチルホルムアミド、N-メチルピロリドン等)ハロゲン化炭化水素類(例えば、クロロホルム、四塩化炭素等)、エステル類(例えば、酢酸エチルエステル、脂肪酸のグリセリンエステル等)、ニトリル類(例えば、アセトニトリル等)およびジメチルスルホキシド等を挙げることができる。 The liquid carrier is not particularly limited as long as it does not react with the active ingredient. Examples of the liquid carrier include water, alcohols (eg, methyl alcohol, ethyl alcohol, ethylene glycol, cellosolve, etc.), ketones (eg, acetone, methyl ethyl ketone, etc.), ethers (eg, dimethyl ether, diethyl ether, dioxane, hydrocarbon, etc.). Etc.), aromatic hydrocarbons (eg, benzene, toluene, xylene, methylnaphthalene, etc.), aliphatic hydrocarbons (eg, gasoline, kerosine, kerosene, machine oil, fuel oil, etc.), acid amides (eg, dimethylformamide). , N-Methylpyrrolidone, etc.) Halogenated hydrocarbons (eg, chloroform, carbon tetrachloride, etc.), esters (eg, ethyl acetate esters, fatty acid glycerin esters, etc.), nitriles (eg, acetonitrile, etc.) and dimethylsulfoxide. And so on.
 また、固体担体としては、カオリンクレー、ベントナイト、酸性白土、パイロフィライト、タルク、珪藻土、方解石、尿素、硫酸アンモニウム等の微粉末あるいは粒状物が使用できる。 As the solid carrier, fine powders or granules such as kaolin clay, bentonite, acidic clay, pyrophyllite, talc, diatomaceous earth, calcite, urea, and ammonium sulfate can be used.
 乳化剤、分散剤としては、石鹸類、アルキルスルホン酸、アルキルアリールスルホン酸、ジアルキルスルホコハク酸、第4級アンモニウム塩、オキシアルキルアミン、脂肪酸エステル、ポリアルキレンオキサイド系、アンヒドロソルビトール系等の界面活性剤が使用できる。 As emulsifiers and dispersants, surfactants such as soaps, alkylsulfonic acids, alkylarylsulfonic acids, dialkylsulfosuccinic acids, quaternary ammonium salts, oxyalkylamines, fatty acid esters, polyalkylene oxides, and anhydrosorbitols. Can be used.
 トリアゾール誘導体(-)-エナンチオマーを有効成分として製剤中に含有させる場合、その含有割合は、剤型および使用目的によっても異なるが、製剤の全量に対して、0.1~99.9重量%とすればよい。なお、実際の使用時においては、その処理濃度は、通常0.0025~5重量%、好ましくは0.005~1重量%となるように適宜、溶剤、希釈剤、増量剤などを加えて調整するのが好ましい。 When the triazole derivative (-)-enantiomer is contained in the pharmaceutical product as an active ingredient, the content ratio varies depending on the dosage form and the purpose of use, but is 0.1 to 99.9% by weight based on the total amount of the pharmaceutical product. do it. In actual use, the treatment concentration is usually adjusted to 0.0025 to 5% by weight, preferably 0.005 to 1% by weight by appropriately adding a solvent, a diluent, a bulking agent or the like. It is preferable to do so.
 以上に説明したように、トリアゾール誘導体(-)-エナンチオマーは、植物病害を引き起こす多くの菌に対して優れた殺菌作用を示す。すなわち、トリアゾール誘導体(-)-エナンチオマーを有効成分として含む農園芸用病害防除剤は、人畜に対する毒性が低く取扱い安全性に優れ、かつ広範な植物病害に対して高い防除効果を示すことができる。 As explained above, the triazole derivative (-)-enantiomer shows an excellent bactericidal action against many bacteria that cause plant diseases. That is, the agricultural and horticultural disease control agent containing the triazole derivative (-)-enantiomer as an active ingredient has low toxicity to humans and animals, is excellent in handling safety, and can exhibit a high control effect on a wide range of plant diseases.
 [4.工業材料保護剤]
 〔1.工業材料保護効果〕
 本実施形態に係るトリアゾール誘導体(-)-エナンチオマーは、工業材料を侵す広汎な有害微生物から材料を保護する優れた効果を示すことから工業材料保護剤にも使用し得る。かかる微生物の例としては、以下に示す微生物を挙げることができる。
[4. Industrial material protectant]
[1. Industrial material protection effect]
The triazole derivative (-)-enantiomer according to the present embodiment can also be used as an industrial material protectant because it exhibits an excellent effect of protecting the material from a wide range of harmful microorganisms that attack the industrial material. Examples of such microorganisms include the following microorganisms.
 紙・パルプ劣化微生物(スライム形成菌を含む)であるアスペルギルス(Aspergillus sp.)、トリコデルマ(Trichoderma sp.)、ペニシリウム(Penicillium sp.)、ジェオトリカム(Geotrichum sp.)、ケトミウム(Chaetomium sp.)、カドホーラ(Cadophora
 sp.)、セラトストメラ(Ceratostomella sp.)、クラドスボリウム(Cladosporium sp.)、コーティシウム(Corticium sp.)、レンティヌス(Lentinus sp.)、レンズィテス(Lenzites sp.)、フォーマ(Phoma sp.)、ポリスティクス(Polysticus sp.)、プルラリア(Pullularia sp.)、ステレウム(Stereum sp.)、トリコスポリウム(Trichosporium sp.)、アエロバクタ-(Aerobacter sp.)、バチルス(Bacillussp.)、デスルホビブリオ(Desulfovibrio sp.)、シュードモナス(Pseudomonas sp.)、フラボバクテリウム(Flavobacterium sp.)、ミクロコッカス(Micrococcus sp.)など、繊維劣化微生物であるアスペルギルス(Aspergillus sp.)、ペニシリウム(Penicillium sp.)、ケトミウム(Chaetomium sp.)、ミロテシウム(Myrothecium sp.)、カーブラリア(Curvularia sp.)、グリオマスティックス(Gliomastix sp.)、メンノニエラ(Memnoniella sp.)、サルコポディウム(Sarcopodium sp.)、スタキボトリス(Stschybotrys sp.)、ステムフィリウム(Stemphylium sp.)、ジゴリンクス(Zygorhynchus sp.)、バチルス(bacillus sp.)、スタフィロコッカス(Staphylococcus sp.)など、木材変質菌であるオオウズラタゲ(Tyromyces palustris)、カワラタケ(Coriolus versicolor)、アスペルギルス(Aspergillus sp.)、ペニシリウム(Penicillium sp.)、リゾプス(Rhizopus sp.)、オーレオバシディウム(Aureobasidium sp.)、グリオクラディウム(Gliocladum sp.)、クラドスポリウム(Cladosporium sp.)、ケトミウム(Chaetomium sp.)、トリコデルマ(Trichoderma sp.)など、皮革劣化微生物であるアスペルギルス(Aspergillussp.)、ペニシリウム(Penicillium sp.)、ケトミウム(Chaetomium sp.)、クラドスポリウム(Cladosporium sp.)、ムコール(Mucor sp.)、パエシロミセス(Paecilomycessp.)、ピロブス(Pilobus sp.)、プルラリア(Pullularia sp.)、トリコスポロン(Trichosporon sp.)、トリコテシウム(Tricothecium sp.)など、ゴム・プラスチック劣化微生物であるアスペルギルス(Aspergillus sp.)、ペニシリウム(Penicilliumsp.)、リゾプス(Rhizopus sp.)、トリコデルマ(Trichoderma sp.)、ケトミウム(Chaetomium sp.)、ミロテシウム(Myrothecium sp.)、ストレプトマイセス(Streptomyces sp.)、シュードモナス(Pseudomonas sp.)、バチルス(Bacillus sp.)、ミクロコッカス(Micrococcus sp.)、セラチア(Serratia sp.)、マルガリノマイセス(Margarinomyces sp.)、モナスクス(Monascus sp.)など、塗料劣化微生物であるアスペルギルス(Aspergillussp.)、ペニシリウム(Penicillium sp.)、クラドスポリウム(Cladosporium sp.)、オーレオバシディウム(Aureobasidium sp.)、グリオクラディウム(Gliocladium sp.)、ボトリオディプロディア(Botryodiplodia sp.)、マクロスポリウム(Macrosporium sp.)、モニリア(Monilia sp.)、フォーマ(Phoma sp.)、プルラリア(Pullularia sp.)、スポロトリカム(Sporotrichum sp.)、トリコデルマ(Trichoderma sp.)、バチルス(bacillussp.)、プロテウス(Proteus sp.)、シュードモナス(Pseudomonas sp.)、セラチア(Serratia sp.)。
Paper and pulp-deteriorating microorganisms (including slime-forming microorganisms), Aspergillus sp., Trichoderma sp., Penicillium sp., Geotrichum sp., Chaetomium sp. (Cadophora
sp. ), Ceratostomella sp., Cladosporium sp., Corticium sp., Lentinus sp., Lentinus sp., Phomatics sp. Polysticus sp., Pulularia sp., Stereum sp., Trichosporium sp., Aerobacter sp., Bacillus sp., Desulfobibrio sp. , Pseudomonas sp., Flavobacterium sp., Micrococcus sp., and other fiber-degrading microorganisms such as Aspergillus sp., Penicillium sp., Penicillium sp. ), Micrococcium sp., Curvularia sp., Gliomatics sp., Memnoniella sp., Sarcopodium sp., Sarcopodium sp. Stereum sp., Zygorhynchus sp., Bacillus sp., Staphylococcus sp. Aspergillus sp., Penicillium sp., Rhizopus sp., Aureobasidium sp., Gliocladum sp., Cladosporium sp. Aspergillus (Asp), which is a leather-deteriorating microorganism such as Chaetomium sp.) And Trichoderma sp. erguillussp. ), Penicillium sp., Chaetomium sp., Cladosporium sp., Mucor sp., Paecilomyces sp., Pilobus sp. ), Trichosporon sp., Trichothecium sp., Aspergillus sp., Penicillium sp., Rhizopus sp., Trichothecium sp., Trichothecium sp., Trichothecium sp. , Chaetomium sp., Myrothecium sp., Streptomyces sp., Pseudomonas sp., Bacillus sp., Bacillus sp., Micrococcus sp. .), Margarinomyces sp., Monascus sp., And other paint-degrading microorganisms such as Aspergillus sp., Penicillium sp., Cladosporium sp., Cladosporium sp. Sidium (Aureobasideium sp.), Gliocladium sp., Botriodiplodia sp., Macrosporium sp., Monilia sp., Forma (Ph) , Pluraria sp., Sporotrichum sp., Trichoderma sp., Bacillus sp., Proteus sp., Pseudomonas sp., Serra, Pseudomonas sp.
 〔2.製剤〕
 本実施形態に係るトリアゾール誘導体(-)-エナンチオマーを有効成分として含む工業用材料保護剤は、トリアゾール誘導体(-)-エナンチオマー以外にも種々の成分を含んでいてもよい。トリアゾール誘導体(-)-エナンチオマーを有効成分として含む工業用材料保護剤は、適当な液体担体に溶解あるいは分散させるか、または固体担体と混合して使用することができる。トリアゾール誘導体(-)-エナンチオマーを有効成分として含む工業用材料保護剤は、必要に応じて、さらに乳化剤、分散剤、展着剤、浸透剤、湿潤剤または安定剤等を含んでいてもよい。また、トリアゾール誘導体(-)-エナンチオマーを有効成分として含む工業用材料保護剤の剤型としては、水和剤、粉剤、粒剤、錠剤、ペースト剤、懸濁剤および噴霧材などを挙げることができる。トリアゾール誘導体(-)-エナンチオマーを有効成分として含む工業用材料保護剤は、他の殺菌剤、殺虫剤または劣化防止剤等を含んでいてもよい。
[2. pharmaceutical formulation〕
The industrial material protective agent containing the triazole derivative (-)-enantiomer as an active ingredient according to the present embodiment may contain various components other than the triazole derivative (-)-enantiomer. The industrial material protectant containing the triazole derivative (-)-enantiomer as an active ingredient can be dissolved or dispersed in a suitable liquid carrier, or mixed with a solid carrier for use. The industrial material protectant containing the triazole derivative (-)-enantiomer as an active ingredient may further contain an emulsifier, a dispersant, a spreading agent, a penetrant, a wetting agent, a stabilizer and the like, if necessary. Examples of the dosage form of the industrial material protective agent containing the triazole derivative (-)-enantiomer as an active ingredient include wettable powders, powders, granules, tablets, pastes, suspensions and spray materials. can. The industrial material protective agent containing the triazole derivative (-)-enantiomer as an active ingredient may contain other fungicides, insecticides, deterioration inhibitors and the like.
 液体担体としては、有効成分と反応しないものであれば特に限定されるものではない。液体担体としては、例えば、水、アルコール類(例えば、メチルアルコール、エチルアルコール、エチレングリコール、セロソルブ等)、ケトン類(例えば、アセトン、メチルエチルケトンなど)、エーテル類(例えばジメチルエーテル、ジエチルエーテル、ジオキサン、テトラヒドロフラン等)、芳香族炭化水素類(例えば、ベンゼン、トルエン、キシレン、メチルナフタレン等)、脂肪族炭化水素類(例えばガソリン、ケロシン、灯油、機械油、燃料油等)、酸アミド類(例えばジメチルホルムアミド、N-メチルピロリドン等)ハロゲン化炭化水素類(例えばクロロホルム、四塩化炭素等)、エステル類(例えば、酢酸エチルエステル、脂肪酸のグリセリンエステル等)、ニトリル類(例えば、アセトニトリル等)およびジメチルスルホキシド等を挙げることができる。 The liquid carrier is not particularly limited as long as it does not react with the active ingredient. Examples of the liquid carrier include water, alcohols (eg, methyl alcohol, ethyl alcohol, ethylene glycol, cellosolve, etc.), ketones (eg, acetone, methyl ethyl ketone, etc.), ethers (eg, dimethyl ether, diethyl ether, dioxane, hydrocarbon, etc.). Etc.), aromatic hydrocarbons (eg, benzene, toluene, xylene, methylnaphthalene, etc.), aliphatic hydrocarbons (eg, gasoline, kerosine, kerosene, machine oil, fuel oil, etc.), acid amides (eg, dimethylformamide). , N-Methylpyrrolidone, etc.) Halogenated hydrocarbons (eg, chloroform, carbon tetrachloride, etc.), esters (eg, ethyl acetate esters, fatty acid glycerin esters, etc.), nitriles (eg, acetonitrile, etc.), dimethylsulfoxide, etc. Can be mentioned.
 また、固体担体としては、カオリンクレー、ベントナイト、酸性白土、パイロフィライト、タルク、珪藻土、方解石、尿素および硫酸アンモニウム等の微粉末または粒状物が使用できる。 As the solid carrier, fine powders or granules such as kaolin clay, bentonite, acidic clay, pyrophyllite, talc, diatomaceous earth, calcite, urea and ammonium sulfate can be used.
 乳化剤、分散剤としては、石鹸類、アルキルスルホン酸、アルキルアリールスルホン酸、ジアルキルスルホコハク酸、第4級アンモニウム塩、オキシアルキルアミン、脂肪酸エステル、ポリアルキレンオキサイド系およびアンヒドロソルビトール系等の界面活性剤が使用できる。 As emulsifiers and dispersants, surfactants such as soaps, alkylsulfonic acids, alkylarylsulfonic acids, dialkylsulfosuccinic acids, quaternary ammonium salts, oxyalkylamines, fatty acid esters, polyalkylene oxides and anhydrosorbitols Can be used.
 トリアゾール誘導体(-)-エナンチオマーを有効成分として製剤中に含有させる場合、その含有割合は、剤型および使用目的によっても異なるが、製剤の全量に対して、0.05~99.9重量%とすればよい。なお、実際の使用時においては、その処理濃度は、通常0.0025~5重量%、好ましくは0.005~1重量%となるように適宜、溶剤、希釈剤および増量剤などを加えて調整するのが好ましい。 When the triazole derivative (-)-enantiomer is contained in the pharmaceutical product as an active ingredient, the content ratio varies depending on the dosage form and the purpose of use, but is 0.05 to 99.9% by weight based on the total amount of the pharmaceutical product. do it. In actual use, the treatment concentration is usually adjusted to 0.0025 to 5% by weight, preferably 0.005 to 1% by weight by appropriately adding a solvent, a diluent, a bulking agent, or the like. It is preferable to do so.
 [まとめ]
 本発明に係る化合物は、上述の一般式(I)で表されるトリアゾール誘導体の(-)-エナンチオマーまたはその農薬学的に許容可能な塩である。
[summary]
The compound according to the present invention is a (-)-enantiomer of the triazole derivative represented by the above general formula (I) or a pesticide-acceptable salt thereof.
 本発明に係る化合物の一態様では、一般式(I)において、
 Rが、-ORであり;
 Rが、ハロゲン基、シアノ基、C-C-アルキル基、C-C-ハロアルキル基、C-C-アルコキシ基、-SORまたは-SFであり;
 Rが、ハロゲン基、ニトロ基、シアノ基、アミノ基、C-C-アルキル基、C-C-ハロアルキル基、C-C-アルコキシ基、C-C-ハロアルコキシ基、C-C-アルキルアミノ基、C-C-ジアルキルアミノ基、C-C-アルキルアシルアミノ基、-SORまたは-SFである化合物またはその塩である。
In one aspect of the compound according to the present invention, in the general formula (I),
R 1 is -OR 4 ;
R 2 is a halogen group, a cyano group, a C 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group, a C 1- C 4 -alkoxy group, -SOR 7 or -SF 5 ;
R 3 is a halogen group, a nitro group, a cyano group, an amino group, a C 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group, a C 1- C 4 -alkoxy group, and a C 1- C 4 -halo. alkoxy groups, C 1 -C 4 - alkyl acyl amino group, the compound or a salt thereof -SOR 7 or -SF 5 - alkylamino group, C 1 -C 4 - dialkylamino group, C 1 -C 4.
 本発明に係る化合物の一態様では、一般式(I)において、Rが、C-C-アルキル基であり;
 Rが、ハロゲン基、シアノ基、C-C-アルキル基、C-C-ハロアルキル基またはC-C-アルコキシ基であり;
 Rが、ハロゲン基、シアノ基、C-C-アルキル基、C-C-ハロアルキル基、C-C-アルコキシ基またはC-C-ハロアルコキシ基である。
In one embodiment of the compounds according to the present invention, in the general formula (I), R 4 is, C 1 -C 6 - an alkyl group;
R 2 is halogen, cyano, C 1 -C 4 - alkyl group, C 1 -C 4 - haloalkyl group or a C 1 -C 4 - alkoxy group;
R 3 is halogen, cyano, C 1 -C 4 - haloalkoxy group - alkyl group, C 1 -C 4 - haloalkyl group, C 1 -C 4 - alkoxy group or a C 1 -C 4.
 なお、本発明に係るトリアゾール誘導体(-)-エナンチオマーを有効成分として含有する農園芸用薬剤または工業用材料保護剤も本発明の範疇に含まれる。 Agricultural and horticultural agents or industrial material protective agents containing the triazole derivative (-)-enantiomer according to the present invention as an active ingredient are also included in the category of the present invention.
 以下に実施例を示し、本発明の実施の形態についてさらに詳しく説明する。もちろん、本発明は以下の実施例に限定されるものではなく、細部については様々な態様が可能であることはいうまでもない。さらに、本発明は上述した実施形態に限定されるものではなく、請求項に示した範囲で種々の変更が可能であり、それぞれ開示された技術的手段を適宜組み合わせて得られる実施形態についても本発明の技術的範囲に含まれる。また、本明細書中に記載された文献の全てが参考として援用される。 Examples are shown below, and embodiments of the present invention will be described in more detail. Of course, the present invention is not limited to the following examples, and it goes without saying that various aspects are possible for details. Further, the present invention is not limited to the above-described embodiment, and various modifications can be made within the scope of the claims, and the present invention also relates to an embodiment obtained by appropriately combining the disclosed technical means. It is included in the technical scope of the invention. In addition, all of the documents described in this specification are incorporated by reference.
<製造例1:光学分割によるトリアゾール誘導体(-)-エナンチオマーの調製>
 特許文献1を参照し、2-(2-クロロ-4-(4-クロロフェノキシフェニル)フェニル)-2-ヒドロキシ-3-(1H-1,2,4-トリアゾール-1-イル)プロパン酸メチルのラセミ体(以下、化合物1(ラセミ)と称する)を得た。
<Production Example 1: Preparation of triazole derivative (-)-enantiomer by optical resolution>
Methyl 2- (2-chloro-4- (4-chlorophenoxyphenyl) phenyl) -2-hydroxy-3- (1H-1,2,4-triazole-1-yl) propanoate with reference to Patent Document 1. (Hereinafter referred to as compound 1 (racemic)) was obtained.
 化合物1(ラセミ)をメタノールに溶解し、アミローストリス(3-クロロ-5-メチルフェニルカルバメート)がシリカゲル担体に固定化された分取カラムをつないだ高速液体クロマトグラフィー(HPLC)に供し、エナンチオマーの分取分離を行った。 Compound 1 (racemi) was dissolved in methanol and subjected to high performance liquid chromatography (HPLC) in which amylose tris (3-chloro-5-methylphenylcarbamate) was connected to a preparative column immobilized on a silica gel carrier. Separation was performed.
 具体的な条件は以下の通りである。
高速液体クロマトグラフ:分取カラム:製品名「CHIRALPAK IG」、ダイセル化学工業社製、内径4.6mm、長さ250mm、粒子径5μm
サンプル濃度:0.5mg/mL
移動相:100%メタノール
流速:1.0mL/min
カラム温度:40℃
検出波長:230nm
The specific conditions are as follows.
High Performance Liquid Chromatograph: Preparative Column: Product Name "CHIRALPAK IG", manufactured by Daicel Chemical Industries, Ltd., Inner diameter 4.6 mm, Length 250 mm, Particle size 5 μm
Sample concentration: 0.5 mg / mL
Mobile phase: 100% methanol flow rate: 1.0 mL / min
Column temperature: 40 ° C
Detection wavelength: 230nm
 上記条件下で分離したところ、溶出時間が異なる2つのピークが検出された。それぞれのピークに由来する化合物の比旋光度を測定した結果、最初に溶出された化合物は、(+)-エナンチオマーであり、後に溶出された化合物は、(-)-エナンチオマーであった。以下、(-)-エナンチオマーおよび(+)-エナンチオマーを、それぞれ、化合物1(-)および化合物1(+)という。 When separated under the above conditions, two peaks with different elution times were detected. As a result of measuring the specific rotation of the compound derived from each peak, the compound eluted first was (+)-enantiomer, and the compound eluted later was (-)-enantiomer. Hereinafter, the (-)-enantiomer and the (+)-enantiomer are referred to as compound 1 (-) and compound 1 (+), respectively.
 比旋光度の測定は、P-1020(日本分光社製、Naランプ:589nm)を用いて行った。具体的な測定結果は以下の通りである。 The specific rotation was measured using P-1020 (manufactured by JASCO Corporation, Na lamp: 589 nm). The specific measurement results are as follows.
 (+)-エナンチオマーの比旋光度:
 [α]20  = +120.8°(1mLのクロロホルム当たり10mg)
 (-)-エナンチオマーの比旋光度:
 [α]20  = -123.1°(1mLのクロロホルム当たり10mg)
(+)-Specific rotation of enantiomers:
[Α] 20 D = + 120.8 ° (10 mg per 1 mL of chloroform)
(-)-Specific rotation of enantiomers:
[Α] 20 D = -123.1 ° (10 mg per 1 mL of chloroform)
 <製造例2:化学合成によるトリアゾール誘導体(-)-エナンチオマーの調製>
 2-(2-クロロ-4-(4-クロロフェノキシ)フェニル)プロパ-2-エン-1-オールの合成
 (反応スキーム1)
<Production Example 2: Preparation of triazole derivative (-)-enantiomer by chemical synthesis>
Synthesis of 2- (2-chloro-4- (4-chlorophenoxy) phenyl) propa-2-en-1-ol (reaction scheme 1)
Figure JPOXMLDOC01-appb-C000005
Figure JPOXMLDOC01-appb-C000005
 2-(2-クロロ-4-(4-クロロフェノキシ)フェニル)-2-オキソ酢酸メチル5.0gをテトラヒドロフラン(以下THF)76.9mLに溶解し、ドライアイス/アセトン浴で-78℃に冷却した。得られた溶液に1.07M/メチルマグネシウムブロミド/THF溶液17.2mLをゆっくり滴下した後、1時間撹拌した。塩化アンモニウム水溶液を当該反応溶液に加えることで、反応を停止した。得られた溶液に対し、水層を酢酸エチルで抽出し、これを飽和食塩水で洗浄し、無水硫酸ナトリウムにより乾燥した。溶媒留去して2-(2-クロロ-4-(4-クロロフェノキシ)フェニル)-2-ヒドロキシプロパン酸メチルの粗生成物Aを5.38g得た。 Dissolve 5.0 g of 2- (2-chloro-4- (4-chlorophenoxy) phenyl) -2-oxoacetate in 76.9 mL of tetrahydrofuran (THF) and cool to -78 ° C in a dry ice / acetone bath. bottom. 17.2 mL of 1.07 M / methylmagnesium bromide / THF solution was slowly added dropwise to the obtained solution, and the mixture was stirred for 1 hour. The reaction was stopped by adding an aqueous ammonium chloride solution to the reaction solution. For the obtained solution, the aqueous layer was extracted with ethyl acetate, washed with saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off to obtain 5.38 g of a crude product A of methyl 2- (2-chloro-4- (4-chlorophenoxy) phenyl) -2-hydroxypropanoate.
 続いて、粗生成物A5.38gをトルエン92.3mLに溶解した。そこに、パラトルエンスルホン酸一水和物1.46g加え、130℃に加熱したオイルバス中で、還流条件下で撹拌した。反応開始から1時間後に、反応液を室温まで放冷した後、飽和炭酸水素ナトリウム水溶液を加え、反応を停止した。得られた溶液に対し、水層をトルエンで抽出し、これを飽和食塩水で洗浄した。無水硫酸ナトリウムで乾燥後、溶媒を留去し、2-(2-クロロ-4-(4-クロロフェノキシ)フェニル)アクリル酸メチルの粗生成物B4.83gを得た。 Subsequently, 5.38 g of the crude product A was dissolved in 92.3 mL of toluene. 1.46 g of paratoluenesulfonic acid monohydrate was added thereto, and the mixture was stirred under reflux conditions in an oil bath heated to 130 ° C. One hour after the start of the reaction, the reaction solution was allowed to cool to room temperature, and then a saturated aqueous sodium hydrogen carbonate solution was added to stop the reaction. For the obtained solution, an aqueous layer was extracted with toluene and washed with saturated brine. After drying over anhydrous sodium sulfate, the solvent was distilled off to obtain 4.83 g of a crude product of methyl 2- (2-chloro-4- (4-chlorophenoxy) phenyl) acrylate.
 粗生成物B2.43gをトルエン18.5mLに溶解し、ドライアイス/アセトン浴中で冷却した後、1.0M/水素化ジイソプロピルアルミニウム/トルエン溶液18.5mLを加えた。冷却下で1時間撹拌した後、塩酸(1N)に反応溶液を加えて反応を停止した。さらに水と酒石酸ナトリウムカリウムを加え、室温下で1時間撹拌した。得られた溶液に対し、水層をトルエンで抽出し、これを飽和食塩水で洗浄し、無水硫酸ナトリウムにより乾燥した。溶媒を留去して粗生成物Cを得た。また、他のバッチにおいて、上記の操作と同一の操作をすることで同じ粗生成物Cを得た。それらを併せて粗生成物Cとして、シリカゲルカラムクロマトグラフィー(シリカゲル40gヘキサン/酢酸エチル:20→50%)で精製することにより、標記の化合物3.68gを無色液体として得た。H NMR (400MHz,CDCl) δ:7.34-7.30(m,2H),7.18(d,J=8.4Hz,1H),7.00-6.92(m,3H),6.89(dd,J=8.4,2.0Hz,1H),5.37(s,1H),5.18(s,1H),4.41(d,J=6.4Hz,2H),OHのシグナルはH/D交換のため消失。 2.43 g of crude product B was dissolved in 18.5 mL of toluene, cooled in a dry ice / acetone bath, and then 18.5 mL of 1.0 M / diisopropylaluminum hydride / toluene solution was added. After stirring for 1 hour under cooling, the reaction solution was added to hydrochloric acid (1N) to stop the reaction. Further, water and potassium sodium tartrate were added, and the mixture was stirred at room temperature for 1 hour. For the obtained solution, the aqueous layer was extracted with toluene, washed with saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off to obtain a crude product C 1 . Further, in another batch, the same crude product C 2 was obtained by performing the same operation as the above operation. Together, they were purified as crude product C by silica gel column chromatography (silica gel 40 g hexane / ethyl acetate: 20 → 50%) to obtain 3.68 g of the title compound as a colorless liquid. 1 1 H NMR (400 MHz, CDCl 3 ) δ: 7.34-7.30 (m, 2H), 7.18 (d, J = 8.4 Hz, 1H), 7.00-6.92 (m, 3H) ), 6.89 (dd, J = 8.4, 2.0Hz, 1H), 5.37 (s, 1H), 5.18 (s, 1H), 4.41 (d, J = 6.4Hz) , 2H), OH signal disappeared due to H / D exchange.
 (2-(2-クロロ-4-(4-クロロフェノキシ)フェニル)オキシラン-2-イル)メタノールの合成
 (反応スキーム2)
(2- (2-Chloro-4- (4-chlorophenoxy) phenyl) oxylan-2-yl) Methanol synthesis (reaction scheme 2)
Figure JPOXMLDOC01-appb-C000006
Figure JPOXMLDOC01-appb-C000006
 真空条件下で加熱乾燥させたモレキュラーシーブス4A306mgの入ったフラスコにジクロロメタン10.5mLを入れ、氷冷により冷却した。その溶液にチタン(IV)テトライソプロポキシド1.23mLおよびL-(+)-酒石酸ジエチル0.89mLを加えた後、-20℃の低温恒温槽に移し、冷却しながら10分間撹拌した。得られた溶液に対し、1.16M/tert-ブチルヒドロペルオキシド/無水ジクロロメタン溶液17.9mLを加え、更に20分間撹拌を行い、反応液Aを得た。続いて、前項で得られた2-(2-クロロ-4-(4-クロロフェノキシ)フェニル)プロパ-2-エン-1-オール613mgをジクロロメタン10.5mLに溶解し、反応液Bを得た。反応液Bを反応液Aに対して、パスツールピペットを用いて滴下した。-20℃冷却下で6時間撹拌した後、飽和炭酸水素ナトリウム水溶液および飽和亜硫酸ナトリウム水溶液を反応溶液に加えることで反応を停止した。続いて、この溶液に対しセライト濾過を行うことで得られた濾液に対し、水層を酢酸エチルで抽出し、これを飽和食塩水で洗浄し、無水硫酸ナトリウムにより乾燥した。溶媒を留去して粗生成物Dを得た。粗生成物Dをシリカゲルカラムクロマトグラフィー(シリカゲル16g、ヘキサン/酢酸エチル:9→50%)で精製することにより、標記の化合物318mgを無色液体として得た。1H NMR (400MHz,CDCl)δ:7.41(d,J=8.8Hz,1H),7.35-7.30(m,2H),7.00-6.96(m,3H),6.89(dd,J=8.4,2.0Hz,1H),4.02-3.89(m,2H),3.35(d,J=4.8Hz,1H),2.88(d,J=4.8Hz,1H),1.76-1.72(m,1H)。 10.5 mL of dichloromethane was placed in a flask containing 306 mg of Molecular Sieves 4A, which had been heat-dried under vacuum conditions, and cooled by ice cooling. After adding 1.23 mL of titanium (IV) tetraisopropoxide and 0.89 mL of diethyl L- (+)-tartarate to the solution, the mixture was transferred to a low temperature constant temperature bath at −20 ° C. and stirred for 10 minutes while cooling. To the obtained solution, 17.9 mL of 1.16 M / tert-butyl hydroperoxide / anhydrous dichloromethane solution was added, and the mixture was further stirred for 20 minutes to obtain a reaction solution A. Subsequently, 613 mg of 2- (2-chloro-4- (4-chlorophenoxy) phenyl) propa-2-ene-1-ol obtained in the previous section was dissolved in 10.5 mL of dichloromethane to obtain a reaction solution B. .. The reaction solution B was added dropwise to the reaction solution A using a Pasteur pipette. After stirring for 6 hours under cooling at −20 ° C., the reaction was stopped by adding a saturated aqueous sodium hydrogen carbonate solution and a saturated aqueous sodium sulfite solution to the reaction solution. Subsequently, an aqueous layer was extracted with ethyl acetate from the filtrate obtained by filtering the solution with Celite, washed with saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off to obtain a crude product D. The crude product D was purified by silica gel column chromatography (silica gel 16 g, hexane / ethyl acetate: 9 → 50%) to obtain 318 mg of the title compound as a colorless liquid. 1 1 H NMR (400 MHz, CDCl 3 ) δ: 7.41 (d, J = 8.8 Hz, 1H), 7.35-7.30 (m, 2H), 7.00-6.96 (m, 3H) ), 6.89 (dd, J = 8.4,2.0Hz, 1H), 4.02-3.89 (m, 2H), 3.35 (d, J = 4.8Hz, 1H), 2 .88 (d, J = 4.8 Hz, 1H), 1.76-1.72 (m, 1H).
 メチル2-(2-クロロ-4-(4-クロロフェノキシ)フェニル)オキシラン-2-カルボキシレートの合成
 (反応スキーム3)
Synthesis of Methyl 2- (2-Chloro-4- (4-Chlorophenoxy) Phenyl) Oxylan-2-carboxylate (Reaction Scheme 3)
Figure JPOXMLDOC01-appb-C000007
Figure JPOXMLDOC01-appb-C000007
 前項で得られた(2-(2-クロロ-4-(4-クロロフェノキシ)フェニル)オキシラン-2-イル)メタノール102mgを四塩化炭素0.65mL、アセトニトリル0.65mL、水1.0mLに溶解し、過ヨウ素酸ナトリウム280mgを加えた後、三塩化ルテニウム7mgを加えた。この反応液を室温下で1時間撹拌した後、飽和炭酸水素ナトリウム水溶液および飽和亜硫酸ナトリウム水溶液を反応溶液に加えることで反応を停止した。さらに塩酸(1N)を溶液のpHが3程度になるまで加え、水層を酢酸エチルで抽出し、これを飽和食塩水で洗浄し無水硫酸ナトリウムで乾燥した。溶媒を留去して得られた粗成生物Eをそのまま次の反応に用いた。 102 mg of (2- (2-chloro-4- (4-chlorophenoxy) phenyl) oxylan-2-yl) methanol obtained in the previous section is dissolved in 0.65 mL of carbon tetrachloride, 0.65 mL of acetonitrile, and 1.0 mL of water. Then, after adding 280 mg of sodium periodate, 7 mg of ruthenium trichloride was added. After stirring this reaction solution at room temperature for 1 hour, the reaction was stopped by adding a saturated aqueous solution of sodium hydrogen carbonate and a saturated aqueous solution of sodium sulfite to the reaction solution. Further, hydrochloric acid (1N) was added until the pH of the solution reached about 3, and the aqueous layer was extracted with ethyl acetate, washed with saturated brine, and dried over anhydrous sodium sulfate. The crude organism E obtained by distilling off the solvent was used as it was in the next reaction.
 粗生成物EをN,N-ジメチルホルムアミド3.3mLに溶解し、ヨードメタン0.061mLを加えた。氷浴中で冷却した後、次いで炭酸カリウム136mgを加えた。室温下で1時間撹拌した後、ヨードメタン0.182mL、次いで炭酸カリウム407mgをさらに加えた。室温下で1時間撹拌した後、飽和塩化アンモニウム水溶液を反応溶液に加えることで反応を停止した。水層を酢酸エチルで抽出し、これを飽和食塩水で洗浄し無水硫酸ナトリウムで乾燥した。溶媒留去して得られた粗成生物Fをシリカゲルカラムクロマトグラフィー(シリカゲル7g、ヘキサン/酢酸エチル:9→50%)で精製することにより、標記の化合物51mgを無色液体として得た。H NMR(400MHz,CDCl):7.39(d,J=8.5Hz,2H),7.34(d,J=8.8Hz,2H),7.01-6.96(m,3H),6.88(dd,J=8.5,2.4Hz,1H),3.79(s,3H),3.59(d,J=6.3Hz,1H),3.02(d,J=6.3Hz,1H)。 Crude product E was dissolved in 3.3 mL of N, N-dimethylformamide and 0.061 mL of iodomethane was added. After cooling in an ice bath, 136 mg of potassium carbonate was then added. After stirring at room temperature for 1 hour, 0.182 mL of iodomethane and then 407 mg of potassium carbonate were further added. After stirring at room temperature for 1 hour, the reaction was stopped by adding a saturated aqueous solution of ammonium chloride to the reaction solution. The aqueous layer was extracted with ethyl acetate, washed with saturated brine and dried over anhydrous sodium sulfate. The crude product F obtained by distilling off the solvent was purified by silica gel column chromatography (silica gel 7 g, hexane / ethyl acetate: 9 → 50%) to obtain 51 mg of the title compound as a colorless liquid. 1 1 H NMR (400 MHz, CDCl 3 ): 7.39 (d, J = 8.5 Hz, 2H), 7.34 (d, J = 8.8 Hz, 2H), 7.01-6.96 (m, 3H), 6.88 (dd, J = 8.5, 2.4Hz, 1H), 3.79 (s, 3H), 3.59 (d, J = 6.3Hz, 1H), 3.02 ( d, J = 6.3Hz, 1H).
2-(2-クロロ-4-(4-クロロフェノキシフェニル)フェニル)-2-ヒドロキシ-3-(1H-1,2,4-トリアゾール-1-イル)プロパン酸メチル(化合物1)の合成
 (反応スキーム4)
Synthesis of methyl 2- (2-chloro-4- (4-chlorophenoxyphenyl) phenyl) -2-hydroxy-3- (1H-1,2,4-triazole-1-yl) methyl propanoate (Compound 1) ( Reaction scheme 4)
Figure JPOXMLDOC01-appb-C000008
Figure JPOXMLDOC01-appb-C000008
 前項で得られたメチル2-(2-クロロ-4-(4-クロロフェノキシ)フェニル)オキシラン-2-カルボキシレート51mgをジメチルアセトアミド0.75mLに溶解し、1,2,4-トリアゾール31mgを加えた。氷浴中で冷却した後、次いで炭酸カリウム21mgを加えた。60℃に加熱したオイルバス中で3時間撹拌した後、15時間室温下で放置した。再度60℃に加熱したオイルバス中で3時間撹拌した後、氷冷下で飽和塩化アンモニウム水溶液を反応溶液に加えることで反応を停止した。水層をトルエンで抽出し、これを飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥した。溶媒を留去して得られた粗成生物Gをシリカゲルカラムクロマトグラフィー(シリカゲル7g、ヘキサン/酢酸エチル:40→100%)で精製することにより、標記の化合物(化合物1)19mgを無色固体として得た。1H NMR(400MHz,CDCl)δ :8.00(s,1H),7.88(s,1H),7.40(d,J=8.8Hz,1H),7.34(d,J=8.7Hz,2H),6.99-6.95(m,3H),6.81(d,J=8.8Hz,1H),5.02(d,J=14.3Hz,1H),4.93(d,J=14.3Hz,1H),4.88(br,1H),3.80(s,3H)。 Methyl 2- (2-chloro-4- (4-chlorophenoxy) phenyl) oxylan-2-carboxylate 51 mg obtained in the previous section was dissolved in 0.75 mL of dimethylacetamide, and 31 mg of 1,2,4-triazole was added. rice field. After cooling in an ice bath, 21 mg of potassium carbonate was then added. After stirring for 3 hours in an oil bath heated to 60 ° C., the mixture was left at room temperature for 15 hours. After stirring again in an oil bath heated to 60 ° C. for 3 hours, the reaction was stopped by adding a saturated aqueous solution of ammonium chloride to the reaction solution under ice-cooling. The aqueous layer was extracted with toluene, washed with saturated brine and dried over anhydrous sodium sulfate. By purifying the crude product G obtained by distilling off the solvent by silica gel column chromatography (silica gel 7 g, hexane / ethyl acetate: 40 → 100%), 19 mg of the title compound (Compound 1) was made into a colorless solid. Obtained. 1 1 H NMR (400 MHz, CDCl 3 ) δ: 8.00 (s, 1H), 7.88 (s, 1H), 7.40 (d, J = 8.8 Hz, 1H), 7.34 (d, J = 8.7Hz, 2H), 6.99-6.95 (m, 3H), 6.81 (d, J = 8.8Hz, 1H), 5.02 (d, J = 14.3Hz, 1H) ), 4.93 (d, J = 14.3Hz, 1H), 4.88 (br, 1H), 3.80 (s, 3H).
 前項で得られた化合物1の比旋光度の測定を、P-1020(日本分光社製、Naランプ:589nm)を用いて行った。具体的な測定結果は以下の通りである。 The specific rotation of compound 1 obtained in the previous section was measured using P-1020 (Na lamp: 589 nm, manufactured by JASCO Corporation). The specific measurement results are as follows.
 [α]20  = -102.0°(1mLのクロロホルム当たり8.9mg)
 製造例2で調製した化合物1をメタノールに溶解し、アミローストリス(3-クロロ-5-メチルフェニルカルバメート)がシリカゲル担体に固定化された分取カラムをつないだ高速液体クロマトグラフィー(HPLC)に供し、得られた化合物1に含まれる各エナンチオマー体の存在比を測定した。
[Α] 20 D = −102.0 ° (8.9 mg per 1 mL of chloroform)
Compound 1 prepared in Production Example 2 was dissolved in methanol and subjected to high performance liquid chromatography (HPLC) in which a preparative column in which amylostris (3-chloro-5-methylphenylcarbamate) was immobilized on a silica gel carrier was connected. , The abundance ratio of each enantiomer contained in the obtained compound 1 was measured.
 具体的な条件は以下の通りである。
高速液体クロマトグラフ:分取カラム:製品名「CHIRALPAK IG」、ダイセル化学工業社製、内径4.6mm、長さ150mm、粒子径5μm
サンプル濃度:1.0mg/mL
移動相:100%メタノール
流速:1.0mL/min
カラム温度:40℃
検出波長:230nm
The specific conditions are as follows.
High Performance Liquid Chromatograph: Preparative Column: Product Name "CHIRALPAK IG", manufactured by Daicel Chemical Industries, Ltd., Inner diameter 4.6 mm, Length 150 mm, Particle size 5 μm
Sample concentration: 1.0 mg / mL
Mobile phase: 100% methanol flow rate: 1.0 mL / min
Column temperature: 40 ° C
Detection wavelength: 230nm
 上記条件下で分離したところ、溶出時間が異なる2つのピークが検出された。そのピークのエリア値から算出される各エナンチオマー体の存在比は、(-)-エナンチオマー:(+)-エナンチオマー=95:5であった。 When separated under the above conditions, two peaks with different elution times were detected. The abundance ratio of each enantiomer calculated from the area value of the peak was (-)-enantiomer: (+)-enantiomer = 95: 5.
 <製剤例1:水和剤>
 調製した本特許記載の任意のトリアゾール誘導体(-)-エナンチオマーを用いて以下のように水和物を調製した。
トリアゾール誘導体(-)-エナンチオマー   20.0部
ラウリル硫酸ナトリウム   2部
アルキルナフタレンスルホン酸ホルマリン縮合物のナトリウム塩   5部
ステアリン酸亜鉛   0.2部
ホワイトカーボン   3部
クレー   69.8部
を混合・粉砕して水和剤とし、水で希釈して使用した。
<Formation example 1: wettable powder>
A hydrate was prepared as follows using any of the prepared triazole derivatives (-)-enantiomers described in this patent.
Triazole derivative (-)-enantiomer 20.0 parts Sodium lauryl sulfate 2 parts Sodium salt of alkylnaphthalene sulfonic acid formalin condensate 5 parts Zinc stearate 0.2 parts White carbon 3 parts Clay 69.8 parts are mixed and pulverized. It was used as a wettable powder, diluted with water.
 <製剤例2:乳剤>
 調製した本特許記載の任意のトリアゾール誘導体(-)-エナンチオマーを用いて以下のように乳剤を調製した。
トリアゾール誘導体(-)-エナンチオマー   5.0部
ポリオキシアルキレンアルキルエーテル・アルキルベンゼンスルホン酸金属塩・アルキルベンゼン混合物   3.75部
ポリオキシアルキレンアルキルエーテル   11.25部
5-(ジメチルアミノ)-2-メチル-5-オキソペンタン酸メチル   12.0部
N,N‐ジメチルオクタンアミド・N,N‐ジメチルデカンアミド   44.0部
ソルベントナフサ   24.0部
を均一に混合溶解して乳剤とし、水で希釈して使用した。
<Pharmaceutical example 2: Emulsion>
An emulsion was prepared as follows using any of the prepared triazole derivatives (-)-enantiomers described in this patent.
Triazole derivative (-)-enantiomer 5.0 parts polyoxyalkylene alkyl ether / alkylbenzene sulfonic acid metal salt / alkylbenzene mixture 3.75 parts polyoxyalkylene alkyl ether 11.25 parts 5- (dimethylamino) -2-methyl-5 -Methyl oxopentanoate 12.0 parts N, N-dimethyloctaneamide / N, N-dimethyldecaneamide 44.0 parts Solventnaphtha 24.0 parts are uniformly mixed and dissolved to form an emulsion, which is diluted with water before use. bottom.
 <試験例1:植物病原菌に対する抗菌性試験>
 製造例1で調製した化合物1(-)の各種植物病原菌に対する抗菌性を、シャーレ試験により試験した。対照化合物として化合物1(ラセミ)を用いた。オートクレーブ滅菌後、60℃前後まで冷却したPDA培地(ポテト-デキストロース-アガー培地)に2.5mg/Lの薬剤濃度となるように、ジメチルスルホキシド(DMSO)に溶解した化合物1(-)または化合物1(ラセミ)をPDA培地に1%v/v添加した。PDA培地中の薬剤濃度が均一になるように混合し、シャーレに培地を流し込み、化合物1(-)または化合物1(ラセミ)を含む平板培地を作製した。
<Test Example 1: Antibacterial test against phytopathogens>
The antibacterial property of compound 1 (-) prepared in Production Example 1 against various plant pathogens was tested by a Petri dish test. Compound 1 (racemic) was used as a control compound. After sterilization by autoclave, compound 1 (-) or compound 1 dissolved in dimethyl sulfoxide (DMSO) so as to have a drug concentration of 2.5 mg / L in PDA medium (potato-dextrose-agar medium) cooled to around 60 ° C. (Potato) was added to PDA medium at 1% v / v. The mixture was mixed so that the drug concentration in the PDA medium was uniform, and the medium was poured into a petri dish to prepare a plate medium containing compound 1 (−) or compound 1 (racemic).
 一方、あらかじめPDA培地上で培養した表1に示す各種植物病原菌の菌叢を、直径4mmのコルクボーラーで打ち抜き、上記の薬剤含有平板培地に植菌した。所定の期間、温度で培養後、薬剤処理平板培地に菌叢直径を測定した。薬剤を含まない無処理平板上の菌叢直径と比較して、下記式により菌糸伸長抑制率(%)を算出した。菌糸伸長抑制率が大きいほど、抗菌性に優れていることを示す。 On the other hand, the flora of various phytopathogens shown in Table 1 previously cultured on the PDA medium was punched out with a cork borer having a diameter of 4 mm and inoculated into the above-mentioned drug-containing plate medium. After culturing at a temperature for a predetermined period, the bacterial flora diameter was measured on a drug-treated plate medium. The hyphal elongation inhibition rate (%) was calculated by the following formula in comparison with the diameter of the flora on the untreated plate containing no drug. The greater the rate of hyphal elongation inhibition, the better the antibacterial property.
 菌糸伸長抑制率(%)=(1-薬剤処理平板上の菌叢直径/無処理平板上の菌叢直径)×100
菌糸伸長抑制率R(%)について、結果を表1に示す。
Hyphal elongation inhibition rate (%) = (1-Diameter of flora on drug-treated plate / Diameter of flora on untreated plate) x 100
The results of the hyphal elongation inhibition rate R (%) are shown in Table 1.
Figure JPOXMLDOC01-appb-T000009
Figure JPOXMLDOC01-appb-T000009
 <試験例2:コムギ赤さび病防除効果試験>
 製造例1で調製した化合物1(-)または化合物1(ラセミ)を所定の薬剤濃度となるようにアセトンに溶解し、グラミンSを含むイオン交換水に5%v/v添加した(グラミンSの終濃度60ppm)。調製した薬剤を、角型プラスチックポット(6cm×6cm)で栽培した第1~2葉期のコムギ(品種:農林61号)に1000L/haの割合で散布した(薬剤処理区)。なお、化合物を含まないアセトン5%含有のイオン交換水(グラミンSの終濃度60ppm)をコムギに散布したものを無処理区とした。散布後、コムギ葉上の散布液を風乾させ、コムギ赤さび病菌の胞子液(1×106個/mlに調製、終濃度60ppmのグラミンSを含む)を噴霧接種し、20℃高湿度条件下で24時間保った。その後は温室内で管理した。接種後10日目にコムギ赤さび病の発病面積を調査し、防除価を下記式より算出した。
防除価(%)=(1-薬剤処理区の平均発病面積/無処理区の平均発病面積)×100
<Test Example 2: Wheat red rust control effect test>
Compound 1 (-) or compound 1 (racemic) prepared in Production Example 1 was dissolved in acetone so as to have a predetermined drug concentration, and 5% v / v was added to ion-exchanged water containing Gramin S (of Gramin S). Final concentration 60 ppm). The prepared drug was sprayed at a rate of 1000 L / ha on wheat (variety: Norin 61) in the first and second leaf stages cultivated in a square plastic pot (6 cm × 6 cm) (drug treatment group). The untreated plot was obtained by spraying wheat with ion-exchanged water containing 5% acetone (final concentration of Gramin S 60 ppm) containing no compound. After spraying, the spray solution on the wheat leaves is air-dried, and the spore solution of wheat red rust fungus ( prepared to 1 × 10 6 cells / ml, containing Gramin S having a final concentration of 60 ppm) is spray-inoculated, and under high humidity conditions at 20 ° C. I kept it for 24 hours. After that, it was managed in the greenhouse. On the 10th day after inoculation, the affected area of wheat red rust was investigated, and the control value was calculated from the following formula.
Control value (%) = (1-Average diseased area in drug-treated area / Average diseased area in untreated area) x 100
 試験例2において、0.5g/haの濃度では化合物1(ラセミ)の防除価は67%であったの対し、化合物1(-)の防除価は90%であった。 In Test Example 2, the control value of compound 1 (racemic) was 67% at a concentration of 0.5 g / ha, whereas the control value of compound 1 (-) was 90%.
 <試験例3:コムギうどんこ病防除効果試験>
 製造例1で調製した化合物1(-)または化合物1(ラセミ)を所定の薬剤濃度となるようにアセトンに溶解し、グラミンSを含むイオン交換水に5%v/v添加した(グラミンSの終濃度60ppm)。調製した薬剤を、角型プラスチックポット(6cm×6cm)で栽培した第1~2葉期のコムギ(品種:農林61号)に1000L/haの割合で散布した(薬剤処理区)。なお、化合物を含まないアセトン5%含有のイオン交換水(グラミンSの終濃度60ppm)をコムギに散布したものを無処理区とした。散布後、コムギ葉上の散布液を風乾させ、コムギうどんこ病菌の胞子を振りかけ接種し、温室内で管理した。接種後10日目にコムギうどんこ病の発病面積を調査し、防除価(%)を算出した。
<Test Example 3: Wheat powdery mildew control effect test>
Compound 1 (-) or compound 1 (racemic) prepared in Production Example 1 was dissolved in acetone so as to have a predetermined drug concentration, and 5% v / v was added to ion-exchanged water containing Gramin S (of Gramin S). Final concentration 60 ppm). The prepared drug was sprayed at a rate of 1000 L / ha on wheat (variety: Norin 61) in the first and second leaf stages cultivated in a square plastic pot (6 cm × 6 cm) (drug treatment group). The untreated plot was obtained by spraying wheat with ion-exchanged water containing 5% acetone (final concentration of Gramin S 60 ppm) containing no compound. After spraying, the spray liquid on the wheat leaves was air-dried, sprinkled with spores of wheat powdery mildew, and inoculated, and managed in a greenhouse. On the 10th day after inoculation, the affected area of wheat powdery mildew was investigated, and the control value (%) was calculated.
 試験例において、7.5g/haの濃度では化合物1(ラセミ)の防除価は38%であったの対し、化合物1(-)の防除価は56%であった。 In the test example, the control value of compound 1 (racemic) was 38% at a concentration of 7.5 g / ha, whereas the control value of compound 1 (-) was 56%.
 本発明に係るトリアゾール誘導体の(-)-エナンチオマーは、農園芸用の殺菌剤および工業用材料保護剤の有効成分として好適に利用することができる。 The (-)-enantiomer of the triazole derivative according to the present invention can be suitably used as an active ingredient of a fungicide for agriculture and horticulture and a protective agent for industrial materials.

Claims (4)

  1.  下記一般式(I)で表される、トリアゾール誘導体の(-)-エナンチオマー、またはその農薬学的に許容可能な塩。
    Figure JPOXMLDOC01-appb-C000001
     [式(I)中、
     Rは、-ORまたは-NRであり;
     R、RおよびRは、それぞれ独立に、水素、C-C-アルキル基、C-C-アルケニル基、C-C-アルキニル基、C-C-シクロアルキル基、C-C-シクロアルキル-C-C-アルキル基、フェニル基、フェニル-C-C-アルキル基、フェニル-C-C-アルケニル基またはフェニル-C-C-アルキニル基であり、RとRとは環を形成していてもよく;
     ここで、R、R、およびRにおける脂肪族基は、1、2、3もしくは可能な最大数の同一のまたは異なる基Rを有していてもよく、Rは、ハロゲン基、シアノ基、ニトロ基、C-C-アルコキシ基およびC-C-ハロアルコキシ基から互いに独立して選択され;
     Rはハロゲン基、シアノ基、ニトロ基、フェニル基、フェニル-オキシ基、C-C-アルキル基、C-C-ハロアルキル基、C-C-アルコキシ基、C-C-ハロアルコキシ基、-SORまたは-SFであり;
     Rは、ハロゲン基、シアノ基、ニトロ基、アミノ基、フェニル基、フェニル-オキシ基、C-C-アルキル基、C-C-ハロアルキル基、C-C-アルコキシ基またはC-C-ハロアルコキシ基、C-C-アルキルアミノ基、C-C-ジアルキルアミノ基、C-C-アルキルアシルアミノ基、-SORまたは-SFであり;
     R、R、およびRにおけるシクロアルキル基およびフェニル基部分ならびにRにおけるフェニル基部分は、1、2、3、4、5もしくは可能な最大数の同一のまたは異なる基Rを有していてもよく、Rは、ハロゲン基、シアノ基、ニトロ基、C-C-アルキル基、C-C-アルコキシ基、C-C-ハロアルキル基およびC-C-ハロアルコキシ基から互いに独立して選択され;
     ここで、Rは、C-C-アルキル基またはC-C-ハロアルキル基であり;
     nは0,1,2,3,または4であり;
     mは1,2,3,4または5であり、
     アスタリスク(*)は不斉炭素原子を指す。]
    A (-)-enantiomer of a triazole derivative represented by the following general formula (I), or a pesticide-acceptable salt thereof.
    Figure JPOXMLDOC01-appb-C000001
    [In formula (I),
    R 1 is -OR 4 or -NR 5 R 6 ;
    R 4 , R 5 and R 6 are independently hydrogen, C 1- C 6 -alkyl group, C 2- C 6 -alkenyl group, C 2- C 6 -alkynyl group, C 3- C 8 -cyclo. Alkyne group, C 3- C 8 -cycloalkyl-C 1- C 4 -alkyl group, phenyl group, phenyl-C 1- C 4 -alkyl group, phenyl-C 2- C 4 -alkenyl group or phenyl-C 2 -C 4- It is an alkynyl group, and R 5 and R 6 may form a ring;
    Here, the aliphatic groups in R 4 , R 5 and R 6 may have 1, 2, 3 or the maximum possible number of the same or different groups R a , where R a is a halogen group. , cyano group, nitro group, C 1 -C 4 - alkoxy and C 1 -C 4 - is selected from haloalkoxy groups independently of each other;
    R 2 is a halogen group, a cyano group, a nitro group, a phenyl group, a phenyl-oxy group, a C 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group, a C 1- C 4 -alkoxy group, and a C 1-. C 4 -haloalkoxy group, -SOR 7 or -SF 5 ;
    R 3 is a halogen group, a cyano group, a nitro group, an amino group, a phenyl group, a phenyl-oxy group, a C 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group, and a C 1- C 4 -alkoxy group. or C 1 -C 4 - haloalkoxy group, C 1 -C 4 - alkylamino group, C 1 -C 4 - dialkylamino group, C 1 -C 4 - alkyl acyl amino group, in -SOR 7 or -SF 5 can be;
    The cycloalkyl and phenyl group moieties in R 4 , R 5 , and R 6 and the phenyl group moieties in R 3 have 1, 2, 3, 4, 5 or the maximum number of possible identical or different groups R b . may also be, R b is halogen, cyano, nitro, C 1 -C 4 - alkyl group, C 1 -C 4 - alkoxy group, C 1 -C 4 - haloalkyl and C 1 -C 4- Selected independently of each other from the haloalkoxy group;
    Wherein, R 7 is, C 1 -C 4 - alkyl group or a C 1 -C 4 - haloalkyl group;
    n is 0,1,2,3, or 4;
    m is 1,2,3,4 or 5,
    An asterisk (*) refers to an asymmetric carbon atom. ]
  2.  上記一般式(I)において、
     Rが、-ORであり;
     Rが、ハロゲン基、シアノ基、C-C-アルキル基、C-C-ハロアルキル基、C-C-アルコキシ基、-SORまたは-SFであり;
     Rが、ハロゲン基、ニトロ基、シアノ基、アミノ基、C-C-アルキル基、C-C-ハロアルキル基、C-C-アルコキシ基、C-C-ハロアルコキシ基、C-C-アルキルアミノ基、C-C-ジアルキルアミノ基、C-C-アルキルアシルアミノ基、-SORまたは-SFである、請求項1に記載のトリアゾール誘導体の(-)-エナンチオマーまたはその塩。
    In the above general formula (I)
    R 1 is -OR 4 ;
    R 2 is a halogen group, a cyano group, a C 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group, a C 1- C 4 -alkoxy group, -SOR 7 or -SF 5 ;
    R 3 is a halogen group, a nitro group, a cyano group, an amino group, a C 1- C 4 -alkyl group, a C 1- C 4 -haloalkyl group, a C 1- C 4 -alkoxy group, and a C 1- C 4 -halo. alkoxy groups, C 1 -C 4 - alkylamino group, C 1 -C 4 - dialkylamino group, C 1 -C 4 - alkyl acyl amino group, an -SOR 7, or -SF 5, according to claim 1 (-)-Enantiomer of a triazole derivative or a salt thereof.
  3.  上記一般式(I)において、
     Rが、C-C-アルキル基であり;
     Rが、ハロゲン基、シアノ基、C-C-アルキル基、C-C-ハロアルキル基またはC-C-アルコキシ基であり;
     Rが、ハロゲン基、シアノ基、C-C-アルキル基、C-C-ハロアルキル基、C-C-アルコキシ基またはC-C-ハロアルコキシ基である、請求項2に記載のトリアゾール誘導体の(-)-エナンチオマーまたはその塩。
    In the above general formula (I)
    R 4 is, C 1 -C 6 - an alkyl group;
    R 2 is halogen, cyano, C 1 -C 4 - alkyl group, C 1 -C 4 - haloalkyl group or a C 1 -C 4 - alkoxy group;
    R 3 is halogen, cyano, C 1 -C 4 - alkyl group, C 1 -C 4 - haloalkyl group, C 1 -C 4 - alkoxy group or a C 1 -C 4 - haloalkoxy group, wherein Item 2. The (-)-enantiomer of the triazole derivative according to Item 2 or a salt thereof.
  4.  請求項1から3のいずれか1項に記載のトリアゾール誘導体の(-)-エナンチオマーを有効成分として含有する、農園芸用薬剤または工業用材料保護剤。 An agricultural or horticultural agent or an industrial material protective agent containing (-)-enantiomer of the triazole derivative according to any one of claims 1 to 3 as an active ingredient.
PCT/JP2021/018610 2020-05-15 2021-05-17 (-)-enantiomer of triazole derivative, agricultural or horticultural chemical, and industrial material protectant WO2021230382A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020086053 2020-05-15
JP2020-086053 2020-05-15

Publications (1)

Publication Number Publication Date
WO2021230382A1 true WO2021230382A1 (en) 2021-11-18

Family

ID=78525195

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2021/018610 WO2021230382A1 (en) 2020-05-15 2021-05-17 (-)-enantiomer of triazole derivative, agricultural or horticultural chemical, and industrial material protectant

Country Status (1)

Country Link
WO (1) WO2021230382A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023209045A1 (en) 2022-04-26 2023-11-02 Syngenta Crop Protection Ag Enantiomerically enriched fungicides for the control of resistant phytopathogenic fungi
WO2024014282A1 (en) * 2022-07-14 2024-01-18 株式会社クレハ Method for producing triazole derivative enantiomer (r)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019093522A1 (en) * 2017-11-13 2019-05-16 株式会社クレハ Azole derivative, intermediate compound, method for producing azole derivative, agent for agricultural and horticultural use, and material protection agent for industrial use
WO2020213739A1 (en) * 2019-04-19 2020-10-22 株式会社クレハ Bactericidal agent for agricultural or horticultural use, plant disease control method, and product for plant disease control use
JP2020186178A (en) * 2019-05-10 2020-11-19 株式会社クレハ Agent for agricultural and horticultural use, plant disease control method, and plant disease control product

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019093522A1 (en) * 2017-11-13 2019-05-16 株式会社クレハ Azole derivative, intermediate compound, method for producing azole derivative, agent for agricultural and horticultural use, and material protection agent for industrial use
WO2020213739A1 (en) * 2019-04-19 2020-10-22 株式会社クレハ Bactericidal agent for agricultural or horticultural use, plant disease control method, and product for plant disease control use
JP2020186178A (en) * 2019-05-10 2020-11-19 株式会社クレハ Agent for agricultural and horticultural use, plant disease control method, and plant disease control product

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Optical isomer separation", KIKAN KAGAKU SOSETSU NO. 6, 1989, pages 2 - 5, 9- 11 *
NOHIRA, HIROYUKI: "Optically Active Substances: Its organic industrial chemistry", ASAKURA PUBLISHING CO LTD., 1989, pages 20 - 21 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023209045A1 (en) 2022-04-26 2023-11-02 Syngenta Crop Protection Ag Enantiomerically enriched fungicides for the control of resistant phytopathogenic fungi
WO2024014282A1 (en) * 2022-07-14 2024-01-18 株式会社クレハ Method for producing triazole derivative enantiomer (r)

Similar Documents

Publication Publication Date Title
KR102148124B1 (en) Azole derivatives, intermediate compounds, and methods for preparing azole derivatives, as well as agricultural and horticultural drugs and protective agents for industrial materials
JP6942284B2 (en) Agricultural and horticultural fungicides, plant disease control methods and plant disease control products
WO2021230382A1 (en) (-)-enantiomer of triazole derivative, agricultural or horticultural chemical, and industrial material protectant
JP7150213B2 (en) Azole derivative, method for producing azole derivative, and agricultural and horticultural agent
TW202112771A (en) Thienylhydroxyisoxazolines and derivatives thereof
JP2019031463A (en) Azole derivative and utilization thereof as agricultural and horticultural agent
JP2021080280A (en) Agricultural and horticultural disease control agent and plant disease control method
JP2022532529A (en) Active compound combination
WO2023033180A1 (en) R-enantiomer of azole derivative, agricultural or horticultural chemical agent, and industrial material protective agent
JP2022512712A (en) Heteroarylaminoquinolines and analogs
JP2020186178A (en) Agent for agricultural and horticultural use, plant disease control method, and plant disease control product
CN110582484A (en) Trisubstituted silylmethylphenoxyquinolines and analogs thereof
JP2021014437A (en) Azole derivatives, and agricultural and horticultural chemicals and industrial material protecting agents
JPWO2018069842A5 (en)
JP2020180055A (en) Azole derivatives, and agricultural and horticultural chemicals and industrial material protecting agents
EA041705B1 (en) AGRICULTURAL OR HORTICULTURAL FUNGICIDE, PLANT DISEASE CONTROL METHOD AND PLANT DISEASE CONTROL PRODUCT
JP2020176097A (en) Azole derivative, agricultural and horticultural chemical and industrial material protective agent
BR112020002160B1 (en) AZOLE DERIVATIVE, INTERMEDIATE COMPOUND, METHOD FOR PRODUCTION OF AZOLE DERIVATIVE, AGRICULTURAL OR HORTICULTURAL CHEMICAL AGENT AND PROTECTIVE AGENT FOR INDUSTRIAL MATERIAL, METHOD FOR CONTROLLING A DISEASE IN A PLANT, COATED SEED AND USE OF THE COMPOUND
NZ762344B2 (en) Azole derivative, intermediate compound, method for producing azole derivative, agricultural or horticultural chemical agent, and protective agent for industrial material
JP2021031418A (en) N-substituted glycine carboxamide derivative or its salt and fungicide using the same as active ingredient
JP2022512719A (en) Pyridylphenylaminoquinolines and analogs

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21804018

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21804018

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP